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The Integrator complex (INT) is the latest and largest multi-subunit protein complex to be 
added to the list of factors involved in RNA Polymerase II (Pol II) transcription. INT consist of 
15 subunits with an estimated molecular weight of 1.5 MDa. It is recruited to Pol II during 
initiation or early elongation of transcription. It plays important roles in transcription regulation 
during early elongation including premature termination of some messenger RNAs (mRNAs). 
It has also been shown to terminate small nuclear RNAs (snRNAs), enhancer RNAs and some 
viral RNAs. Despite the important roles of INT in transcription, there is currently no protocol 
to reconstitute INT for in vitro biochemical and structural studies. Here, I used the baculovirus 
and insect cell recombinant protein expression system to reconstitute INT. Most subunits of 
INT express poorly and form oligomers when purified independently and it was not possible to 
co-express all 15 subunits. I therefore divided INT into 4 subcomplexes based on identified 
inter-subunit interactions. Namely, a 7-subunits core-INT, a 3-subunit cleavage module (CM), 
a 3-subunit cleavage module interacting module (CMIM) and INTS1/12 heterodimer. 
Subsequently I established purification protocols for all these subcomplexes or their stable 
interacting domains as in the case of INTS1/12 heterodimer. Negative stain EM reveals that the 
core-INT (INTS2/3/5/6/7/8-DDX26B) is monomeric showing that the oligomerization of the 
constituent subunits is circumvented in the core-INT. Further cryo-EM reconstruction of core-
INT reveals a low-resolution doughnut shape for this subcomplex. The CM (INTS4/9/11) has 
a trilobal shape as revealed by a cryo-EM reconstruction at ~20 Å.  
For the first time, I reconstituted the full INT in vitro from the purified subcomplexes by 
amylose affinity pulldown. The interactions between the subcomplexes were assessed by 
crosslinking mass spectrometry (XL-MS). XL-MS reveals many crosslinks between core-INT, 
CMIM, and INTS1/12 heterodimer while the CM has very few crosslinks to the other 
subcomplexes. This result suggests that the CM may be a loosely associated module of INT.  
Furthermore, I showed for the first time the in vitro binding of INT to the paused elongation 
complex (PEC) of Pol II, DSIF (DRB sensitivity-inducing factor) and NELF (negative 
elongation factor). I characterized inter complex protein-protein interactions between INT and 
PEC by XL-MS. It emerges that INT interacts mostly with NELF and Pol II but not DSIF 
according to the crosslinks observed. The INTS1, INTS6, and INTS12 subunits of INT appear 
to be involved in most of these interactions with PEC. This work has created the foundation for 
biochemical and structural characterization of INT as a complex and INT in the context of Pol 




1.1 General overview of transcription and RNA polymerases 
Information pertaining to the phenotype of all organisms is stored in their deoxyribonucleic 
acid (DNA) macromolecule(s). The flow of this information from DNA to proteins via a 
ribonucleic acid (RNA) intermediate is simplified in the so-called central dogma of molecular 
biology coined by Francis Crick (Crick, 1970). The process of copying the information stored 
in DNA to RNA is called transcription and it is done by DNA-dependent RNA polymerases.  
The simplest RNA polymerase is a single subunit enzyme encoded by some viruses and phages 
(Jeruzalmi & Steitz, 1998). 
In prokaryotes, a single RNA polymerase (RNAP: used here for prokaryotic RNA polymerase 
only) composed of four polypeptides transcribes all genes (Hurwitz, 2005; Hurwitz et al., 1960; 
Stevens, 1960). In contrast to prokaryotes, eukaryotes employ three main RNA polymerases 
(Pols: for eukaryotic RNA polymerases) to transcribe their nuclear genomes namely Pol I, Pol 
II and Pol III (Roeder & Rutter, 1969). Plants have additional nuclear Pols, Pol IV and Pol V 
(Zhou & Law, 2015). Pol I has 14 subunits, Pol II has 12 subunits and Pol III has 17 subunits. 
The Pols share several subunits and some subunits are close homologues. (Cramer et al., 2000; 
Engel et al., 2013; Jasiak et al., 2006; Kuhn et al., 2007; Vannini & Cramer, 2012).  
All the multi-subunit DNA-dependent RNA polymerases require additional factors for 
promoter DNA recognition and transcription initiation (Burgess et al., 1969; Sainsbury et al., 
2015; Vannini & Cramer, 2012) (Table 1.1). The core structure of the three Pols is highly 
conserved from yeast to human but the Pols differ substantially in the transcription factors they 
require for RNA synthesis (Goodfellow & Zomerdijk, 2013) (Figure 1.1). The eukaryotic 
polymerases also share important structural features with the bacterial 4-subunit counterpart 
suggesting a conserved mechanism of catalysis (Allison et al., 1985; Cramer et al., 2001). The 
subunit composition of the three eukaryotic Pols in yeast is summarized in Table 1.1. 
Soon after their discovery, it became clear that the three Pols have dedicated class of genes they 
transcribe. Pol I transcribes the precursor for the large ribosomal RNAs, Pol II transcribes all 
protein coding genes and some non-coding RNAs and Pol III produces transfer RNAs and 5S 





Table 1.1. Homology between the subunits of three Pols in yeast.  Auxiliary factors 
important for transcription initiation by each Pol are also indicated. Table is modified from 
Vannini and Cramer, 2012.   
Pol I Pol II Pol II Function 
Polymerase core    
A190 Rpb1 C160 Active center 
AC135 Rpb2 C128 Active center 
AC40 Rpb3 AC40  
Rpb5 Rpb5 Rpb5  
Rpb6 Rpb6 Rpb6  
Rpb8 Rpb8 Rpb8  
A12.2 N ribbon Rpb9 C 11 N ribbon RNA cleavage 
Rpb10 Rpb10 Rpb10  
AC19 Rpb11 AC19  
Rpb12 Rpb12 Rpb12  
Polymerase stalk    
A14 Rpb4 C17 Initiation complex 
formation 
A43 Rpb7 C25 Initiation complex 
formation 
Transcription initiation factors in Pol II and their homologues in Pol I and III 
A49 and A34.5 TFIIF C37 and C53 Initiation complex 
formation 
A49 TFIIE C31,34, 82 Open complex 
stabilization 
TBP TBP TBP Promoter 
recognition 
 TAFs  Promoter 
recognition 








Figure 1.1. Structures of pre-initiation complexes of the three eukaryotic Pols. The conserved core of the Pols 
is depicted in grey. The transcription initiation factors decorating the Pols are indicated. The Pol II PIC has the 
coactivator complex, Mediator and the TFIIH complex which brings additional enzymatic activities and play 
regulatory functions. The figure was adapted from (Cramer, 2019). 
 
1.2 Pol II transcription cycle 
Pol II transcribes all protein-coding genes and a class of non-coding RNAs (ncRNA) in 
eukaryotic organisms (R. Weinmann et al., 1974). The ncRNAs include small nucleolar RNAs 
(snoRNA) that are important for ribosomal RNA (rRNA) modification and small nuclear RNAs 
(snRNAs) that are used in spliceosome assembly. Regulation of Pol II transcription is central 
to many cellular and biological processes including cell differentiation, organismal 
development and growth (Cramer, 2019; Sainsbury et al., 2015). Gene Transcription by Pol II 
is divided into three main phases: initiation, elongation, termination and recycling of Pol II 
(Hantsche & Cramer, 2016) (Figure 1.2). Each of these steps involve many auxiliary factors 





Figure 1.2. The Pol II transcription cycle. Pol II is shown in grey, initiation factors in yellow, 
elongation factors in green and termination factors in red. TSS stands for transcription start site. Figure 
is modified from Hantsche and Cramer, 2016. 
 
 
1.2.1 Transcription initiation by Pol II 
The DNA template at core promoters must be cleared of nucleosomes for Pol II to initiate 
transcription (Fuda et al., 2009; Lorch et al., 1987). This nucleosome barrier to transcription is 
removed by chromatin remodelers which create nucleosome-free DNA template at promoter 
regions (Lorch & Kornberg, 2017). Even in the absence of the nucleosome barrier, Pol II (like 
the other RNA polymerases) cannot initiate RNA synthesis by itself. This stimulated the hunt 
for Pol II initiation factors leading to the discovery of general transcription factors (GTFs) 
(Conaway & Conaway, 2019). In the classical view, Pol II assembles with the GTFs at 
nucleosome-free promoters in a sequential manner (Buratowski et al., 1989). This pioneering 
biochemical work paved way for detailed structural analysis of Pol II transcription initiation 
intermediates (Sainsbury et al., 2015). The TATA box binding protein (TBP) binds the minor 
groove of DNA at the promoter region and induces a 90 degrees bend (J. L. Kim et al., 1993). 
The mechanism of DNA binding by TBP confers no sequence specificity explaining how it is 
used by all three Pols in transcription initiation. The TBP-DNA complex is bound by the Pol II 
transcription factor IIA and IIB (TFIIA and TFIIB) and the Pol II-specific TBP-associated 
factors (TAFs). These factors stabilize the TBP-DNA complex by making contacts with both 
TBP and the promoter elements in the DNA and bestow specificity (Andel et al., 1999). TFIIB 
then recruits Pol II-TFIIF complex to form the core pre-initiation complex (cPIC). TFIIF is 
tightly associated with Pol II, is critical for promoter selectivity and stimulates RNA synthesis 
once the promoter DNA is opened (reviewed in Sainsbury et al., 2015). The 3D architecture of 
the core pre-initiation complex of TBP, TFIIA, TFIIB, Pol II and TFIIF is conserved between 
yeast and human (He et al., 2013; Mühlbacher et al., 2014; Sainsbury et al., 2015) and Figure 
1.3. The transcription factor IIE (TFIIE) is recruited to the cPIC which in turn recruits the 
transcription factor IIH (TFIIH). The formation of an open initiation complex (OC) can happen 
spontaneously in some promoters (Dienemann et al., 2019) or requires ATPase activity of 
TFIIH (Schilbach et al., 2017) depending on physical properties of the DNA sequence such as 
meltability. The requirement of ATP for promoter melting is a major difference between Pol II 





Figure 1.3. Structures of yeast and human core pre-initiation complexes. Shows the conservation of the 
architecture of the cPIC between these species. The factors are colored identically in each structure. Image was 
taken from Sainsbury et al., 2015. 
 
The transcription co-activator complex Mediator, also regulates transcription initiation by Pol 
II (Kornberg, 2005). Mediator binds activating transcription factors bound to upstream 
enhancer elements of the promoter and at the same time interacts with TFIIB and TFIIH 
components of the Pol II initiation complex. This way it integrates upstream activation signals 
and transcription initiation to activate gene expression (Cramer, 2019). The Mediator complex 
and TFIIH have dissociable kinase modules, which phosphorylate the C-terminal domain 
(CTD) of the Pol II largest subunit, RPB1. The CTD of Pol II RPB1 is a conserved feature 
unique to Pol II. It consists of 26 (in yeast) and 52 (in human) repeats of the consensus sequence 
Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7 (YSPTSPS). Residues of this repeat are subjected to 
reversible modifications such as phosphorylation (Tyr, Thr and Ser) and isomerization (Pro) 
throughout the transcription cycle. Phosphorylations are known to facilitate recruitment of 
factors to Pol II after initiation for regulation, co-transcriptional processing of the nascent RNA 
and termination (Dahmus, 1996; Eick & Geyer, 2013; Kwak & Lis, 2013; Shah et al., 2018; 
Zaborowska et al., 2016).  
1.2.2 Pol II transcription elongation 
The recruitment of TFIIE and TFIIH to the cPIC leads to promoter DNA melting and synthesis 
of RNA by Pol II (Sainsbury et al., 2015). TFIIH helicase XPB is furthermore required for 
promoter escape (Goodrich & Tjian, 1994; Moreland et al., 1999). After promoter escape, 
transcription is said to be in early elongation after the synthesis of about 12 nt long nascent 
RNA. The growing chain of newly synthesized RNA clashes with TFIIB leading to its 
displacement from the initiation complex (Sainsbury et al., 2013). The rate of elongation 
Introduction 
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observed in primer extension assays using purified Pol II is several folds lower than the in vivo 
synthesis rate of 100s of bases/min to an average of 2,300 bases/min (Conaway & Conaway, 
2019; Gressel et al., 2017; Thummel et al., 1990). This suggests that, like the initiation phase, 
Pol II elongation requires additional factors to stimulate RNA synthesis. The requirement of 
transcription elongation and RNA processing factors as well as co-transcriptional processing of 
RNA makes the elongation phase of Pol II transcription an attractive regulatory step of gene 
expression (Kwak & Lis, 2013; Perales & Bentley, 2009). Several factors have been discovered 
that play a role in stimulating or repressing Pol II transcription. Transcription factor IIS (TFIIS) 
was the first Pol II elongation stimulating factor to be discovered (Sekimizu et al., 1976). TFIIS, 
like the GreA and GreB factors in the bacterial transcription system (Borukhov et al., 2005), 
stimulates endoribonuclease activity of Pol II when it is arrested and backtracked during 
transcription (Cheung & Cramer, 2011; Ehara et al., 2017; Izban & Luse, 1992; Reines et al., 
1992). TFIIS-like subunits A12.2 and C11 in the Pol I and Pol III systems respectively stimulate 
RNA cleavage in these Pols (Kuhn et al., 2007; Riva et al., 1998; Vannini & Cramer, 2012). 
Selective inhibition of transcription elongation by the purine nucleoside analog 5,6-dichloro-l-
3-ribofuranosylbenzimidazole (DRB) (Chodosh et al., 1989) led to the discovery of the DRB 
sensitivity inducing factor (DSIF) (Wada et al., 1998). DSIF is a heterodimer of SPT4 and SPT5 
and conserved from yeast to human (Swanson & Winston, 1992; Wada et al., 1998). DSIF binds 
to the upstream DNA and makes contacts with the exiting RNA while interacting with Pol II to 
enhance its processivity during elongation (Bernecky et al., 2017; Ehara et al., 2017). 
A key regulatory feature of Pol II early elongation is promoter-proximal pausing (PPP) where 
Pol II accumulates about 12-65 nt downstream of the transcription start site (Gilmour & Lis, 
1986). PPP is a conserved regulatory mechanism from C. elegans to human (but not in yeast) 
and have been observed in many protein-coding genes (Core & Adelman, 2019). The 
accumulation of paused Pol II prevents new initiation events. This makes PPP an effective way 
to repress transcription (Gressel et al., 2017). Many factors contribute in establishing PPP 
including DNA and RNA sequence as well as protein factors (Core & Adelman, 2019; Kwak 
& Lis, 2013). The negative elongation factor (NELF) composed of 4 polypeptides, NELF -A, -
B, -C/-D and -E is important for establishing PPP (Narita et al., 2003; Yamaguchi et al., 1999). 
The NELF complex arrests mobile domains of Pol II necessary for escaping the paused state. 
It additionally induces tilting of the DNA-RNA hybrid in the Pol II active site into a non-
canonic state which is not compatible with nucleotide addition. And sterically prevents binding 
of TFIIS thereby maintaining the PPP (Vos, Farnung, Urlaub, et al., 2018). NELF is a 
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metazoan-specific factor needed to regulated the metazoan-specific process of PPP (Narita et 
al., 2003).  
 Transition from the promoter-proximally paused state to processive elongation or activated 
transcription requires specific phosphorylation of the Pol II CTD (Core & Adelman, 2019; 
Dahmus, 1996; Kwak & Lis, 2013). The positive elongation factor b (P-TEFb) was identified 
as the main CTD kinase responsible for this transition and it is inhibited by DRB (Marshall & 
Price, 1995). Recent structural and biochemical studies shows that P-TEFb kinase, CDK9 
phosphorylates the CTD of Pol II, the CTD linker domain, NELF and DSIF to stimulate 
activated transcription (Vos, Farnung, Boehning, et al., 2018; Vos, Farnung, Urlaub, et al., 
2018). NELF phosphorylation weakens its interaction with Pol II and allows it to be competed 
off by the PAF complex. Also, phosphorylation of the CTD linker domain recruits the histone 
chaperone SPT6 to the activated elongation complex (Vos, Farnung, Boehning, et al., 2018). 
This study confirms a wide variety of in vivo studies that highlight P-TEFb, DSIF and NELF 
as key players of transcription regulation at the step of PPP (Core & Adelman, 2019; Kwak & 
Lis, 2013). Furthermore, additional factors such as histone methyltransferases SET1 and SET2 
may be recruited to allow transcription through nucleosome bound regions within the gene body 
(Cramer, 2019; Kwak & Lis, 2013).  
 
1.2.3 Transcription termination by Pol II  
Among the eukaryotic Pols, RNA Pol II transcribes the most diverse groups of genes. It 
transcribes genes coding to very short enhancer RNAs (eRNAs) to protein-coding genes that 
can be larger than 100 kb. This suggests Pol II must be very processive in the latter case, which 
in turn requires robust mechanism(s) for termination (Proudfoot, 2016). Pol II termination relies 
on DNA encoded sequence features that induce slowing down/pausing of the polymerase at the 
end of a transcription unit. The binding of termination factors are thought to play major roles 
in inducing Pol II pausing at the end of the transcriptional unit (Nojima et al., 2015). Pol II CTD 
modifications such as phosphorylation of Ser2 and Tyr1 of the heptad repeat installed earlier in 
the transcription cycle play key roles in recruiting terminations factors (Larochelle et al., 2018; 
Mayer et al., 2012; Shah et al., 2018; Zaborowska et al., 2016). For mRNAs, transcription 
termination and 3’ processing is done by the multi-subunit cleavage and polyadenylation 
specific factor, cleavage stimulating factor and the poly(A) polymerase referred to as CPF for 
simplicity (Mandel et al., 2006; Y. Zhang et al., 2019). The CPF is a modular complex 
conserved from yeast to human that can recognize the polyA site (PAS), cleave and 
polyadenylate the nascent RNA. (Casañal et al., 2017; Mandel et al., 2006; Sun et al., 2020). 
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The CPF subunit Pcf11 possesses a CTD interaction domain, which binds Ser2- phosphorylated 
CTD demonstrating how the CTD phosphorylation recruits the CPF (Licatalosi et al., 2002; 
Mayer et al., 2012).  
Substantial effort has been dedicated into characterizing the CPF but it is not clear how the 
elongating Pol II is cleared of the gene during termination. Two models are currently used to 
describe Pol II termination. The allosteric model suggests that the Pol II elongation complex 
undergo conformational changes upon transcribing through the PAS which leads to termination. 
This model is supported by the observation that in vitro reconstituted transcription can terminate 
without pre-mRNA cleavage and without an exonuclease (Zhang et al., 2015). The allosteric 
model is challenged by an alternative model called the ‘torpedo’ model. The torpedo model 
proposes a mechanism of Pol II termination in which pre-mRNA cleavage at the PAS by the 
CPF generate an uncapped 5’ ended RNA. This free 5’ end recruits a 5’ - 3’ exonuclease which 
degrades the exposed RNA and dismantles the polymerase when it catches-up with it (Porrua 
et al., 2016; Proudfoot, 2016). This model is supported by observation in both yeast and 
mammals that knockdown of Rat1 and XRN2 (the ‘torpedo’ nucleases) respectively causes 
major Pol II termination defects (Fong et al., 2015; M. Kim et al., 2004). A recent genome-
wide study in yeast further highlighted requirement of Rat1 for global mRNA termination in 
support of the torpedo model but also observed rearrangements of Pol II elongation complex 
that might support the allosteric model. The authors therefore suggested that the two models 
are not mutually exclusive and likely a combination of both is at play. (Baejen et al., 2017). 
In Saccharomyces cerevisiae, Pol II transcribed ncRNAs are terminated by an alternative 
termination pathway, the Nrd1-Nab3-Sen1 pathway (NNS pathway) (Porrua et al., 2016). Nrd1 
binds phosphorylated Pol II CTD similar to Pcf11 of the CPF and interacts with Nab3. Nrd1 
preferentially binds to CTD phosphorylated on Ser5 instead of Ser2 by Pcf11 of the CPF (Mayer 
et al., 2012; Vasiljeva et al., 2008). Nrd1 and Nab3 bind specific sequence elements in both the 
DNA and the nascent RNA at the termination site of snRNAs and snoRNAs and recruit Sen1 
for termination (Creamer et al., 2011). Sen1 is an ATP dependent helicase similar to the Rho 
factor in the bacterial RNAP termination. Sen1 uses ATP hydrolysis to dismantle the elongation 
complex (Porrua et al., 2016; Porrua & Libri, 2013). 
The NNS pathway is not conserved in fission yeast where the CPF complex is employed in the 
termination of Pol II-transcribed ncRNA (Larochelle et al., 2018). It is also not present in 
metazoans. Senataxin, the mammalian homologue of Sen1 is involved in resolution of non-
template DNA-RNA hybrids (R-loops) formed by paused Pol II (Skourti-Stathaki et al., 2011) 
and upon DNA damage (Cohen et al., 2018).  
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Since Pol II-transcribed snRNAs do not have PAS prerequisite for CPF cleavage and the 
NNS pathway is not conserved in metazoans, it was enigmatic how this class of Pol II-
transcribed genes is terminated in multicellular organisms until the discovery of the 
Integrator complex (INT).  
 
1.3 The Integrator complex, discovery and subunit composition 
INT was discovered by serendipity when Baillat and colleagues identified a set of 12 
polypeptides in a search for proteins associated with DSS1 (deleted in split hand/split foot 
protein 1). These polypeptides turned out to interact with the CTD of Pol II. In a preliminary 
amino acid sequence analysis of these polypeptides, they discovered that two of them share 
conserved domains with CPSF73 and CPSF100 subunits of the CPF hinting at a potential role 
of the newly discovered Pol II associated complex in RNA processing. Indeed, mutation of a 
conserved active site residue in the CPSF73-like polypeptide (later names INTS11) resulted in 
misprocessing of snRNAs consistent with their suspicion. This set of 12 polypeptides was then 
characterized biochemically as a complex, shown to be metazoan-specific, and named the 
Integrator complex (INT) for integrating CTD phosphorylation signal and 3’ processing of 
snRNAs (Baillat et al., 2005). The 12 polypeptides were named INTS1 to INTS12 according to 
their apparent molecular weight on SDS-PAGE. Based on its elution profile on gel filtration 
chromatography, it was estimated that INT is over 1 MDa in size (Baillat et al., 2005; Baillat 
& Wagner, 2015). Further genetic screen in Drosophila identified two additional proteins, 
which associates with INT and are important for snRNA 3’ processing namely Asunder and 
VWA9. Asunder and VWA9 were therefore named INTS13 and INTS14 respectively 
(Jiandong Chen et al., 2012a). Subsequent, proteomic analysis of human INT confirmed 
INTS13, INTS14 as well as DDX26B are bona fide members of the complex. DDX26B is also 
called INTS6-like (INTS6L) because it shares some sequence similarities with INTS6 







Figure 1.4 Subunit composition of INT. INT subunits are depicted as rectangle scaled to their sizes (number 
of amino acids). Interacting domains of INTS9, INTS11, and INTS12 are indicated. The part of INTS3 that 
interacts with SOSS-B and SOSS-C is also indicated. The molecular weight in kDa of each subunit is 
indicated in brackets. 
 
The INT subunits are predicted to be alpha helical with protein-protein interactions folds such 
as ARM, HEAT, TPR and vWA (vWFA) (Baillat & Wagner, 2015; Gómez-Orte et al., 2019) 
(Figure 4.1). Apart from INTS9 and INTS11, which are highly similar to CPSF100 and CPSF73 
respectively, none of the other subunits share similarity with any known protein (Baillat & 
Wagner, 2015). Further characterization of INTS9 and INTS11 showed that they form a 
heterodimer and this heterodimerization is important for snRNA 3’ processing (Albrecht & 
Wagner, 2012). Molecular characterization reveals that the very C-terminal regions of INTS9 
and INTS11 are important for INTS9/11 heterodimer formation (Wu et al., 2017).  
INTS12 has a PHD domain known for binding methylated histones. This subunit was shown to 
interact with INTS1 via an N-terminal microdomain in the Drosophila INT (Jiandong Chen et 
al., 2013). Yeast two-hybrid analysis revealed an interaction between Drosophila IntS10 and 
IntS14 (Jiandong Chen et al., 2012a). INTS3 was shown to be part of the SOSS complex 
involved in sensing DNA double strand breaks. Careful analysis of proteins co-
immunoprecipitated with the SOSS complex showed that INTS6 interacts with this complex 
(Ren et al., 2014; Skaar et al., 2009, 2015). 
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1.3.1 Pol II transcription of snRNA genes and the role of INT 
Pol II-transcribed snRNA genes have a relatively simple structure composed of a conserved 
distal sequence element (DSE) which act as an upstream enhancer, a proximal sequence 
element (PSE) which is equivalent to a core promoter in protein-coding genes, an intronless 
gene body and a 3’ box where pre-snRNAs are cleaved for termination (Guiro & Murphy, 2017) 
(Figure 1.5a). The DSE and PSE are conserved elements in the Pol III-transcribed 7SK and U6 
snRNAs (Jawdekar & Henry, 2008). The 7SK and U6 snRNA genes have in addition to DSE 
and PSE a TATA box, which is important for the selective recruitment of Pol III to these genes. 
Addition of a TATA box downstream of the PSE of a Pol II-transcribed snRNA switches its 
transcription to Pol III. Analogously, mutation of the TATA box downstream of the PSE within 
the Pol III-transcribed U6 snRNA gene switches its transcription to Pol II (Lobo & Hernandez, 
1989; Mattaj et al., 1988). These observations show that the promoter elements of snRNA genes 
determine which Pol transcribes them and therefore insure their accurate termination since Pol 
II and Pol III termination are substantially different. However, changing the U1 snRNA 
promoter to the promoter of a Pol II-transcribed protein-coding gene resulted in severe 
misprocessing of the resultant pre-snRNA, even though the 3’box was not changed (Neuman 
de Vegvar et al., 1986). It can therefore be assumed that the promoter elements of the Pol II-
transcribed snRNAs encode information for the specific recruitment of factors needed for their 
3’ processing beyond the DSE and PSE binding factors. Pol II transcription initiation from an 
snRNA promoter requires the Pol II-specific GTFs except that only a subset of TBP associated 
factors (TAFs 5-9, 11 and 13) are recruited (Guiro & Murphy, 2017; Zaborowska et al., 2012).  
Beyond the recruitment of gene-specific factors, specific Pol II CTD modifications installed 
during snRNA specific initiation complex assembly have important roles in snRNA gene 
transcription. In line with this notion, phosphorylation of Ser-7 of the CTD heptad repeat has 
been shown to be important for transcription of U2 snRNA but not protein-coding genes (Egloff 
et al., 2007). This implies that, this modification among others may recruit specific factors for 
elongation and 3’processing of Pol II-transcribed snRNA genes. As expected, Egloff and 
colleagues showed that CTD phosphorylated on Ser-7 of the consensus repeat recruits the 
protein phosphatase RPAP2 to the promoter region of the U2 snRNA gene which facilitates 





Figure 1.5 snRNA gene organization and transcription. (a) Organization of a typical Pol II-transcribed 
snRNA gene. Distal sequence elements (DSE) are bound by snRNA gene-specific activators such as Oct1, Sp1 
or NF1. SNAPc an snRNA-specific Pol II transcription initiation factor binds to the proximal sequence element 
(PSE) and interacts with activators. TSS stands for transcription start site and the 3’box is indicated with a red 
filled box. (b) A model depicting the Pol II transcription cycle on a typical snRNA gene highlighting the 
involvement of INT. Phosphorylation status of the Pol II CTD is indicated and the kinases installing such 
modifications are indicated below the cartoon. INTS11 (red) is shown cleaving the pre-snRNA at the 3’ box 
during termination. 
 
Interestingly, the catalytic subunits of INT (INTS11) was not present at the promoter regions. 
Phosphorylation of Ser-2 of the Pol II CTD by the P-TEFb kinase CDK9 has been shown to be 
required for termination of snRNAs (Albrecht & Wagner, 2012). In summary, phosphorylation 
of Ser-7 by CDK7 (THIIH kinase) during initiation and Ser-2 by CDK9 in early elongation are 
the two marks required to efficiently recruit the full INT to allow for correct Pol II mediated 
snRNA transcription (Egloff et al., 2010) (Figure 1.5b).  
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Termination of Pol II-transcribed snRNA genes requires the enzymatic activity of INTS11 
(Baillat et al., 2005) and is dependent on the Pol II elongation factors NELF and DSIF. 
Knockdown of NELF resulted in polyadenylation of the Pol II-transcribed snRNAs which are 
not polyadenylated (Yamamoto et al., 2014). The exact roles these Pol II elongation factors 
play in termination of snRNAs is not clear, although it can be speculated that they induce 
pausing (slow down) of Pol II to allow 3’ box recognition and RNA cleavage by INT. It has 
also been shown that recruitment of NELF in the 3’ region of snRNAs blocks the recruitment 
of the mRNA-specific CPF (Yamamoto et al., 2014). 
1.3.2 INT beyond snRNA transcription 
Regulation of pre-mRNA synthesis 
The discovery of a role for NELF and DSIF in snRNA 3’ processing was inspired by the 
observation that INT co-immunoprecipitated with SPT5 (DSIF) and NELF -E suggesting 
interaction between these complexes (Yamamoto et al., 2014). Interaction between INT and 
these transcription elongation factors suggests that INT might have a broader role in Pol II 
transcription. The first evidence in this direction came from Gardini and coworkers who 
observed that INT is recruited to immediate early genes (IEG) upon epidermal growth factor 
(EGF) stimulation (Gardini et al., 2014). These genes, similar to Drosophila Hsp70, are 
strongly regulated by promoter-proximal pausing (PPP). They showed that knockdown of 
INTS1 and INTS11 abrogated escape of paused Pol II into productive elongation upon EGF 
stimulation. Mechanistically, INT controls release of paused Pol II by recruiting the super 
elongation complex which contains the positive transcription elongation factor (P-TEFb). P-
TEFb then releases paused Pol II by phosphorylating Pol II, NELF and DSIF (Gardini et al., 
2014; Vos, Farnung, Urlaub, et al., 2018). 
Furthermore, it was observed that more than 2000 protein-coding genes are differentially 
expressed when INTS3 and INTS11 are knocked down, suggesting a broader role of INT in 
regulating expression of protein-coding genes (Stadelmayer et al., 2014). Stadelmayer and 
colleagues observed some genes that are upregulated upon INTS11 knockdown in the absence 
of stimulus (resting cells) contrary to downregulation of IEGs reported by Gardini and 
colleagues. This suggests a dual function of INT at protein-coding genes in a stimulus-
dependent manner. Additionally, recent studies demonstrated INTS11-dependent premature 
termination of paused Pol II within a class of INT regulated genes (Elrod et al., 2019; Tatomer 
et al., 2019). This study is well supported by the observation that INT regulated pre-mRNAs 
are rich in 3’box-like sequences which might be recognized and cleaved by INT to attenuate 
these genes (Stadelmayer et al., 2014).  
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Taken together, these in vivo studies suggest a model where INT is a critical switch that 
represses promoter proximally paused Pol II to downregulate certain genes via endonuclease 
activity of INT11 or recruits the super elongation complex containing P-TEFb that releases Pol 
II from PPP and activates other genes.  
 
Termination of other RNAs 
Apart from termination of snRNAs, INT has been shown to play important roles in termination 
of other classes of genes. Knockdown of INTS3 and INTS9 was shown to induce aberrant 3’ 
processing of replication-dependent histone mRNAs (Skaar et al., 2015). These class of 
mRNAs are intronless and non-polyadenylated. They require a unique complex of U7 snRNP, 
the cleavage module of the CPF and other accessory factors for their 3’ formation (Marzluff et 
al., 2008; Sun et al., 2020). 
Additionally, INT is recruited to the promoter region of enhancer RNAs (eRNA) in a stimulus-
dependent manner where its catalytic activity was shown to be important for their termination 
(Lai et al., 2015). The Herpesvirus saimiri also require INT for the biogenesis of a microRNA 
important for downregulating host gene expression. This microRNA possesses a 3’ sequence 
highly analogous to the 3’ box of snRNAs (Xie et al., 2015). 
In summary, it emerges that INT is needed for termination of genes that are relatively short 
compared to pre-mRNAs and this activity depends on a 3’ box-like sequence and catalytic 
activity of INTS11. 
 
1.4. Aims and scope of this work 
I have described in section 1.3 above the multi-subunit INT which is added recently to the list 
of Pol II transcription regulators in metazoans. There has been substantial amount of in vivo 
work dedicated to understanding the specific roles of INT in Pol II transcription and regulation 
summarized in the aforementioned section. While these studies have been important in 
disentangling the in vivo functions of INT, there are critical questions that can only be addressed 
by in vitro biochemical reconstitution approach using purified components. For example, to 
obtain structural and biochemical details on the architecture of INT and its roles in Pol II 
transcription regulation, purification of INT is absolutely necessary. There seems to be 
redundancy in the kinases that phosphorylate the Pol II CTD (Zaborowska et al., 2016). To 
unequivocally identify which CTD phosphorylation is important for INT recruitment to Pol II 
transcriptional complexes, an in vitro biochemical assay using purified components is 
necessary. Furthermore, INT has been shown to interact with phosphorylated Pol II CTD, 
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NELF, DSIF and the super elongation complex to orchestrate its functions in Pol II 
transcription. Identification of the specific INT subunits that interact with these key components 
also requires in vitro biochemical reconstitution. While there are well-established protocols for 
the purification of Pol II, DSIF and NELF (Vos, Farnung, Urlaub, et al., 2018), protocols for 
production of INT in good amounts and purity for biochemical studies is still lacking. Miniscule 
amounts of INT has been obtained from endogenous sources but these are normally 
contaminated with Pol II and other interacting complexes of INT (Baillat et al., 2005; 
Stadelmayer et al., 2014; Yamamoto et al., 2014). This difficulty in obtaining homogenous INT 
in good quantity hampers biochemical and structural characterization of INT. To avert the 
problems of low yield and heterogeneity, recombinant reconstitution of INT was pursued in 
this study. The Integrator complex (INT) comprises 15 polypeptides with an estimated 
molecular weight of ~1.5 MDa assuming a single copy of each subunit (Baillat et al., 2005; 
Jiandong Chen et al., 2012). The large size of this complex poses a major challenge for 
recombinant expression. Furthermore, it is not known how the subunits are interacting within 
INT, as in which subunits might need each other for co-translational folding. This poses the 
challenge of first identifying interacting subunits and then establishing an expression and 
purification protocol for the full INT. 
The baculovirus-insect cell recombinant protein expression system has been used successfully 
to produce large multi-subunit protein complexes (Berger et al., 2004; Gradia et al., 2017; 
Schilbach et al., 2017; Zhang et al., 2013).  
In this study, I sought to reconstitute INT recombinantly using the baculovirus-insect cell 
expression system and its interaction with Pol II paused elongation complex (PEC) using the 
following steps  
1. Identify interacting subunits of INT that form stable subcomplexes for co-expression 
and purification using a co-infection assay in insect cells coupled to XL-MS 
2. Reconstitute the full INT from the identified subcomplex and obtain an inter-subunit 
interaction network using XL-MS 
3. Study the interaction between INT and PEC in vitro and identify the proteins involved 








Table 2.1. Sources of cDNA of INT subunits and GenBank Accession codes  
Plasmid ID 
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Table 3.2. Vectors, tags and resistance marker 
Name Affinity tag Resistance marker 
438-A No tag Ampicillin 
438-B 6xHis Ampicillin 
438-C 6xHis-MBP Ampicillin 
 
Tables 3.3. Bacteria strains and their genotypes  
Strain Genotype  Provider 
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 
relA1lac [F’ proAB lacIqZΔM15 Tn10 (Tetr)] 
 Agilent 
NEB Stable Not available  NEB 
DH10EMBacy F- mcrA Δ(mrr-hsdRMS-mcrBC) 
ϕ80dlacZΔM15 ΔlacX74 
endA1 recA1 deoR Δ(ara, leu)7697 araD139 
galU galK 
λ- rpsL nupG / bMON14272‡ yfp+/ 
pMON7124 






Table 3.4. Composition of bacterial growth media 
Media Composition 
LB broth 1% (w/v) tryptone, 0.5% (w/v) yeast extract, 1% (w/v) NaCl 
(+/- antibiotics or additives based on specific needs) 
LB Agar 1% (w/v) tryptone, 0.5% (w/v) yeast extract, 1% (w/v) NaCl, 
0.1 mg/ml Ampicillin sulphate 
2% agar (+/- antibiotics or additives based on specific needs) 
 
Table 3.5. Insect cell lines  















Trichoplusia ni Hi5 (BTI-TN-5B1-
4) 
ESF921™ Thermo Fisher 
Scientific 
 
Table 3.6. Chemicals and their supplies  
Chemical (full name) Supplier 
Acetic acid  Merck 
Acetone Merck 
Agarose  Invitrogen  
BME (-mercaptoethanol) Roth 
BS3 (bissulfosuccinimydyl suberate) Thermo Fisher Scientific 
DTT (Dithiothreitol)  Roth  
EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide) Thermo Fisher Scientific 
EDTA (Ethylenediaminetetraacetic acid) Roth  
Ethanol, Isopropanol Merck 
Glycerol  Roth 
HCl  Merck 
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) Roth 
Imidazole Roth 











Tris (trisaminomethane) VWR 
TCEP (tris(2-carboxyethyl) phosphine) Roth 
x-gal (5-bromo-4-chloro-3-indolyl-β-D-galactoside) Roth 
ZnCl2 Merck 
 
Table 3.7. Buffers and their composition/suppliers  
Buffer Composition/Supplier Application 




10x PBS 137 mM NaCl, 2.7 mM KCl, 10 
mM Na2HPO4 pH 7.4, 





Thermo Fisher Scientific LDS-PAGE 
20x MES (2-ethanesulfonic 
acid) 
Thermo Fisher Scientific LDS-PAGE 
4x LDS (lithium dodecyl 
sulfate) sample buffer 
 
Thermo Fisher Scientific LDS-PAGE 
6x DNA loading dye NEB Agarose gel 
electrophoresis 
Cutsmart buffer NEB Restriction 
endonuclease digestion 
with PmeI and SspI 
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Table 3.8. Antibodies used in this study 
Antibody Host organism Supplier/catalogue 
Number 
Anti INTS2 Rabbit Abcam/ab178334 
Anti INTS3 Rabbit Abcam/ab70451 
Anti INTS5 Rabbit Abcam/ab74405 
Anti Histag-HRP Mouse Mitenyl Biotech/130-092-
785 
Anti MBP-HRP Mouse Abcam/ab49923 
Donkey anti Rabbit  donkey Abcam/ab150075 
 












LIC cloning of 
wt-INTS1 
E46_INTS1_
Seq_1     
GCCAGTTCTCGTCCTCCTC                  Sequencing of 
INTS1 
E47_INTS1_
Seq_2     
GAGCCTCATGTACCTGGCC                  Sequencing of 
INTS1 
E48_INTS1_
Seq_3     
CAACCACTTCATGCTGTGCA                 Sequencing of 
INTS1 
E49_INTS1_
Seq_4     
CCATGGAGCTTGCTGACCAC                 Sequencing of 
INTS1 
E50_INTS1_s
qe_5     





Seq_6     
GTCGGAGTCTCAGGACCAGG                 Sequencing of 
INTS1 
E52_INTS1_s
eq_7     
CTCGGTGGCAGAGCTCC                    Sequencing of 
INTS1 
E53_INTS1_s
eq8      
GCCTCCTAGTGGACTGGCTG                 Sequencing of 
INTS1 
E54_INTS1_s
eq_9     













































_438C_1F         











438    


























C)_LicV1_F   
TACTTCCAATCCAATATGGAGGAGGATGTGGG






AGTAATAATGACTG              






LIC cloning of 
INTS2 
E57_INTS2_s
eq_1      
GAGACACAAGAACCAGGCACC                                       Sequencing of 
INTS2 
E58_INTS2_s
eq_2      
GAGAGTCCAGTATATTTGGAGGAAGC                                  Sequencing of 
INTS2 
E59_INTS2_s
eq_3      
CTGCAGTTGATGACGAGCCG                                        Sequencing of 
INTS2 
E60_INTS2_s
eq_4      





eq_5      



























CAC   
Lic cloning of 
INTS3 
E64_INTS3_s
eq_1     
CCTTCTGTCGCAGGGCC                      Sequencing of 
INTS3 
E65_INTS3_
Seq_2     
CAGCCAAAAATATCTGGTTGGCAG               Sequencing of 
INTS3 
E66_INTS3_s
eq_3     
CAACTTCTATCCACCATTGGAGGG               Sequencing of 
INTS3 
E67_INTS3_s
eq_4     
CTACCCAGCTGGGCGATCTG                   Sequencing of 
INTS3 
IF96_INTS3_
471_RTH_R     
GTGTGCCAAGACCCGTTTCTC           Truncation of 
INTS3 
IF97_INTS3_
800_RTH_R     





TGAATTGGAAGTGGATAACGGATCCG      Truncation of 
INTS3 
IF99_TEV_4
38c_RTH        
ATTGGATTGGAAGTACAGGTTTTCCTCG    Truncation of 
INTS3 
IF100_INTS3
_472_RTH_F    





_801_RTH_F    












LIC cloning of 
INTS4 
E70_INTS4_
Seq_1     
CAGTCCTCTTTCATGGAGCTGC             Sequencing of 
INTS4 
E71_INTS4_
Seq_2     
GTGCCTGCAGTTACTTGGCAATC            Sequencing of 
INTS4 
E72_INTS4_
Seq_3     
TGCCTTGATTTCCTAGTTGACATGTTC        Sequencing of 
INTS4 
E73_INTS4_s
eq_4     










LIC cloning of 
INTS5 
E39_INTS5_s
eq_1      
GGCCACAGGAGAGAACCC                  Sequencing of 
INTS5 
E40_INTS5_s
eq_2      
GGATACCTCTGTTCAGCATTCTCC            Sequencing of 
INTS5 
E41_INTS5_s
eq_3      
CTGGTTCATCACCGGGGAG                 Sequencing of 
INTS5 
E42_INTS5_s
eq_4      
GGGACAATGAGACTCTCTCAGTTG            Sequencing of 
INTS5 
E43_INTS5_s
eq_5      





CTGATAGAC       






LIC cloning of 
INTS6 
E35_INTS6_s
eq_1      





Seq_2      
GTGTCTGGAGTCCTTGGTGC                             Sequencing of 
INTS6 
E37_INTS6_s
eq_3      
GATGGGAGCACCTAACCTAATAGC                         Sequencing of 
INTS6 
E38_INTS6_
Seq_4      






ACTGGC          
Mutation of 






AAAAGC          
Mutation of 











ATTGCG     
LIC cloning of 
INTS7 
E76_INTS7_
Seq_1     
GCAAGCAGAGTGAAAGTGTGC                       Sequencing of 
INTS7 
E77_INTS7_s
eq_2     
GAGGAAGAATGCTCATCATAGTATTCGTC               Sequencing of 
INTS7 
E78_INTS7_
Seq_3     
CCTGGAATCCCTACTGGTACTTTGTAG                 Sequencing of 
INTS7 
E79_INTS7_
Seq_4     










LIC cloning of 
INTS8 
E31_INTS8_
Seq_1      
CATAGCACACCTGGCACTGC                        Sequencing of 
INTS8 
E32_INTS8_s
eq_2      
GGCCATGGAACCAGGC                            Sequencing of 
INTS8 
E33_INTS8_
Seq_3      





Seq_4      





TCAGGG           


















 GGTCCACTTCATGGAGCTCTG Sequencing of 
INTS9 
E14_Int10_Li
cV1_For   
TACTTCCAATCCAATGAAATCAGCATTATTACA
TCAGCATTAAGGAAC 












GAGC            
LIC cloning of 
INTS9 
E28_INTS10
_Seq_1      
GACCAGCATGGTGGAATACACC                           Sequencing of 
INTS10 
E29_INTS10
_seq_2      
GAATGGCAGATGGATAAAGGAAGACG                       Sequencing of 
INTS10 
E30_INTS10
_seq_3      















ACG              










_seq_1        
CAGCACCTTCCCACCACG                   Sequencing of 
INTS11 
E26_INTS11
_Seq_2        
GTACGCCACGACCATCCG                   Sequencing of 
INTS11 
E27_INTS11
_seq_3        





TTGG      






LIC cloning of 
INTS12 
E88_INTS12
_Seq_1     
CCCTCGCCTGGTGTGG                           Sequencing of 
INTS12 
E89_INTS12
_Seq_2     




ATTGGAAGTGGATAACGGATCCG     Truncation of 
INTS12 
IF88_12-
194_RTH    











TC              
LIC cloning of 
INTS13 
119_INTS13_
Seq_1   
GTGTTAGCATGCTGTTCTTCCTTC                         Sequencing of 
INTS13 
120_INTS13_
Seq_2   
GTCCCCGGTTTTAACCAGTG                             Sequencing of 
INTS13 
121_INTS13_
Seq_3   










LIC cloning of 
INTS14 
124_INTS14_
Seq_1    





Seq_2   
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ATCCGTTC   
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LIC cloning of 
DDX26B 
Note: Primers are written in 5’ to 3’ direction, CPEC – circular polymerase extention cloning. LIC – Ligation 
independent cloning. 
 
Table 3.10. Expression constructs 
A comprehensive list of final expression vector and all intermediates generated during this 




3.1 General methods for cloning  
3.1.1 Polymerase Chain reactions (PCR) 
The open reading frames (ORFs) of Integrator subunits were amplified from purchased plasmid 
DNA using PCR except INTS1, INTS2 and DDX26B. INTS1, INTS2 and DDX26B were 
assembled from DNA fragments (Table 2.1). PCR primers were design targeting the 5’ and 3’ 
ends of the ORFs with lengths between 10 and 20 nt and a melting temperature of 58 – 60 oC. 
Additional DNA overhangs were added to the primers for compatibility with the ligation 
independent cloning (LIC) into the MacroLab 438 series of vectors (Gradia et al., 2017). A 
typical PCR reaction was carried out using the Phusion® High-Fidelity DNA polymerase (NEB) 
and contained 1 - 10 ng of plasmid DNA depending on the size, ~3% (v/v) DMSO and all other 
reagents were added in the recommended amounts of the manufacturer’s protocol. Normally, 
25 - 30 thermocycles were carried out in a TProfessional TRIO Thermocycler® (Biometra).  
Parameters such as the primer annealing temperature and primer extension time were set for 
each PCR according to primers and the size of the gene of interest. In some cases, it was 
necessary to test a gradient of annealing temperatures for amplification. Under standard 
conditions an average synthesis rate of 1,000 nt/min was assumed for Phusion® polymerase 
(NEB). To reduce background after PCR in subsequent cloning steps, the plasmid DNA (which 
is methylated) in the product was removed with DpnI (NEB) digestion for 3 hrs or overnight. 
The products were then analyzed on agarose gel. Products of interest were excised from the gel 
and purified using the QIAquick gel extraction kit (QIAGEN) according to the manufacturer’s 
instructions or in some cases using the QIAGEN PCR purification kit. 
3.1.2 Round-the-horn PCR for mutagenesis  
The ORFs of INTS3 and INTS6 in the purchased plasmids had the restriction sites of PmeI and 
SwaI respectively. Since these restriction enzymes are used to combine vectors into polyprotein 
expression plasmids, it was necessary to mutate these positions. For some INT subunits 
disordered regions were removed or different truncation variants were cloned (INTS1, INTS3 
and INTS12).  
For these purposes, the ‘round-the-horn’ PCR (RTH-PCR) technique was applied ((Liu & 
Naismith, 2008)). This method entails the amplification of an entire template vector and re-
ligation of the ends. This provides the flexibility to add a DNA sequence as an overhang, make 
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a point mutation in the annealing region of the primer, or design primers to remove a DNA 
fragment in the vector. Genes of interest were first cloned into a Macrolab 438 vector of choice 
and primers were designed to change a base in the sequence of an undesired restriction site or 
remove a whole region. For efficient ligation of the amplified vector DNA, one of primers in a 
primer pair for RTH-PCR was purchased pre-phosphorylated at the 5’ end. PCR conditions 
were as for a standard PCR described above with primer extension time adjusted depending on 
the size of the vector. Successful amplification was assessed by analyzing 5 % of the RTH-PCR 
product on agarose gel. DpnI digestion was then used to remove the template vector and the 
amplified vector was purified using the QIAGEN PCR purification kit (QIAGEN). An amount 
of 100 - 200 ng of the purified vector was then ligated using Quick Ligase (NEB) following the 
manufacturer’s instructions. An aliquot of 10 µl of the ligation reaction was transformed into 
XL1 blue chemically competent bacteria. 
3.1.3 Restriction endonuclease digestion of DNA 
Linear vectors and inserts for LIC were generated by restriction endonuclease digestion. A 
typical reaction included 1 - 2 µg of DNA, 5 µl of the recommended 10x buffer of the restriction 
enzyme used (NEB) and 10000 - 20000 U of the restriction enzyme in a final volume of 50 µl. 
The reaction was incubated for 4 - 5 hrs or overnight at 25 oC for SwaI and 37 oC for SspI and 
PmeI. The restriction digest of inserts was always purified from agarose gel using the QIAGEN 
gel extraction kit while the linearized vectors were mostly purified using the QIAGEN quick 
PCR purification kit. 
3.1.4 Agarose gel electrophoresis 
Agarose gel electrophoresis was applied to visualize DNA (plasmid or PCR products) and for 
preparative isolation of DNA after restriction digestion and PCR. 
The products of PCR or restriction digestions were analyzed by separation on 1 - 2 % (w/v) 
agarose in 1x TAE buffer depending of the expected product sizes. SYBR™ Safe DNA gel 
stain (Invitrogen) was added (1:20 v/v) to the molten agarose upon casting for subsequent 
visualization of DNA samples under ultraviolet (UV) light. DNA samples were supplemented 
with DNA loading buffer to a final concentration of 1x and loaded on the gel covered with 1x 
TAE buffer. Commercial DNA ladders were used as a size standard. The electrophoresis was 
run at 120 V for 20 - 45 min or until sufficient separation of the DNA fragments was achieved. 
DNA bands were visualized with the GEL iX20 Imager system (Intas) for analytical gels or 




3.1.5 DNA Extraction from agarose gel and PCR purification 
After agarose gel electrophoresis, the desired DNA fragments were visualized by UV-
illumination with the BST-20G-D2E BlueLED BioTransilluminator (Biostep), excised with a 
sterile razor blade and the gel pieces were weighed. 
The DNA was then extracted from the gel using the QIAquick Gel Extraction kit following the 
manufacturer’s protocol. Alternatively, only about 5% of the PCR product or restriction digest 
reaction of SwaI and SspI is analyzed on agarose gel. The products were then purified using 
the QIAGEN PCR purification kit following the manufacturer’s protocol. The DNA was always 
eluted in 20 - 40 µl of double distil water (ddH2O). 
3.1.6 Strategy for cloning of INT subunits in MacroLab 438 series vectors  
The baculovirus - insect cell system was employed for the expression of proteins in this study. 
The 438 series of MacroLab vectors (modified from pFastBac, Addgene #55218 and #55220) 
allows for the cloning of multiple gene cassettes together and further permits the integration of 
these genes into the baculoviral genome for subsequent baculovirus production. There are 
several types of these vectors allowing one to exploit different tagging options. The three main 
ones employed in this study were 438-A (No tag), 438-B (amino (N) terminus 6xHis tag 
cleavable by TEV protease) and 438-C (N-terminus 6xHis followed by maltose binding protein 
(6xHis-MBP) and a TEV protease cleavage site). Each of these vectors have a polyhydrin 
(polH) promoter, an SV40 polyadenylation signal and a SspI restriction site in between them. 
A gene of interest can be cloned into the SspI restriction site creating an expression cassette 
with a polH promoter and an SV40 terminator. Figure 3.1 provides a schematic summary of the 
LIC cloning method. 
The empty vectors were linearized by digestion with SspI. The linearized vectors were purified 
using the QIAGEN PCR purification kit. To generate sticky overhangs on the linearized vectors 
to make them amenable to ligation independent cloning (LIC), they were treated with LIC 
certified T4 DNA polymerase (purified in our laboratory) in the present of dGTP. The lack of 
dNTPs in the reaction activated the 3‘ - 5‘ exonuclease activity of the T4 DNA polymerase 
which then digests one strand of the DNA in the 3’ to 5’ direction until a dCMP nucleotide is 
encountered and then gets arrested in a futile cycle of addition and removal of dGMP nucleotide 
due to the presence of dGTP. This generates a linear vector with sticky ends compatible with 
LIC cloning (Gradia et al., 2017).  
The primers for PCR amplification of ORFs of the INT subunits were designed to contain 
adaptor sequences called the LICV1 sequences. When the PCR products are treated with the 
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T4 DNA polymerase in the presence of dCTP, a sticky overhang complementary to the sticky 




Figure 3.1. Schematic Summary of ligation independent cloning using the MacroLab system. The key 
steps are illustrated including the restriction sites of the enzymes; SspI, SwaI and PmeI. The polH (polyhedrin) 
promoter and the SV40 (simian virus 40) termination signal are also shown. Scheme was created based on 





The T4 polymerase treated linearized vector and insert were annealed at room temperature and 
transformed into XL1 blue chemically competent E. coli. The nick in the annealed product is 
repaired in E. coli. 3 - 5 single colonies were picked and cultured overnight, plasmid DNA 
isolated and analyzed by restriction digest using PmeI for 1 - 2 hrs followed by agarose gel 
electrophoresis. One or two positive clones (containing the bands corresponding to the right 
size of the vector and the insert) were sequenced by sanger sequencing (seqlab) for final 
validation. This approach was used for all subunits of INT except INTS1, INTS2, INTS10 and 
DDX26B. 
3.1.7 Uracil excision cloning of INTS1 into MacroLab 438 series vectors 
Uracil excision PCR provides a robust way to assemble several DNA fragments into one 
construct (Bitinaite & Nichols, 2009). It is particularly useful for cloning large DNA fragments 
that are challenging to amplify by PCR. This method was used to assemble INTS1 into the 438 
series vector. 
To achieve this, the ORF of INTS1 was divided into 4 DNA fragments and purchased from 
IDT (Integrated DNA Technologies). Each fragment was amplified with PCR primers 
containing 6 nt overlap to the adjoining fragment and a deoxyuridine placed at the boundary of 
the overlapping regions. The PCR reactions were performed using Phusion U hot start DNA 
polymerase (Thermo Fisher Scientific) which can permit extension from the deoxyuridine 
containing primer. The first and last fragments had overlaps with the polH promoter and SV40 
polyadenylation signal-containing ends of the linear vector. The 438 vectors were linearized by 
PCR amplification from the SspI site. The first primer was designed to contain a 6 nt overlap 
with the first fragment of the INTS1 (N-terminus) with a deoxyuridine at the boundary whiles 
the right primer had a 6 nt overlap with the fourth fragment of INTS1 (C-terminus) with a 
deoxyuridine in the boundary region. This arrangement ensured that the ORF is correctly 
assembled in the 438 vector which will guarantee expression of the correct protein. The PCR 
products of the fragments and the vector backbone were treated with the USER enzyme mix 
(Thermo Fisher Scientific) according the manufacturer’s protocol and transformed into XL1 
blue E. coli. The plasmid DNA was than extracted from overnight cultures prepared from single 
colonies in LB medium supplemented with ampicillin. Successful assembly of INTS1 ORF into 
a 438 vector was assessed by restriction analysis with PmeI and sanger sequencing using 





3.1.8 Circular polymerase extension cloning (CPEC) for assembly of INTS2, INTS10 and 
DDX26B from DNA fragments into MacroLab 438 vectors 
To obtain the ORFs for INTS2 and DDX26B, synthetic DNA fragments for the full ORFs for 
each gene were purchased and assembled into the 438 series vectors using Circular Polymerase 
Extension Cloning (CPEC)(Quan & Tian, 2009) (Figure 3.2).  
Each of INTS2 and DDX26B ORFs were divided into 2 DNA fragments. The first fragment 
for each gene corresponding to the N-terminal half of the protein had a 32 nt sequence from the 
438 series vector when it is linearized with SspI. This created a 60 oC melting temperature 
homology region between the first fragment of each gene and the upstream region of the vector 
(Figure 3.2). Similar homology regions were created between the first and second fragments, 
the second and the downstream end of the linearized vector. To assemble the full-length gene 
from its fragments into a vector, a 50 µl PCR mix was prepared containing 1x Q5 DNA 
polymerase buffer (NEB), 150 ng each of the INTS2 or DDX26B fragments, 200 ng of SspI 
linearized 438 vector, 200 µM dNTPs (NEB), and 0.02 U/µl of Q5 DNA polymerase (NEB). 
After initial denaturation for 30 s at 98 oC, the reaction was cooled 55 oC for annealing and 
extension was done at 72 oC for 4 mins. This was repeated for 26 cycles in a thermos cycler. At 
the end of the cycles, 40 µl of the reaction was transformed into chemically competent XL1 
blue E. coli. Plasmid DNA was isolated from the single colonies that was cultured overnight in 
LB supplemented with ampicillin. Assembly of ORFs were assessed by restriction digestion 
with PmeI and positive clones were sequenced using sequencing primers covering the full 
length of the ORF. For INTS10, I purchased a construct with a truncated cDNA missing amino 
acid 1 to 78 and it was cloned into a 438 vector by the standard LIC cloning. To generated a 
CPEC compatible fragment for this deletion mutant of INTS10, the shortened cDNA was 
amplified from the vector with primers that created a 60 oC -melting-temperature overlap 
between the C-terminal region and the downstream end of the vector. A DNA fragment 
corresponding to amino acids 1 to 89 of INTS10 which encompasses the missing region, an 
additional 32 nt overlap with the upstream region of the SspI linearized 438 vector and a 33 nt 
overlap with the rest of the INTS10 ORF was purchased from IDT. A CPEC reaction was set 
up including the linearized vector, and the two fragments of INTS10. Successful cloning of the 
full length INTS10 was verified by restriction digestion and Sanger sequencing from a single 




Figure 3.2. Schematic illustration of CPEC cloning strategy. DNA fragments of gene of interest is illustrated 
by a red lines. Homology regions between two DNA fragments of gene of interest is colored green and 
homology region between cDNA fragments and the linearized vector are shown in black. In step ii, arrows show 
direction of extension by DNA polymerase in the PCR reaction. 
3.1.9 Cloning of multiple genes into one construct for co-expression 
The MacroLab 438 vectors have a restriction site of PmeI flanking a cloned expression cassette 
and a SwaI site downstream of the SV40 polyadenylation signal and before the PmeI restriction 
site (Figure 3.1). It is possible to combine two vectors containing expression cassettes into a 
polyprotein co-expression vector. To achieve this, the ‘acceptor vector’ was linearized by 
digestion with SwaI and sticky ssDNA overhangs were generated by treating the linear 
‘acceptor vector’ with T4 DNA ligase in the presence of dGTP. The expression cassette from 
the ‘donor vector’ was cut out by digestion with PmeI. The DNA fragment was separated on 
agarose gel and fragment of interest was purified by gel extraction. ssDNA overhangs 
complementary to the overhangs of the linearized T4 DNA polymerase treated ‘acceptor vector’ 
were generated by treating the gel purified expression cassette with T4 DNA polymerase in the 
presence of dCTP. The two fragments were annealed and transformed into E. coli for repair of 
the nick in the annealed fragments creating a multi protein expression vector in which each 
gene has its own promoter and termination sequence. This approach allowed for the creation of 
co-expression vectors containing up to 8 subunits of INT and ~34,000 bp in size.  
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3.1.10 Cloning of a heteropentameric (INTS3/5/6/8-DDX26B) and heteroheptameric 
(INTS2/3/5/6/7/8-DDX26B) subcomplexes 
Cloning of co-expression constructs larger that 30,000 bp in size was problematic. Due to the 
size of this construct, the transformation efficiency of the standard XL1 blue chemically 
competent cells used was extremely low. Additionally, the cells turn to remove one or two 
subunits from the constructs (frequently the ORF for INTS5). To avert these problems, the 
‘NEB stable’ chemically competent cells were employed for cloning this construct and 
generally any construct bigger than 25,000 base pairs in size. Briefly, LIC qualified T4 DNA 
polymerase-treated SwaI digest of vector containing ORFs for INTS3, INTS6 and DDX26B 
was annealed with LIC qualified T4 DNA polymerase-treated PmeI digested insert of INTS5/8 
heterodimer to create the heteropentameric subcomplex. Variants of this construct where 
INTS3 or INTS6 was tagged were created. 
Constructs expressing INTS2, INTS5, INTS7 and INTS8 were also generated by the standard 
LIC cloning with affinity tag on INTS5 or INTS7 or no affinity tag. An expression constructs 
harbouring ORFs for INTS2, INTS3, INTS5, INTS6, INTS7, INTS8 and DDX26B (core-INT) 
was created by combining INTS2-INTS5-INTS7- INTS8 expression vector and INTS3-INTS6-
DDX26B expression cassette using LIC cloning with the NEB stable cell lines. Variants of this 
construct with no affinity tagged subunit or 6xHis-MBP affinity tag on INTS5 or INTS6 or 
INTS7 were created.  
3.1.11 Transformation of chemically competent cells   
In order to amplify empty cloning vectors, or for LIC cloning of ORFs into vectors, or for the 
assembly of multiple expression cassettes into a polyprotein expression construct, the ability of 
chemically competent E. coli to take up, repair, maintain and amplify plasmid DNA was 
exploited. To transformed chemically competent E. coli (XL1 Blue or NEB stable), 1 ng of 
vector plasmid DNA or 10 µl of annealed T4 DNA polymerase-treated vector and insert was 
added to 100 µl of freshly thawed cells and incubated on ice for 20 - 30 min. Cells were heat-
shock at 42 oC for 45 s and then kept on ice. Transformed cells were recovered in 1 ml of LB 
media (or the provided media in case of NEB stable cells) at 37 oC for 1 hr shaking at 1000 rpm 
on an Eppendorf thermomixer. For antibiotic selection of transformed cells, recovered cells 
were collected by spinning at 3000 rpm in an Eppendorf table top centrifuge for 3 min and 
plated onto LB agar supplemented with ampicillin (or appropriate antibiotic) and incubated 
overnight at 37 °C. Single colonies were picked from the overnight plate and grown overnight 
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in LB broth supplemented with ampicillin. Plasmid was isolated from each clonal culture using 
the QIAGEN miniprep kit following the manufacturer’s protocol. 
3.1.12 Insertion of expression cassettes into baculovirus shuttle vectors (bacmids) 
The DH10EMBacY strain of bacteria contain two accessory plasmids, pMON7124 and 
bMON14272. The pMON7124 contain among other DNA sequences a tetracycline resistance 
gene and the bacterial Tn7 transposon required for transposition of a DNA sequence flanked by 
TN7 recognition site (TN7L and TN7R) (Waddell & Craig, 1989). The bMON14272 is a 
modified version of the baculovirus shuttle vector which has a mini Tn7 attachment site (mini 
– attTn7) inserted inside a LacZ gene, a kanamycin resistance marker and all genomic regions 
of Autographa californica nuclear polyhedrosis virus (AcNPV, a species of baculoviridae) that 
are necessary for viral DNA stability and propagation in infected host cells. The chiA gene 
encoding chitinase and v-cath gene encoding cysteinase were removed for enhanced protein 
production. The shuttle vector has additionally all sequences needed for the maintenance and 
amplification of the bacmid in bacteria. It contains an eYFP gene under polH promoter for 
tracking the protein expression upon transfection of the host cells (Berger et al., 2004; Luckow 
et al., 1993). The MacroLab 438 vectors used in this study have a Tn7L and Tn7R sequences 
flanking the region which includes cloned expression cassettes and gentamycin resistance 
marker. This allows transposition of the expression cassette(s) in the 438 series into the mini – 
attTn7 in bMON14272 when transformed into DH10EMBacY E. coli. Successful transposition 
results in destruction of the LacZ gene preventing the breakdown of x-gal and resulting in 
white colored colonies. The insertion of an expression cassette was monitored by blue - white 
colony selection by plating transformed cells on LB plates supplemented with 100 ug/ml x-gal, 
1mM IPTG and 50 µg/ml gentamycin. To achieve this, 1 µg (2 µg for constructs bigger that 
25,000 base pairs) of expression vector containing expression cassette(s) of interest was 
transformed into DH10EMBacY electrocompetent cells. Cells were incubated on ice for 15 min 
after DNA was added and then transferred into a BIORAD Gene Pulser®/Micropulser™ 
electroporation cuvettes (0.1 cm gap) (BioRad). For electroporation, one pulse (25 µF, 1.8 kV) 
was applied. Transformed cells were immediately recovered in 1 ml LB media and incubated 
in 13 ml tubes (Sarstedt) at 37 oC for 5 h or overnight shaking at 150 rpm. An amount of 50 – 
100 µl of recovered cells was plated on LB agar plates supplemented with gentamycin, x-gal 
and IPTG for blue-white selection. Few white colonies were re-streaked on fresh LB plates 




3.1.13 Isolation of bacmid DNA by alkaline lysis and isopropanol precipitation  
To isolate bacmid, 5 ml (or 10 ml in the case of construct > 30 kpb) overnight culture was made 
from selected and re-streaked white colonies in LB media supplemented with 50 µg/ml 
gentamycin. Cells were harvested by centrifugation at 4000 rpm for 10 min in Eppendorf 5810 
R centrifuge. Cell pellet was resuspended in 250 µl of buffer P1, lysed by adding 250 µl of 
buffer P2 and the lysate was neutralized by adding 350 µl of buffer N3 (QIAprep SpinMiniprep 
kit). Cell debris were removed by centrifugation (10 min, 21,000g) at 4 oC. The supernatant 
was transferred into a fresh 1.5 ml Eppendorf tube and mixed with 700 µl of isopropanol. For 
efficient precipitation, the mixture was incubated overnight at -20 oC or for 1 - 2 hours at -80 
oC. DNA was pelleted by centrifugation (21,0000g, 30 min) at 4 oC. The DNA pellet was 
washed with 500 µl of 70% (v/v) ethanol and spun at 21,000g for 10 min. Finally, 30 µl of 70% 
(v/v) ethanol was added on top of the DNA and stored at -20 oC until use. 
3.2 Insect cell culture 
The baculovirus insect cell recombinant protein expression system was used for the production 
of proteins in this study because of its documented success in the production of multiprotein 
complexes (Bieniossek et al., 2013; Trowitzsch et al., 2010; Zhang et al., 2013). The SF9 cells 
were used for the production of initial baculoviruses (V0) harboring protein of interest. The 
SF21 cells were used to amplify the V0 to V1 and for expression tests and the Hi5 cells were 
used for large scale expression of proteins by infecting them with baculoviruses generated using 
SF9 and SF21. The cells were maintained in a shaking incubator (60 rpm, 27 oC) with limited 
exposure to light. Stocks were maintained at cell density of 0.5x106 – 1x106 cells/ml. Cell 
density and size were monitored daily by measuring in a CASY cell counter and analyzer 
(OMNI Life Science) and diluted back to the appropriate density. For SF9 and SF21, the final 
volume of culture was always kept at 10% of the volume of the cell culture flask whiles Hi5 
were up to 20% of the volume of the flask to allow adequate aeration. Cell cultures were kept 
under sterile conditions with aseptic techniques to avoid microbial contamination. 
3.2.1 Transfection of SF9 with bacmid for V0 production  
The 30 µl ethanol covering the bacmid DNA (from section 3.1.13) was removed and the DNA 
pellet was dried in the sterile hood for 5 -10 min to remove residual ethanol. The DNA was 
dissolved in 20 µl sterile dH20 by adding it on top of it without pipetting as this may break the 
DNA. For complete resuspension, the mixture was incubated for 10 - 20 minutes until pellet 
was fully dissolved. A master mix for transfection containing 10 µl Xtreme Gene 9 transfection 
agent (Roche) and 100 µL SF9 media (Gibco® Sf-900™ III SFM) was prepared for each 
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bacmid transfection. Once the DNA was completely dissolved, 200 µl Sf9 media and 100 µl of 
transfection agent master mix was added to each bacmid and incubated for 60 minutes.  
Two wells of a 6-well plate were seeded with 3 ml of SF9 cells at a cell density of 1x106 cells/ml 
for each bacmid. The plate was incubated at 27 oC for at least 20 min before the end of the 60 
min incubation of the bacmid and the transfection agent. A volume of 150 µl of the transfection 
master mix of each bacmid was added on top of the cells in each well (two wells for each 
bacmid). For each construct, bacmid was prepared from two independent verified white 
colonies. Plates were incubated at 27 oC and after 48 hrs, checked for successful transfection 
under the fluorescent microscope (the infected cells became fluorescent due the presence of 
eYFP). The media on top of the cells (containing the baculovirus) were harvested after 72 hrs 
and stored at 4 oC as the V0 baculovirus. 
3.2.2 Production of V1 baculoviruses 
In order to generate a highly infective baculovirus solution for large scale protein expression, 
the V0 baculoviruses were amplified in SF21 cells. To this end, 0.5 - 1 ml of V0 baculovirus 
was added to 25 ml of SF21 cells at a concentration of 1x106 cells/ml. Cells were monitored 
daily by measuring their density and size (diameter) using the CASY cell counter and analyzer. 
The cell diameter usually increases as cells swell-up upon infection. The cells were maintained 
at a density of 1x106 cells/ml until growth was arrested by the infection. The V1 was harvested 
24 - 48 hrs after the day of arrest which usually coincided with a drop-in cell viability to below 
90%. To harvest cells, the culture was transferred into a sterile 50 ml falcon and spun at 250xg 
for 15 min. The supernatant containing the V1 baculovirus was collected and stored at 4 oC 
while the cell pellet was used for Ni or Amylose affinity pull-down to monitor protein 
expression. 
3.3 Methods for protein production, purification and analysis 
All assays involving proteins were done on ice or at 4 oC unless otherwise stated. Cell lysis was 
done by sonication using a BRANSON Digital sonifier. Protein concentration was determined 
using UV absorbance values at 280 nm and the predicted molar extinction coefficient,  using 
the Lambert-Beer law.  was calculated for each protein or complex from the amino acid 
sequence using the online tool at https://web.expasy.org/protparam/.   
3.3.1 Pulldown Assay for protein expression and interaction test 
Amylose affinity or Nickel affinity pull-down was used to assess the expression and interaction 
between subunits and subcomplexes of the Integrator complex. Cell pellets from harvested V1 
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baculoviruses or expression tests were suspended in 1 ml of lysis buffer containing 20 mM 
HEPES 7.4, 150 mM NaCl, 10% glycerol, 1 mM DTT or BME or TCEP (30 mM imidazole 
was added in the case of Ni affinity pulldown). Cells were lysed by sonication with 10% 
continuous pulse for 10s. Cell debris were removed by centrifugation at 15000 rpm for 30 min 
in an Eppendorf table top centrifuge operated at 4 oC. An input sample was taken and the rest 
of the supernatant was applied to 150 µl of pre-equilibrated amylose resin (NEB) or Ni-NTA 
agarose (QIAGEN) (washed once with water and three times in lysis buffer). The beads were 
incubated on a rotating wheel (12rpm) at 4 oC for 30 and 20 min to allow binding to amylose 
resin or Ni-NTA agarose respectively. After centrifugation at 2000 rpm for 1 min, the 
supernatant containing unbound proteins was discarded and the beads were washed 3 - 4 times 
with 1 ml of lysis buffer. Bound protein was then eluted with 100 - 200 µl of elution buffer 
(100 mM Maltose in lysis buffer for amylose affinity and 500 mM Imidazole in lysis buffer for 
Ni affinity pulldown). About 10 - 20% of eluted fraction and the aliquots of 0.2 µl of the input 
were analysed by LDS-PAGE. 
3.3.2 LDS-PAGE Electrophoresis 
Protein biochemistry results were analysed using denaturing polyacrylamide gel 
electrophoresis (PAGE). To this end, appropriate fractions of expression tests or protein-protein 
interaction assays or fractions of protein purification procedures were denatured by adding 1 - 
2x of LDS sample buffer (Thermo Fisher Scientific) which denatures proteins and confers the 
same negative charge on them. An appropriate amount of the denatured proteins was resolved 
on a NuPAGE 4 - 12 % bis tris precast gel (Thermo Fisher Scientific) using 1x MOPS buffer 
(for better resolution of proteins bigger than 80 kDA) or 1x MES buffer for proteins with 
molecular weight smaller than 70 kDa. Gels were run at 180 - 200 V for 45 - 60 min and stained 
with Instant Blue (Expedeon) for visualisation. 
3.3.3 Western blotting 
The INT subunits have narrow size distribution with most of them having a molecular weight 
between 100 and 150 kDA (INTS2, INTS3, INTS4, INTS5, INTS6, INTS8 and DDX26B). 
This makes LDS-PAGE insufficient when analysing the expression or interactions of sub 
complexes involving multiple of these subunits. Western blot was applied for the detection of 
specific INT subunits using their specific antibodies. Protein bands from LDS-PAGE were 
transferred onto a nitrocellulose membrane using Trans-Blot Turbo Transfer System™ from 
BioRad. Membrane was blocked by incubating with 2% milk in PBS-T (1x PBS and 0.1% 
Tween20) on a shaker at RT for 1 hr. Specific antibody for protein of interest was added to the 
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blocked membrane and incubated at 4 oC on shaker overnight or at room temperature for 2 - 3 
hrs. Unbound antibody was discarded and the membrane was washed 3 times with 1x PBS-T. 
The membrane was then incubated with specific secondary antibody with reactivity to the 
primary antibody used. Incubation with the secondary antibody was done for 1 - 2 hrs at room 
temperature. The secondary antibodies were conjugated with horseradish peroxidase (HRP). 
Free secondary antibody was discarded and the membrane was washed 3 times with 1x PBS-
T. The membrane was covered with equal amounts (0.5 - 1 ml) of each of peroxide and an 
enhancer solution (Thermo Fisher Scientific). The blot was then imaged for chemiluminescence 
using an Intas imager.  
3.3.4 Identification of interacting subunits by systematic co-expression of subunits 
3.3.4.1 INTS5/8 heterodimer 
The ORF of INTS8, INTS10 and INTS12 were cloned into 438-A vector and INTS5 was cloned 
into 438-C which contain an N-terminus 6xHis-MBP tag. The four vectors were further cloned 
by LIC resulting in a four-subunits co-expression construct containing 6xhis-MBP-INTS5, 
INTS8, INTS10 and INTS12. For protein expression, V0 and V1 baculoviruses were produced 
for this construct (Section 3.2). The cell pellet from the V1 baculovirus was used for amylose 
affinity pulldown (Section 3.3.1) followed my mass spectrometric identification of proteins in 
the elution fraction of the pulldown.  
3.3.4.2 INTS/14 heterodimer 
The ORFs of INTS14 was cloned into 438-A vector and INTS13 was cloned into 438-C which 
contain an N-terminus 6xHis-MBP tag. The vectors were combined by LIC into a two-subunits 
expression construct containing 6xhis-MBP-INTS13, and INTS14. V0 and V1 baculoviruses 
were produced for this construct. The cell pellet from the V1 baculovirus was used for amylose 
affinity pulldown followed my mass spectrometric identification of proteins in the elution 
fraction of the pulldown.  
The experiment described above (sections 3.3.4.1 and 3.3.4.2) was done using various 
combinations of INT subunits/subcomplexes varying the tagged subunit in order to test their 
direct protein-protein interaction 
3.3.5 Co-infection and partial purification of full Integrator complex from three 
baculoviruses 
3.3.5.1 Co-infection  
Based on the information accumulated from systematic co-expression and the available 
literature (Section 1.3), three polyprotein expression constructs were made each containing 
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interacting subunits of INT where possible. Subunits, INTS1, INTS3, INTS6 and INTS12 were 
in one vector with a 6xHis-MBP affinity tag on INTS1. Subunits, INTS5, INTS8, INTS10, 
INTS13, INTS14 and DDX26B were also in one vector with a 6xHis-MBP affinity tag on 
INTS5. DDX26B was added to this construct because it was convenient and faster to clone into 
it. The third vector contained INTS2, INTS4, INTS7, INTS9 and INTS11 with a 6xHis-MBP 
on INTS11. INTS2 and INTS7 did not interact with the INTS4/9/11 heterotrimer but were clone 
together for convenience. V0 and V1 baculoviruses were produced for each expression construct 
and the expression of at least the affinity tagged subunits and its associated interaction partners 
were assessed via amylose affinity pulldown and LDS-PAGE analysis. This was important in 
order to know that all baculoviruses are viable. Protein co-expression from each baculoviruses 
was induced by co-infecting 600ml of Hi5 cells at 1x106 cells/ml with 100 µl of each 
baculovirus. Cell viability, density and diameter were monitored in 24 – hour interval and cells 
were diluted when density exceeded 1x106 cells/ml. Cultures were harvested after 72 hours, the 
supernatant was discarded and the cell pellet was resuspended in 60 ml of resuspension buffer 
(20 mM HEPES pH 7.4, 300 mM NaCl, 5% glycerol, 1 mM DTT, 0.284 μg/ml leupeptin, 1.37 
μg/ml pepstatin A, 0.17 mg/ml PMSF, 0.33 mg/ml benzamidine), flash frozen in liquid nitrogen 
and stored at -80 oC. 
3.3.5.2 Partial purification of full INT. 
The term “partial purification” is used here because three 6xHis-MBP affinity tagged subunits 
of INT were involved in the purification and the stoichiometry of the resultant complex cannot 
be guaranteed. Pellets were quickly thawed in water bath at room temperature and transferred 
on ice. Lysis was done by sonication (30% amplitude for 4 min 0.4 s pulse on and 0.6 s pulse 
off). After sonication, lysate was cleared by centrifugation at 87,207xg for 30 min at 4 oC and 
the supernatant was transferred into an ultracentrifuge tube and further spun for 1 hr at 45000 
rpm at 4 oC using a Ti45 rotor in an ultracentrifuge (Beckman Coulter). The supernatant was 
then filtered through a 0.8 um syringe filter for additional clearance.  
A 20ml of 50% amylose slurry (NEB) was washed 3x with ddH2O water and then another 3x 
with lysis buffer. Each wash and equilibration step were done in a 50 ml falcon tube and all 
centrifugations were done at 190xg for 5 min. The cleared lysate was incubated with the 
equilibrated slurry for 60 min rotating at 4 rpm at 4 °C to bind the complexes through the tagged 
proteins. After binding, beads were washed 2x with 30 ml lysis buffer and then 2x with low salt 
buffer (20 mM HEPES pH 7.4, 150 mM NaCl, 5% glycerol, 1 mM DTT). After the washing 
steps, bound protein was eluted 4x with 20ml of 100 mM maltose in low salt buffer and 5 µl of 
each elution fraction and 5 µl of 1 in 30 dilution of the unbound and wash fractions were 
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analyzed on LDS-PAGE. Elution fractions containing protein of interest were pulled and 
applied to a 5 ml HiTrap Q column equilibrated in low salt buffer. The column was washed 
with 50 ml (10 column volumes) of the low salt buffer and then eluted with a gradient from 0 
to 100% high salt buffer (20 mM HEPES pH 7.4, 850 mM NaCl, 5% glycerol, 1 mM DTT) 
over 18 column volumes. A 10 µl sample from each fraction of the elution peak was analysed 
by LDS-PAGE. Peak fractions were pulled and concentrated and a 100 µg portion was removed 
and crosslinked with 1 mM BS3 for 30 min on ice. The crosslinking reaction was quenched by 
adding 50 mM NH4HCO3 and the proteins were precipitated using 4 volumes of acetone. The 
precipitates were dissolved in 4 M urea/50 mM NH4HCO3 followed by identification of 
crosslinked peptides by mass spectrometry (XL-MS). An aliquot of the partially purified 
complex (~100 µg) was used for analytical gel filtration by applying it to a Superose 6 Increase 
3.2/300 column (GE life sciences) equilibrated in low salt buffer (20 mM HEPES pH 7.4, 150 
mM NaCl, 5% glycerol, 1 mM DTT). A sample from the main peaks of the gel filtration run 
(0.05 - 0.1 mg/ml) was stabilized by crosslinking with 0.1% glutaraldehyde for 10 min on ice. 
The crosslinking reaction was quenched by adding 100 mM Tris - HCl (pH 8) and and 10 mM 
aspartate. The stabilized complex was analysed by negative stain electron microscopy. 
3.3.6 Identification of interaction partners of INTS3/6-DDX26B heterotrimer by co-
infection with different subcomplexes/subunits of INT 
The XL-MS results from section 3.3.5 show a strong interaction between INTS3 and DDX26B 
leading to the identification of the heterotrimeric subcomplex of INTS3, INTS6 and DDX26B. 
V1 baculoviruses expressing INTS3/6-DDX26B (no affinity tag) as well as 6xHis-MBP tagged 
INTS1, 6xHis-MBP tagged INTS12, INTS2/7 heterodimer with a 6xHis-MBP tag on INTS7, 
INTS5/8 heterodimer with a 6xHis-MBP tag on INTS5, INTS4/9/11 heterotrimer with 6xHis-
MBP tag on INTS11 and INTS10/13/14 heterotrimer with 6xHis-MBP tag on INTS13 were 
produced. To identify which subcomplexes/subunits have direct protein–protein interaction 
with INTS3/6-DDX26B heterotrimer, 25 ml of Hi5 cells at 1x106 cells/ml were co-infected 
with 12.5 µl of the V1 baculovirus expressing INTS3/6-DDX26B and 12.5 µl of another V1 
baculovirus expressing the tagged version of the subunits/subcomplexes of INT mentioned 
above. Cell density, diameter and viability in each culture were measured after 24 hours and 
the cultures were diluted appropriately to bring cell density to 1x106 cells/ml and cultures were 
grown for 48 hrs. After measuring cell density, 25x106 cells were harvested from each culture 
by centrifugation at 385xg for 15 min at 4 oC. Cells were resuspended in a lysis buffer 
containing 20 mM HEPES 7.4, 150 mM NaCl, 10% glycerol, 1 mM TCEP 10 µM ZnCl2, 0.284 
μg/ml leupeptin, 1.37 μg/ml pepstatin A, 0.17 mg/ml PMSF, 0.33 mg/ml benzamidine and used 
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for pulldown as described in section 3.3.1 with 100 µl of 50 % amylose resin. A sample of the 
elution (10 µl) and 0.5 µl of input for each sample were analyzed by LDS-PAGE and western 
blot with a rabbit anti INTS3 antibody (Abcam).  
3.3.7 Sucrose Density Gradient Centrifugation  
Sucrose density centrifugation is a gentle method for separating protein complexes according 
to their sizes in their native state. It is particularly useful for fragile complexes that might fall-
apart under gel filtration conditions and for huge complexes that elute close to the void volume 
and cannot be separated from aggregated proteins by gel filtration. This method was used to 
separate the various subcomplexes of INT as well as complexes between INT and Pol II 
elongation complexes. A light sucrose solution (15 % w/v) was made containing sucrose and 
all other components of the protein buffer of choice as well as a heavy solution prepared 
similarly but contained 30% (w/v) sucrose. A 15 - 30% linear sucrose density gradient was 
prepared by layering 2 ml of light solution (15% sucrose) on top of 2 ml of heavy solution. The 
two layers were mixed into a linear gradient using BioComp 108 Gradient master. 50 - 300 µg 
of protein or complex (in 50 - 200 µl) was loaded on top of the gradient after appropriate volume 
was removed from the top to accommodate the sample. The gradient was then spun at 32,000 
rpm for 16 hours at 4 °C. The gradient was fractionated into 200 µl fractions from the top and 
stored on ice. Sample from selected fractions were analysis by LDS-PAGE. 
3.4 Expression and purification of Proteins 
3.4.1 Expression and Purification of INTS4/9/11 heterotrimer 
Expression 
The ORF of INTS4 and INTS9 were cloned into the MacroLab 438-A vector and INTS11 was 
cloned into 438-C which has an N-terminus 6xHis-MBP tag. The three vectors were combined 
by LIC into a three subunits polyprotein expression construct containing 6xhis-MBP-INTS11, 
INTS4 and INTS9. V0 and V1 baculoviruses were produced for this construct and expression 
of all three proteins was validated by pulldown experiment using the cell pellet from the V1 
baculovirus. For protein expression, 2x 600 ml of Hi5 insect cells at 1x106 cells/ml was infected 
with 300 µl of the V1 baculovirus in a 3 l flask. Cell density, viability and size were monitored 
in 24 hrs intervals and cells were diluted when the density went higher than 1x106 cells/ml. 
Normally, the cells divided once in 24 hours and then got arrested by the baculovirus indicated 
by increase in cell diameter and stationary growth. Cultures were harvested when viability 
drops below 85% (usually within 72 hrs) by centrifugation at 238xg for 30 min. The supernatant 
was discarded and the cell pellet from 1 l culture was resuspended in 35 ml of lysis buffer (20 
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mM HEPES pH 7.4, 300 mM NaCl, 30 mM imidazole 10% glycerol, 10 mM BME 10 µM 
ZnCl2, 0.284 μg/ml leupeptin, 1.37 μg/ml pepstatin A, 0.17 mg/ml PMSF, 0.33 mg/ml 
benzamidine). The harvested cells were flash frozen in liquid nitrogen and store at -80 oC until 
purification. 
Purification 
The frozen pellets were thawed in a water bath at 25 oC and lysed by sonication with 30% 
amplitude for 2 min with 0.6 s pulse on and 0.4 s pulse off. The lysate was cleared by 
centrifugation at 87,207xg for 1 hr and filtered with a 0.8 µm syringe filter. The cleared lysate 
was applied to a pre-equilibrated 5 ml HisTrap column at a flow rate of 1.5 ml/min and the 
column was washed with 100 ml of wash buffer (20 mM HEPES pH 7.4, 300 mM NaCl, 30 
mM imidazole 10% glycerol, 10 mM BME 10 µM ZnCl2). A self-packed amylose column with 
a total bed volume of 15 ml pre-equilibrated in wash buffer was connected in tandem to the 5 
ml HisTrap column and the bound protein was eluted from the HisTrap column unto the 
amylose column using Ni elution buffer containing 20 mM HEPES pH 7.4, 300 mM NaCl, 10% 
glycerol, 10 mM BME 10 µM ZnCl2, 250 mM Imidazole. The HisTrap column was detached 
and the amylose column was washed with 100 ml of wash buffer before eluting with wash 
buffer supplemented with 100 mM maltose. The fractions containing the heterotrimeric 
complex were pulled and treated overnight with catalytic amounts of 6xHis-TEV protease and 
lambda phosphatase (home made in our laboratory) in the presence of 1 mM MnCl2 to remove 
the affinity tag and remove post-translational phosphorylations from the insect cells. The 
protein was applied again to an equilibrated 5 ml HisTrap in a reverse nickel affinity step to 
remove the TEV protease, the affinity tag and proteins with affinity tag. The unbound protein 
was collected and concentrated using a 100 kDa cut-off Amicon ultra centrifugal filter 
(MERCK Millipore). The protein was purified on a superpose 6 increase gel filtration column 
equilibrated in gel filtration buffer containing 20 mM HEPES pH 7.4, 300 mM NaCl, 10% 
glycerol, 10 mM BME 10 µM ZnCl2. The elution peak was concentrated and stored is 5 µl 
aliquots at -80 oC. In order to test interaction with other subunits/subcomplexes via in vitro 
pulldown experiments, INTS4/9/11 heterotrimer was also purified without removing the 
affinity tag. 
3.4.2 Expression and Purification of INTS10/13/14 heterotrimer 
Expression 
The ORF of INTS10 and INTS14 were cloned into the MacroLab 438-A vector and INTS13 
was cloned into 438-C carrying a 6xHis-MBP tag or 438-B carrying a 6xHis tag. The three 
vectors were combined by LIC into a three subunits polyprotein expression construct containing 
Methods 
 19 
6xhis-MBP-INTS13, INTS10 and INTS14 or 6xhis-INTS13, INTS10 and INTS14. V0 and V1 
baculoviruses were produced for these constructs and expression of all three proteins was 
validated by pulldown experiment using the cell pellet from the V1 baculovirus. Protein 
expression and harvesting of cultures was as described for the INTS4/9/11 heterotrimer (section 
3.4.1). The cell pellet from 1 l culture was resuspended in 35 ml of lysis buffer (20 mM HEPES 
pH 7.4, 200 mM NaCl, 10% glycerol, 10 mM BME 30 µM imidazole, 0.284 μg/ml leupeptin, 
1.37 μg/ml pepstatin A, 0.17 mg/ml PMSF, 0.33 mg/ml benzamidine). The harvested cells were 
flash frozen in liquid nitrogen and store at -80 oC until purification. 
Purification 
Frozen cell pellets expressing the recombinant subcomplex was thawed in a water bath at 25 
oC. Cell lysis and clearance of the lysate was as described for the INTS4/9/11 heterotrimer 
(section 3.4.1). The cleared lysate was applied to a pre-equilibrated 5 ml HisTrap column at a 
flow rate of 1.5 ml/min and contaminating proteins were removed by washing the column with 
100 ml of the lysis buffer. A self-packed amylose column with a total bed volume of 15 ml pre-
equilibrated in lysis buffer was connected in tandem to the 5 ml HisTrap column and the bound 
protein was eluted from the HisTrap column onto the amylose column using Ni elution buffer 
containing 20 mM HEPES pH 7.4, 200 mM NaCl, 10% glycerol, 10 mM BME, 250 mM 
Imidazole. The HisTrap column was detached and the amylose column was washed with 100 
ml of lysis buffer before eluting with amylose elution buffer containing 20 mM HEPES pH 7.4, 
200 mM NaCl, 10% glycerol, 10 mM BME, 100 mM maltose. For purification from 
baculovirus expressing 6xhis-INTS13, INTS10 and INTS14, protein was eluted from the 
HisTrap column with a gradient (0-100%) of Ni elution buffer containing 20 mM HEPES pH 
7.4, 200 mM NaCl, 10% glycerol, 10 mM BME, 500 mM Imidazole. Fractions containing the 
heterotrimeric complex were pulled and treated with catalytic amounts 6xHis-tagged TEV 
protease and lambda phosphatase (home made in our laboratory) in the presence of 1 mM 
MnCl2 to remove the affinity tag and potential post-translational phosphorylations. The protein 
was applied again to an equilibrated 5 ml HisTrap in a reverse nickel affinity step to remove 
the TEV protease, the affinity tag and proteins with affinity tag. The unbound protein was 
collected, concentrated using a 100 kDa cut-off Amicon ultra centrifugal filter and applied to a 
Superose 6 Increase gel filtration column equilibrated in gel filtration buffer containing 20 mM 
HEPES pH 7.4, 150 mM NaCl, 10% glycerol, 10 mM BME. The elution peak was concentrated 
and stored in 5 µl aliquots at -80 oC. In order to test interaction with other 
subunits/subcomplexes via affinity pull-down experiments, INTS10/13/14 heterotrimer was 




3.4.3 Expression and purification of heteropentameric subcomplex (INTS3/5/6/8/-
DDX26B) 
Expression 
A construct expressing the pentameric subcomplex of INTS3, INTS5, INTS6, INTS8 and 
DDX26B (INTS3/5/6/8-DDX26B) was created using LIC cloning (Section 3.1.10) with 6xHi-
MBP affinity tag on INTS6. Baculovirus expressing this subcomplex was produced (V0 and 
V1) and expression was confirmed via V1 amylose affinity pulldown. For protein expression, 
Hi5 insect cells at a density of 1x106 cell/ml were infected with the V1 baculovirus at 1:2000 
(v/v) baculovirus to culture volume ratio. Cultures were monitored in 24-hr interval and diluted 
accordingly to ensure cell density did not exceed 1x106 cell/ml. Cultures were harvested after 
48 hours and cell pellets were suspended in a lysis buffer (35 ml/l of culture) containing 25 mM 
Tris-HCl pH 8, 200 mM NaCl, 10% glycerol, 10 mM BME 10 µM ZnCl2, 0.284 μg/ml 
leupeptin, 1.37 μg/ml pepstatin A, 0.17 mg/ml PMSF, 0.33 mg/ml benzamidine. Resuspended 
cells were flash frozen in liquid nitrogen and stored at -80 oC until purification. 
Purification 
Lysis of cells expressing the heteropentamer and clearance of the lysate to remove cell debris 
was as described for the INTS4/9/11 heterotrimer (section 3.4.1). The cleared lysate was 
applied to a preequilibrated 25 ml bed volume self-packed amylose column at a flow rate of 1.0 
ml/min and the column was washed with 100 ml of wash buffer (25 mM Tris–HCl pH 8, 0.2 
M NaCl, 10 mM BME, 10 µM ZnSO4, 10% glycerol). An equilibrated 5 ml HiTrap Q column 
was then connected to the amylose column and the bound protein complex was eluted from the 
amylose column using wash buffer supplemented with 100 mM maltose. The amylose column 
was disconnected and the HiTrap Q column was washed with 50 ml of wash buffer prior to 
elution with a gradient (0-100%) of high salt buffer (25 mM Tris–HCl pH 8, 1 M NaCl, 10 
mM BME, 10 µM ZnSO4, 10% glycerol). The peak fractions were pulled, concentrated (100 
kDa cut-off Amicon Ultra Centrifugal filter form Millipore) and applied to a Sephacryl S-300 
gel filtration column equilibrated in gel filtration buffer (20 mM HEPES pH 8, 0.2 M NaCl, 10 
mM BME, 10 µM ZnSO4, 10% glycerol). An aliquot from the elution peak was used for 
negative stain electron microscopy after fixation with 0.1% glutaraldehyde and the rest was 





3.4.4 Expression and purification of core-INT (INTS2/3/5/6/7/8-DDX26B)  
Expression 
Cloning of the core-INT subcomplex was described (Section 3.1.10) and expression was 
exactly as described for the heteropentameric subcomplex (INTS3/5/6/8-DDX26B) in section 
3.4.3. Harvested Hi5 cells expressing the core-INT were resuspended in lysis buffer (20 mM 
HEPES pH 7.4, 150 mM NaCl, 10% glycerol, 1 mM TCEP 10 µM ZnCl2, 0.284 μg/ml 
leupeptin, 1.37 μg/ml pepstatin A, 0.17 mg/ml PMSF, 0.33 mg/ml benzamidine) and stored at 
-80 oC until purification. 
Purification 
The purification strategy used was the same as for the heteropentameric subcomplex 
(INTS3/5/6/8-DDX26B) described above in section 3.4.3. Except that HEPES pH 7.4 was used 
in place of Tris-HCl pH 8 and the final gel filtration step was omitted. The protein was either 
purified further by a sucrose density gradient or was used directly for downstream experiments 
after concentration. 
3.4.5 Reconstitution of 13-subunits subcomplex of INT and full INT 
Freshly purified core-INT with 6xhis-MBP tag on INTS6 (100 µg) was immobilized on pre-
equilibrated amylose beads by incubating for 1 hr at 4 oC on a rotating wheel (10 rpm). Beads 
were washed 3x with 800 µl of binding buffer (20 mM HEPES pH 7.4, 150 mM NaCl, 10% 
glycerol, 1 mM TCEP 10 µM ZnCl2) to remove unbound core-INT and divided into two parts 
of 100 µl. Purified INTS4/9/11 and INTS10/13/14 were added in 3 molar excess to one part of 
the immobilized core-INT and incubated for 1 hour at 4 oC on a rotating wheel (10 rpm). Beads 
were washed 4x with binding buffer and eluted with 40 µl of binding buffer containing 100mM 
maltose. 10 µl of LDS sample buffer was added to the elution and analyzed by LDS-PAGE.  
The reconstitution of the full Integrator complex for crosslinking mass spectrometry was done 
similarly with the addition of partially purified INTS1 and INTS12 starting with 500 µg of core-
INT. The crosslinking reaction was done as described before (Section 3.3.5.2) except that 3 
mM BS3 was used and the reaction was incubated at room temperature.  
3.4.6 Expression and purification of INTS1 and INTS12 interacting domains 
Expression  
The ORFs for INTS1 and INTS12 were cloned in 438-B and 438-A respectively by LIC. The 
truncation of these proteins was done using ‘round-the-horn’ PCR (see Section 3.1.2). The 
truncated variants in their respective 438 vectors were combined into a polyprotein expression 
vector harboring 6xHis-INTS1(1-294) and INTS12(1-194) by LIC. The production of V0 and 
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V1 baculoviri was done in SF9 and SF21 cells respectively and protein expression was done in 
Hi5 insect cells. The Hi5 cells were monitored and the cells were harvested after 72 hrs and cell 
pellets were resuspended in 20 mM HEPES pH 7.4, 150 mM NaCl, 1 mM TCEP, 10 µM ZnCl2, 
10% glycerol (35 ml/liter of hi5) and flash frozen and stored at -80 oC. 
Purification 
The cell pellets from 1.4 l of Hi5 cells expressing the INTS1(1-294)/INTS12(1-194) 
heterodimer were thawed in a water bath at room temperature and lysed by sonication with 30% 
amplitude for 2 min with 0.6 s pulse on and 0.4 s pulse off in a sonicator. The lysate was cleared 
by centrifugation at 87,207xg for 1 hr and filtered with a 0.8 µm syringe filter. The cleared 
lysate was applied to a preequilibrated 5 ml HisTrap column at a flow rate of 1.5 ml/min and 
the column was washed with 50 ml of a wash buffer (20 mM HEPES pH 7.4, 0.4 M NaCl, 1 
mM TCEP, 10 µM ZnCl2, 10% glycerol) followed by 25 ml of lysis buffer (20 mM HEPES pH 
7.4, 0.15 M NaCl, 1 mM TCEP, 10 µM ZnCl2, 10% glycerol). An equilibrated 5 ml HiTrap Q 
column was then connected in tandem to the HisTrap column and the bound protein complex 
was eluted from the HisTrap column using Ni elution buffer (lysis buffer supplemented with 
500 mM Imidazole). The protein did not bind to the HiTrap Q column but this step was essential 
for removing some contaminating proteins that were bound by this column. The fractions from 
the HisTrap elution containing the heterodimeric complex were pulled and treated overnight 
with 6xHis-TEV and dialyzed against lysis buffer to remove the affinity tag and reduce 
imidazole concentration respectively. The protein was applied again to an equilibrated 5 ml 
HisTrap in a reverse nickel affinity step to remove the TEV protease, the affinity tag and 
proteins with the affinity tag (undigested). The protein still bound the column but could be 
separated from the TEV protease in a different peak. The fractions containing the complex of 
interest were collected, concentrated using a 30 kDa cut-off Amicon ultra Centrifugal filter and 
applied to a hiload 16/600pg Superdex 200 gel filtration column equilibrated in gel filtration 
buffer containing 20 mM HEPES pH 7.4, 150 mM NaCl, 10% glycerol, 10 mM TCEP 10 µM 
ZnCl2. The elution peak was concentrated and stored in 5 µl aliquots at -80 oC. 
 
3.4.7 Expression and purification of NELF and INTS3 
Expression  
The cDNA encoding the full length INTS3 was cloned into 438-C expression vector. This 
expression vector was combined by LIC with an expression vector harbouring the expression 
cassettes of the full length NELF complex comprising NELF -A, NELF -B, 6xHis tagged NELF 
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-C and NELF -E or a NELF complex variants lacking NELF -E or NELF tentacle deletion 
mutants in which NELF -A (1-188) and/or NELF -E (1-138), were combined with full length 
NELF -B and C. All NELF constructs were kindly provided by Seychelle Vos and described 
(Vos, Farnung, Urlaub, et al., 2018). Expression of INTS3-NELF or its variants was done as 
described (Vos, Farnung, Urlaub, et al., 2018). Harvested Hi5 cells expressing INTS3-NELF 
was resuspended in 40 ml of lysis buffer (20 mM HEPES pH 7.4, 300 mM NaCl, 10% glycerol, 
30 mM imidazole, 1 mM DTT, 0.284 µg/ml leupeptin, 1.37 µg/ml pepstatin A, 0.17 mg/ml 
PMSF, and 0.33 mg/ml benzamidine), flash-frozen in liquid nitrogen and stored at –80°C until 
purification. 
Purification 
Frozen pellets were quickly thawed in a water bath at room temperature and 1 mg DNase1 
(Sigma-Aldrich) was added. Cells were lysed by sonication (30% amplitude, 2 minutes, 0.6s 
on, 0.4s off). Lysate was cleared by centrifugation for 60 minutes (87,207xg, 4 oC). Clarified 
lysate was filtered with a 0.8 µm syringe filter. A 5 ml HisTrap column, 5 ml HiTrap Q column 
and a self-packed 15 ml amylose resin were equilibrated in a low salt buffer (20 mM HEPES 
pH 7.4, 150 mM NaCl, 10% glycerol, 30 mM imidazole, 1 mM DTT). 
Filtered lysate was applied to the HisTrap column via a peristaltic pump/sample pump. The 
column was washed with 50 ml lysis buffer, followed by 25 ml low salt buffer. The nickel 
column was connected to the equilibrated self-packed amylose and the HiTrap Q columns 
(HisTrap - amylose - HiTrap Q) and bound proteins were eluted from the HisTrap column using 
Ni elution buffer (250 mM imidazole in low salt buffer). The columns were washed with 150 
ml of low salt buffer and the 5ml HiTrap Q (with bound free NELF) was detached before the 
amylose column was eluted with amylose elution buffer (20 mM HEPES pH 7.4, 150 mM 
NaCl, 10% glycerol, 30 mM imidazole, 1 mM DTT, 100 mM maltose). The HiTrap Q was 
eluted separately with a gradient (0-100%) of high salt buffer (20 mM HEPES pH 7.4, 850 mM 
NaCl, 10% glycerol, 30 mM imidazole, 1 mM DTT). Peak fractions were analyzed by LDS-
PAGE (10 µl, 4-12% Bis-Tris gel, MES buffer). The fractions from the amylose elution, 
containing INTS3 and under-stoichiometric NELF complex as well as the HiTrap Q elution 
with only NELF complex were separately treated with catalytic amounts of His6-TEV protease 
and lambda protein phosphatase to remove affinity tags and potential post-translational 
phosphorylations of the proteins respectively. 
The samples (after amylose and HiTrap Q elution) were applied separately to 5 mL HisTrap 
column equilibrated in low salt buffer with a peristaltic pump and the flow through was 
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collected. The bound proteins were eluted with the Ni elution buffer from the columns and 
fractions from the flow through as well as the elution were analyzed by LDS-PAGE.  
The flow through fractions from both samples were concentrated with a 100K cut-off Amicon 
Ultra filter (MERCK Millipore) to 2-4 ml. The sample containing the NELF complex was 
applied to a hiload 16/600pg Superdex 200 gel filtration column equilibrated in gel filtration 
buffer (20 mM HEPES pH 7.4, 150 mM NaCl, 10% glycerol, 1 mM DTT). The elution peak 
was analyzed by LDS-PAGE (10 µl, 4-12% Bis-Tris gel, MES buffer). The peak fractions were 
pooled and concentrated aliquoted and stored at -80 oC. 
Protein from the amylose elution which contains mostly INTS3 was also applied to the hiload 
16/600pg Superdex 200 gel filtration column equilibrated in gel filtration buffer. The elution 
peaks were analyzed by SDS-PAGE (10 µL, 4-12% Bis-Tris gel, MES buffer). Appropriate 
fractions containing INTS3 – NELF complex as well as just INTS3 were pulled separately and 
concentrated. Proteins were aliquoted, flash-frozen in liquid nitrogen and stored at -80 oC.  
3.4.8 Purification of Mammalian RNA Pol II 
Mammallian RNA Pol II was purified from S. scrofa thymus (obtained from E. Wolf, Ludwig 
Maximilian University of Munich) essentially as described (Bernecky et al., 2016). Gdown 
containing fractions from Uno Q ion exchange step were discarded before a final size-exclusion 
step was done using a Sephacryl S-300 16/60 column preequilibrated into Pol II buffer (10 mM 
HEPES pH 7.25, 150 mM NaCl, 10% glycerol, 10 µM ZnCl2, and 1 mM DTT). Peak fractions 
containing Pol II were concentrated in 100K cut-off Amicon Ultra Centrifugal Filter (Merck 
Millipore), aliquoted, flash-frozen in liquid nitrogen, and stored at -80 oC.  
3.4.9 Purification of human DSIF 
Cloning and expression of full length DSIF (SPT4 and SPT5) was described (Bernecky et al., 
2017) and purification was done according to the protocol by Vos and colleagues (Vos, 








3.5 Formation and characterization of complexes between INT (INTS3) and RNA 
Pol II paused elongation complex  
3.5.1 Formation of INTS3 – Paused elongation complex (INTS3-PEC) 
INTS3 - PEC was formed essentially as described for the PEC (Vos, Farnung, Urlaub, et al., 
2018) using the same nucleic acid scaffolds. Briefly 88 pmol final Pol II, 200 pmol of annealed 
RNA-template DNA, 300 pmol non-template DNA were assembled as described. INTS3, DSIF 
and NELF were added in a fourfold molar excess relative to Pol II in a final buffer containing 
20 mM HEPES pH 7.4, 100 mM NaCl, 3 mM MgCl2, 1 mM DTT, 4% glycerol. The complex 
was incubated for 30 min at 30 oC and applied to a Superose 6 Increase 3.2/300 column 
equilibrated in the complex buffer. Peak fractions were analyzed by LDS-PAGE 
and appropriate fractions from the peak was pulled and crosslinked with 2 mM BS3 for XL-
MS. Similar approach was used for the preparation of cryo-EM grids except that each fraction 
from the elution peak was treated independently and few cryo grids were froze from each 
fraction from the elution peak. 
3.5.2 Formation of INT – PEC 
To test whether the reconstituted INT interacts with the recently described pause elongation 
complex (PEC), PEC was formed as previously described with the following modifications 
(Vos, Farnung, Urlaub, et al., 2018). Briefly 30 pmol final Pol II, 100 pmol of annealed RNA-
template DNA, 200 pmol non-template DNA were assembled as described. ~ 30 pmols of 
freshly purified core-INT, 100 pmol of INTS10/13/14 (CMIM), 100 pmol of INTS4/9/11(CM) 
and 200 pmols of INTS1(1-294)/INTS12(1-194) heterodimer were pre-incubated together for 
1 hr at 4 oC and added to the Pol II and nucleic acids complex and incubated for 10 mins before 
DSIF and NELF were added (200 pmols each). The reaction was incubated for additional 30 
min at 30 oC in a final buffer contain 20 mM HEPES pH 7.4, 100 mM NaCl, 4% glycerol, 3 
mM MgCl2, 1 mM TCEP. The complex was separated on a 15-30% sucrose density gradient 
spinning at 32000 rpm using an SW60 rotor in an ultra-centrifuge (Beckmann Coulter). The 
gradient was manually fractionated into 200 µl from the top. Each gradient fraction was 
concentrated to 40 µl using a 0.5 ml 100 kDa cut-off Amicon Ultra Centrifugal filter and 10 µl 
of LDS sample buffer was added for LDS-PAGE analysis.  
For crosslinking mass spectrometry analysis of INT-PEC complex, PEC was formed as 
described using the same nucleic acid scaffolds (Vos, Farnung, Urlaub, et al., 2018). Briefly 
117 pmol final Pol II, 300 pmol of annealed RNA–template DNA, 400 pmol non-template DNA 
were assembled as described. DSIF and NELF were added in a fourfold molar excess relative 
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to Pol II in a final buffer containing 20 mM HEPES pH 7.4, 100 mM NaCl, 4% glycerol, 3 mM 
MgCl2, 1 mM TCEP. The sample was incubated for 30 min at 30 oC and applied to a Superose 
6 Increase 3.2/300 column equilibrated in the complex buffer. Peak fractions were analyzed by 
SDS–PAGE. In parallel, INT was assembled using 100 pmol of freshly purified core-INT, 100 
pmol each of INTS4/9/11 (CM) and INTS10/13/14 (CMIM) and 200 pmol of INTS1(1-
294)/INTS12(1-194) and incubated on ice for 1 hour in 20 mM HEPES 7.4, 150 mM NaCl, 
10% glycerol, 1 mM TCEP 10 µM ZnCl2. The assembled INT was mixed with the peak 
fractions of PEC and incubated for 30 min at 30 oC. The complex was crosslinked with 3 mM 
BS3 for 30 min at 30 oC. The crosslinking reaction was quenched with 50 mM Tris pH 7.5. The 
crosslinked complex was precipitated with 4 volumes of ice-cold acetone and 0.2 volumes of 
CH3COONa and incubated at -20 oC overnight. Protein precipitates were isolated by 
centrifugation at 15000 rpm for 30 min in an Eppendorf table top centrifuge and dissolved in 4 
M urea, 50 mM NH4HCO3 for mass spectrometric analysis. 
 
3.5.3 Analysis of complexes by XL-MS 
Enzymatic digestion of crosslinked complexes and enrichment of crosslinked peptide 
pairs  
Crosslinked proteins (resuspended in 4 M urea/50 mM ammonium bicarbonate) were reduced 
with 10 mM dithiothreitol (DTT) for one hour at room temperature (RT). Alkylation was 
performed by adding iodoacetamide (IAA) to a final concentration of 40 mM, incubated 30 min 
in the dark at RT. After dilution to 1 M urea with 50 mM ammonium bicarbonate (pH 8.0), 
crosslinked protein complexes were digested with trypsin (Promega) in a 1:50 enzyme-to-
protein ratio at 37 oC overnight. Peptides were acidified with trifluoroacetic acid (TFA) to a 
final concentration of 0.5% (v/v), desalted with MicroSpin Colums (Harvard Apparatus) 
following manufacturer’s instructions and vacuum dried. Dried peptides were dissolved in 50 
µl 30% acetonitrile (ACN)/0.1% TFA and peptide size exclusion (pSEC, Superdex Peptide 
3.2/300 column) was performed to enrich for crosslinked peptides at a flow rate of 50 µl/min. 
Fractions of 50 µl were collected. Fractions containing the crosslinked peptides (1-1.5 ml) were 
vacuum dried and dissolved in 4% ACN/0.05% TFA (v/v) for subsequent LC-MS/MS analysis. 
In-gel digestion 
Cross-linked proteins were separated by SDS-PAGE using a 4-12% gradient gel (NuPAGE, 
Invitrogen) for 45 min at 200 V. After Coomassie staining, gel lanes were cut into 23 slices and 
chopped into small pieces. Proteins were reduced and alkylated with 10 mM DTT and 55 mM 
IAA, respectively. 0.3 µg trypsin (Sigma Aldrich) was used for digestion, incubated at 37°C 
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overnight. Peptides were extracted with 100% ACN and 5% formic acid, vacuum dried, 
dissolved in 2% ACN/0.05% TFA and subjected to LC-MS/MS analysis. 
LC-MS/MS analysis  
Crosslinked peptides derived from pSEC or in-gel digestion were analysed as technical 
duplicates on an Orbitrap Fusion, an Orbitrap Fusion Lumos Tribrid or an Q Exactive HF-X 
Mass Spectrometer (Thermo Scientific), depending on the experimental design, coupled to a 
Dionex UltiMate 3000 UHPLC system (Thermo Scientific) equipped with an in house-packed 
C18 column (ReproSil-Pur 120 C18-AQ, 1.9 µm pore size, 75 µm inner diameter, 30 cm length, 
Dr. Maisch GmbH). Samples were separated applying the following 58 min gradient: mobile 
phase A consisted of 0.1% formic acid (FA, v/v), mobile phase B of 80% ACN/0.08% FA (v/v). 
The gradient started at 5% B, increasing to 8-20% B within 3 min, followed by 8-20% to 46% 
B within 43 min, depending on the experimental design, then keeping B constant at 90% for 6 
min. After each gradient the column was again equilibrated to 5% B for 6 min. The flow rate 
was set to 300 nl/min. MS1 spectra were acquired with a resolution of 120,000 in the orbitrap 
(OT) covering a mass range of 380-1580 m/z. Injection time was set to 60 ms and automatic 
gain control (AGC) target to 5×105. Dynamic exclusion covered 10-30 s. Only precursors with 
a charge state of 3-8 were included. MS2 spectra were recorded with a resolution of 30,000 in 
OT, injection time was set to 128 ms, AGC target to 5×104 and the isolation window to 1.6 
m/z. Fragmentation was enforced by higher-energy collisional dissociation (HCD) at 30%. 
Data analysis  
For crosslinked peptide searches with pLink 1 (v. 1.23, pFind group (Chen et al., 2019; Yang 
et al., 2012)), .raw files were converted to mgf format using ProteomeDiscoverer 1.4 (Thermo 
Scientific, signal-to-noise ratio 1.5, 1000-10000 Da precursor mass). Within pLink 1 BS3 was 
used as crosslinker and trypsin as digestion enzyme with a maximum of two missed cleavage 
sites. Carbamidomethylation of cysteines was set as fixed modification, oxidation of 
methionines as variable modification. Searches were conducted in combinatorial mode with a 
precursor mass tolerance of 5 Da and a fragment ion mass tolerance of 20 ppm. The used 
database contained all proteins within the complexes. FDR was set to 0.01. Results were filtered 
by applying a precursor mass accuracy of ±10 ppm. Spectra of all technical duplicates were 
combined. 
For crosslinked peptide searches with pLink 2 (v. 2.3, pFind group (Chen et al., 2019)), .raw 
files were used as input. The same settings were applied as described for pLink 1 searches, with 
the following changes: BS3 or EDC-DE were used as crosslinker, depending on the 
experimental design. Trypsin was used as protease with a maximum of three missed cleavage 
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sites. Precursor tolerance was set to 10 ppm. FDR was set to 0.01 or 0.05 in separate or global 
mode, depending on the experimental design. Protein interaction networks were generated by 
xiNET (Combe et al., 2015). 
 
3.6 Electron Microscopy 
3.6.1 Negative stain electron microscopy 
Negative stain electron microscopy was used to assess the oligomerization behaviour of the 
subcomplexes of INT prior to cryo-electron microscopy (cryo-EM). To this end, 4 µl of protein 
(~50 nM) was incubated on the film-side of a glow-discharged carbon support copper mesh 
negative stain grid (S160-4; Plano) for 30 - 180 s depending on protein concentration. The grid 
was washed for 30 s in a drop of ddH2O and then stained 3 times for 20 s each in separate drops 
of 2% (w/v) uranyl acetate solution (Electron Microscopy Sciences). The stained grids were 
incubated for 60 - 120 s and then blotted with a Whatman filter paper leaving a thin film of 
stain and then allowed to air-dry. Negative stained grids were images in a Philips CM120 
transmission electron microscope operated at 120 kV at a magnification of 37,000x or 74,000x 
(for the cleavage module) after a defocus of 2.3 µm was applied.  
 
3.6.2 Cryo - electron microscopy 
Samples for cryo-EM analysis were gently fixed by crosslinking with 0.1% glutarylaldehyde 
on ice for 10 min. The crosslinking reaction was quenched by addition of 100 mM NH4HCO3 
(for core-INT) or 8 mM aspartate and 2 mM lysine (INTS4/9/11). The crosslinked samples 
were dialyzed for 4 - 6 hrs into a buffer containing 20 mM HEPES 7.4, 150 mM NaCl, 1 mM 
TCEP 10 µM ZnCl2 using a 20 kDa MWCO Slide-A-Lyzer MINI dialysis units. Samples 
prepared by sucrose density gradient (core-INT), were dialyzed for 10 hrs to overnight and 
concentrated before cryo-grid preparation. The dialyzed samples (4 µl with final concentration 
between 100 and 300 nM) were applied to a glow- discharged UltrAuFoil 2/2 grids (Quantifoil). 
After a 10 s incubation, the grids were blotted for 5-8 s with a blot force of 5 and plunge frozen 







3.6.3 Data collection and processing 
Core-INT 
Cryo-grids were pre-screened for good particle distribution using a Glacios transmission 
electron microscope (FEI) operated at 200 keV. Cryo-EM data was automatically collected on 
the same microscope using EPU and a Falcon 3EC direct electron detector (FEI) operated in 
linear mode. Images were recorded for 1.52 seconds at a nominal magnification of 120,000x 
corresponding to 1.23 Å/pixel with an electron dose rate of 41.58 e-/px/s. The resulting total 
dose of 41.78 e-/Å2 was fractionated into 30 frames. A total of 1900 images were collected 
with a defocus range of 1.5-3 µm. Movie frames were subjected to motion correction and 
contrast transfer function (CTF) estimation in Warp (Tegunov & Cramer, 2019). Particles were 
automatically picked in WARP yielding about 250,000 particles. Calculation of 2D class 
averages, generation of initial model and 3D volume calculations were done in cryoSPARC2 






















4.1 Reconstitution of the Integrator complex 
4.1.1 Sequence Analysis of Integrator complex subunits 
There is currently limited tertiary and quaternary structural information on INT. A crystal 
structure of the C-terminal interacting domains of INTS9 and INTS11 has been solved covering 
about 100 amino acids from each protein (Wu et al., 2017). And a crystal structure of SOSS-
A/INTS3 (1-500) in complex with SOSSB1 and SOSSC in the SOSS1 complex has also been 
reported (Ren et al., 2014). In the absence of experimental data, bioinformatic analysis of the 
primary amino acid sequence may be helpful in providing preliminary insight into the 
secondary and tertiary structure of a protein. To this end, I run protein domain/family 
predictions using the domain/protein family recognition tool ‘InterPro’ 
(https://www.ebi.ac.uk/interpro/about/interpro/) for all subunits of INT from their amino acid 
sequence. The default settings were used for the predictions. Domain predictions were in 
agreement with previously observed predictions when a different domain prediction tool was 
used (Gómez-Orte et al., 2019). The INTS9 and INTS11 subunits of INT have 40% sequence 
identity respectively with CPSF100 and CPSF73 of the cleavage and polyadenylation specific 
factor (Baillat et al., 2005). These subunits are also predicted to have the metallo-beta-lactamase 
and beta CASP domains (Figure 4.1). Other domains predicted included a domain of unknown 
function (DUF3677) in the N-terminus of INTS1, 8 HEAT (Huntingtin, elongation factor 3, the 
A subunit of protein phosphatase 2A (PP2A) and the signaling kinase TOR1) repeats in INTS4, 
A van Willebrand Factor Associated (vWFA) domain in INTS6, INTS14 and DDX26B, an 
armadillo like (ARM) fold in INTS7, 4 TPR (Tetratricopeptide repeat) repeats in INTS8 and a 
PHD like zinc finger in INTS12. The majority of the predicted folds, ARM, TPR, vWFA, 
HEAT, are involved in protein-protein interaction and signaling (Tewari et al., 2010; 
Yoshimura & Hirano, 2016; Zeytuni & Zarivach, 2012a) and might be important for the inter-
subunit interaction within INT and interactions with other proteins in cellular processes that 
INT is involved in. There were no known domains/protein families recognized in INTS2, 
INTS3, INTS5, INTS10 and INTS13.  
Intrinsically disordered proteins and domains are very prevalent in eukaryotic proteins 






Given the low number of recognizable domains found from domain predictions, the disorder
prediction tool, disorder2 (Ward et al., 2004) was used to check for intrinsically disordered 
regions in the amino acid sequences of the INT subunits (Figure 4.1). The protein binding 
propensities of the predicted disordered regions were also predicted. There were widespread 
disordered regions predicted in various subunits with high confidence. Most of the predicted 
disordered regions have high protein binding propensity except a stretch of about 100 amino 
acids in the C-terminal regions of INTS6 and DDX26B (also called INTS6-like). In the 
exception of a small N-terminal domain and the PHD domain, INTS12 is predicted to be 
disordered and lacking in interaction with other proteins. These predictions might be useful 
when it is necessary to truncate a protein to improve expression and solubility or for 
crystallization. 
4.1.2 Co-expression of known subcomplexes 
It is not known how the subunits of INT are interacting to form the complex. For recombinant 
production, it is critical to identify which subunits are interacting and might need each other for 
co-translational folding (Hardesty et al., 1999; Schilbach et al., 2017). The first thing that I 
attempted was to identify the interacting subunits of INT. The INTS9 and INTS11 subunits 
have been shown to form a stable heterodimer in vivo (INTS9/11 heterodimer) which hosts the 
endoribonuclease activity of the complex (Albrecht & Wagner, 2012; Wu et al., 2017). My 
preliminary co-expression test of these subunits show they interact to form INTS9/11 
heterodimer. The expression of INTS9/11 heterodimer was very poor in both E. coli and 
baculovirus - insect cell expression systems suggesting an additional subunit might be needed 
to improve the expression and solubility of these subunits or a different expression condition is 
needed. INT was identified as a target of the protein phosphatase 2A using affinity purification 
and crosslinking coupled to mass spectrometry (Herzog et al., 2012a). In their work, Herzog 
and colleagues identified chemical crosslinks between INTS4 and the heterodimer of INTS9 
and INTS11. They also observed crosslinks between INTS2 and INTS7 (Herzog et al., 2012a; 
Solis-Mezarino & Herzog, 2017). This suggests that, INTS4 have direct protein - protein 







Figure 4.1. Domain and disorder prediction of INT subunits. Disorder predictions (blue) and protein binding 
prediction (red) scores are plotted as a function of amino acid residue numbers for each subunit of INT indicated 
on the top left corner of each plot. The dashed lines represent the cutoff of 0.5 score. Predicted domains from 
InterPro for each subunit, crystallized domain (of INTS3) and interacting C-terminal regions of INTS9 and 
INTS11 are indicated with a yellow filled rectangle. Abbreviations: DUF (domain of unknown function), HEAT 
(Huntingtin, Elongation factor 3, protein phosphatase 2A, and the yeast kinase TOR1), ARM (armadillo-like 
repeats), vWFA (von Willebrand Factor type A domain), β-CASP (CPSF73, Artemis, SNM1 PSO2 domain), 
PHD (plant homeodomain finger) and TPR (tetratricopeptide repeats). 
 
To test this, I constructed a baculovirus co-expressing INTS4, INTS9 and 6xHis-MBP-INTS11. 
Results from amylose affinity pulldown of expression test in Hi5 insect cells showed the three 
proteins interact and form a stable heterotrimeric subcomplex (Figure 4.2a). Also, co-
expressing INTS4 with the INTS9/11 heterodimer drastically improved their expression in 
insect cells and solubility under the same conditions used for INTS9/11 heterodimer. This 
shows that INTS4 is needed for proper folding and assembly of INTS9/11 heterodimer. INTS4 
alone however is soluble, expressible and can be purified in high purity and yield (Figure S5c 
and d). This heterotrimeric subcomplex was characterized around the same time by Albretch 
and colleagues and named as the cleavage module of INT due to its similarity with the cleavage 
module of the CPSF complex involved in the 3’ processing of mRNAs (Albrecht et al., 2018).  
Also, based on the observed chemical crosslink between INTS2 and INTS7 (Solis-Mezarino & 
Herzog, 2017), the interaction between these two subunits could be established by co-
expression and co-purification using affinity tag on INTS7 (Figure 4.2b and Figure S4). 
INTS3 also known as SOSS-A is known to be a part of the SOSS complex involved in single 
stranded DNA sensing (Huang et al., 2009; Li et al., 2009; Ren et al., 2014; Skaar et al., 2009). 
INTS6 is the only subunit of INT that interacted with the SOSS1 (NABP2) complex (Skaar et 
al., 2015). I suspected that INTS6 might have direct protein-protein interaction with INTS3. 
Co-expression of INTS3 and INTS6 and amylose affinity pulldown using 6xHis-MBP affinity 
tag on INTS3 showed the two subunits interact as they co-purified (Figure 4.2c). Taken 
together, the available literature helped to establish preliminary inter-subunit interactions 
within the INT, namely INTS4/9/11 heterotrimer (also known as the cleavage module), 








Figure 4.2. Co-expression test of known INT subcomplexes. LDS-PAGE analysis of expression and 
interaction tests of various subcomplexes of INT. Letter ‘I’ represent an input sample from the soluble fraction 
of the lysate of infected SF21 or Hi5 cells and E is 5 - 10% of the elution of an amylose affinity pulldown from 
infected SF21 or Hi5 cells expressing INTS4/9/11 heterotrimer (a), INTS2/7 heterodimer (b), and INTS3/6 
heterodimer (c). ‘t’ stands for 6xHis-MBP affinity tag. The identity of proteins was confirmed by mass 
spectrometry. 
 
4.1.3 Identification of novel subcomplex of INT by systematic co-expression of subunits 
To further expand on the known subcomplexes, I randomly cloned the rest of the INT subunits 
for co-expression. Amylose affinity pulldown analysis from insect cells infected with a 
baculovirus co-expressing INTS5, INTS8, INTS10 and INTS12 with affinity tag on INTS5 
showed INTS5 and INTS8 are interacting partners (Figure 4.3a). INTS10 and INTS12 had weak 
interaction with INTS5/8 heterodimer as shown on the LDS-PAGE and very few peptides from 
these subunits were identified by mass spectrometry (results not shown). I also identified 
INTS13 and INTS14 as a stable heterodimer by co-expressing them with affinity tag on INTS13 
(Figure 4.3b). Furthermore, I constructed baculoviruses co-expressing INTS5, INTS8, INTS10, 
INTS12, INTS13 and INTS14 with affinity tag on either INTS5 or INTS13. Proteins associated 
with INTS5 and INTS13 in Hi5 expression tests of the two baculoviruses were assessed by 
amylose affinity pulldown, LDS-PAGE and mass spectrometric identification of peptides in the 
elution fractions. Trace amounts of INTS10, INTS12, INTS13 and INTS14 were co-purified 
with INTS5/8 heterodimer when construct with affinity tag on INTS5 was analyzed (virus A 
Figure 4.3 c, d and e). However, when the virus with affinity tagged INTS13 was analyzed, 
there was significant enrichment of INTS10 in the elution fraction alongside INTS13 and 
Results 
 35 
INTS14 (Figure 4.2 d and e) suggesting INTS10 has a strong physical interaction with either 
INTS13 or INTS14 or both in the Integrator complex. Yeast-two-hybrid analysis of Drosophila 




Figure 4.3. systematic co-expression of INT subunits to identify subcomplexes. LDS-PAGE analysis of 
expression test and amylose affinity pulldown of a baculovirus expressing INTS5, INTS8, INTS10 and INT12 
(a) and INTS13 and INTS14 (b). (c) A cartoon representation of baculoviruses expressing 6xH-MBP-INTS5, 
INTS8, INTS10, INTS12, INTS13 and INTS14 (virus A) and INTS5, INTS8, INTS10, INTS12, 6xHis-MBP-
INTS13 and INTS14 (virus B). (d) LDS-PAGE analysis of the elution fractions of amylose affinity pulldown 
from SF21 cells expressing virus A and B described in (c). (e) Mass spectrometric identification of peptides in 
the elution fractions of the expression tests of baculovirus A and B described in (c) and (d). (f) LDS-PAGE 
analysis of expression test of a baculovirus expressing INTS10, INTS13 and INTS14. The prefix ‘t’ before a 
protein name indicated it is tagged with 6xHis-MBP affinity tag. 
 
On the other hand, INTS12 associated weakly to this complex (INTS10/13/14) and INTS5/8 
heterodimers did not show any substantial interaction with the INTS10/13/14 heterotrimeric 
subcomplex (Figure 4.3 c, d, and e). The INTS13/14 heterodimer as well as INTS10 were 
expressed and could be purified to homogeneity (Figure S5a and b, Figure S5 e and f). The 
interaction between INTS10 and INTS13/14 heterodimer was additionally confirmed via 
amylose affinity pulldown using purified 6xHis-MBP-INTS10 and INTS13/14 (Figure S7b lane 
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8) and the three proteins can be purified together when co-expressed in insect cells (Figure 
4.3f).  
 
4.1.4 Identification of interaction partners of INTS1 
The Integrator subunit INTS1 is a 250 kDa DUF (domain of unknown function) containing 
protein (Figure 4.1 INTS1). It is predicted to be rich in alpha helical secondary structures 
indicative of protein-protein interactions. In Drosophila, INTS12 has been shown to interact 
with INTS1 (Jiandong Chen et al., 2013). Co-expression of the full length INTS1 and INTS12 
showed that the two subunits have direct protein-protein interaction (Figure 4.4a). However 
due to poor expression of these two subunits and their instability during purification, INTS1/12 
heterodimer could not be purified. Also, co-expression analysis showed that, INTS1 has some 
interaction with INTS3/6 as well as INTS13/14 heterodimers (Figure 4.4b and c). 
 
 
Figure 4.4. Identification of interacting partners of INTS1. Input (I) and Elution fractions (E) of amylose 
affinity pulldown of protein expression tests were analyzed on LDS-PAGE. Protein bands in the elution fraction 
were identified by mass spectrometry. INTS1 degradation products are indicated as INTS1d and colored red. 
The prefix letter ‘t’ represents 6xHis-MBP affinity tag (a) LDS-PAGE analysis of co-expression of INTS1 and 
INTS12. (b) LDS-PAGE analysis of co-expression of INTS1, INTS13 and INTS14. (c) LDS-PAGE analysis of 
co-expression of INTS1, INTS3 and INTS6 
 
The heterodimers, INTS2/7 and INTS5/8 as well as INTS4/9/11 heterotrimer did not show 
interaction with INTS1 in the co-expression and amylose affinity pulldown assays (results not 
shown).  
In summary, in sections 4.1.3 and 4.1.4, I have identified previously unknown interaction 
between INTS5 and INTS8 subunits as well as between INTS13 and INTS14 subunits of INT. 
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Interaction between INTS10 and the identified INTS13/14 heterodimer was also established. I 
could also recapitulate the interaction between INTS1 and INTS12 subunits reported in 
Drosophila here in the human INT. In additional, I showed that INTS1 interacts with the 
INTS3/6 as well as the INTS13/14 heterodimers. 
 
4.1.5 Co-infection of 3 baculoviruses and partial purification of INT  
A combination of previously known interaction partners and the results of the systematic co-
expression assays informed the creation of three expression vectors with each vector containing 
interacting subunits of INT whenever possible (Section 3.3.5.1).  
Viruses were made from each of these expression vectors (Figure 4.5a) and Hi5 cells were 
infected at 1:6000 v/v for each virus. The cells were harvested after 72 hrs and a test purification 
was done (Figure 4.5b). There was severe degradation of several subunits, notably INTS1, 
INTS3, INTS6, and DDX26B suggestive of suboptimal expression and purification conditions. 
Protein purified by ion exchange chromatography was fractionated into two peaks on analytical 
gel filtration showing the complex is not homogenous. Mass spectrometry analysis identified 
peptides for all the subunits of INT in the two elution peaks of gel filtration (Figure 4.5c). The 
first peak at 1 ml may represent the intact full-length INT while the second peak may be a 
heterogenous mixture of subcomplexes of INT. Negative stain analysis of the two elution peaks 
revealed heterogenous population of particles with varying sizes for both peaks. This may 
represent different views of INT and/or INT subcomplexes. The sample may not be 
homogenous as there were three subunits with the same affinity tag and hence different 
populations of complexes may have been enriched. Particles in the first peak (Figure 4.5d) have 
broader size distribution with the majority of the particles having diameter in the range of 250 
- 450 Å which is the approximate expected size of the full-length INT (approximately 1.5 MDa). 
In contrast, particles in the second peak (Figure 4.5e) have relatively smaller particle diameters 
with a narrower particle dimeter distribution representing heterogenous population of 






Figure 4.5. Co-infection and partial 
purification of INT. (a) Cartoon 
representation of the three 
baculoviruses expressing subcomplexes 
of INT. The subunits co-expressed are 
indicated in each cartoon. The prefix 
letter ‘t’ implies the specific subunit has 
6xHis-MBP affinity tag. (b) A 
flowchart for the experimental design 
showing the expression and purification 
strategy used. (c) LDS-PAGE analysis 
of fractions from gel filtration on 
Superose 6 Increase 3.2/300 column and 
mass spectrometric identification of 
protein. Proteins running at their 
expected molecular weight are indicated 
in black while degradation products are 
indicated in red. The retention volumes 
of the fractions analyzed are indicated 
above the gel. (d) and (e) are 
representative negative stain 
micrographs of the first and second peak 
respectively from the gel filtration. 
Particles of the expected size 
(approximately 450 Å or 45 nm) are 
indicated with red circles. Blue circles 
represent oligomeric particles or 
negative stain artifacts and blue squares 
are representative particles smaller than 
the expected size for the full-length INT 
and might be subcomplexes. 
Micrographs were acquired at 37,000x 




4.1.6 XL-MS on partially purified INT identifies new interaction partners  
To have an appreciation of how the various subcomplexes may be interacting in the partially 
purified INT, a sample of the HiTrap Q elution peak corresponding to the full INT was 
crosslinked with 1 mM BS3 for 30 min on ice and subjected to XL-MS. There were very few 
inter subunit crosslinks observed. High confidence crosslinks were observed between known 
interacting subunits for examples INTS3 and INTS6 as well as INTS13 and INTS14 serving as 
internal positive controls. 
Interestingly, INTS3 had high number of high-ranking crosslinks to DDX26B. Specifically, 
K842 of DDX26B had high scoring crosslinks with K557 of INTS3 (Figure 4.6a and b). This 
was outstanding because of the very few inter subunit crosslinks observed in general. This 
prompted the idea that DDX26B might have strong direct protein-protein interaction with 
INTS3/6 heterodimer. To test this INTS3, INTS6 and DDX26B were cloned together for co-
expression. Indeed, all three proteins were present in good stoichiometry in the elution of 
amylose affinity pulldown using affinity tag on INTS6 (Figure 4.6c). This confirms for the first 
time DDX26B has direct protein-protein interaction with a subunit (INTS3) of the Integrator 
complex. Affinity tagging of INTS3 resulted in overrepresentation of this subunit (Figure S6) 
whereas affinity tag on INTS6 produces a stoichiometric complex. The proteins can be co-
purified in pulldown assays but turn to aggregate (oligomerize) when analyzed by gel filtration 
suggesting that there is an interaction partner they might be missing. I came to this conclusion 
after several expression and purification protocols were tested with no success at preventing the 
aggregation or oligomerization. 
 
4.1.7 INTS3/6-DDX26B heterotrimer interacts with INTS5/8 heterodimer 
To identify which subunits/subcomplexes have direct physical interaction with the identified 
INTS3/6-DDX26B heterotrimer, a co-infection and amylose affinity purification assay was 
designed. This entailed co-infecting Hi5 insect cells with a V1 baculovirus expressing this 
trimer (virus 0) and V1 baculoviruses expressing tagged subunits/subcomplexes of INT as 
shown in Figure 4.7a and b. The cultures were monitored and harvested after 48 hrs.  
 Amylose affinity pulldown followed by western blot analysis (using anti-INTS3 antibody) of 
input and elution fractions showed that all the subunit/subcomplexes have some physical 
interaction with the INTS3/6-DDX26B heterotrimer showing that this trimer might represent a 
central core of INT (Figure 4.7b). Pulldown from control cells expressing only INTS3/6-
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DDX26B without affinity tag had no signal for INTS3 in the elution fraction showing that 
INTS3 does not bind nonspecifically to the beads. 
 
Figure 4.6. Crosslinking mass spectrometry identifies interaction between INTS3 and DDX26B. (a) 
Cartoon representing the crosslinking network of the INT obtained from BS3 mediated XL-MS of the partially 
purified INT. INT subunits are depicted as rectangles and BS3 mediated chemical crosslinks as black line 
segments. Red dashed lines represent known interacting subunits without chemical crosslinks. (b) A bar chart 
plot of the scores (top ten) of the crosslinks as well as their spectra counts. Specific crosslinked Lys residues 
are indicated beneath the bar chart. A file containing all crosslinks can be provided upon request. (c) An LDS-
PAGE analysis of amylose affinity pulldown of SF21 cells expressing INTS3/6-DDX26B heterotrimer created 







Figure 4.7. Identification of interaction partner(s) of INTS3/6-DDX26B heterotrimer. (a) Cartoon 
representation of baculoviruses (1-6) expressing subunits/subcomplexes of INT. The prefix letter ‘t’ stands for 
6xHis-MBP affinity tag. The subunits of INT expressed by each virus are indicated. (b) An LDS-PAGE analysis 
of input (I) and elution fractions of amylose affinity pulldown (E) from Hi5 insect cells expressing various 
combinations of baculoviruses in (a). Numbers on top of the gel represents which baculoviruses were co-
infected. Red rectangles indicate the fragment of the LDS-PAGE gel analyzed by mass spectrometry. An anti 
INTS3 western blot of the same fractions in the LDS-PAGE is appended to the LDS-PAGE gel. (c) Exclusive 
unique spectra count for INTS3, INTS6 and DDX26B from regions of the pulldown indicated with the red 
rectangles in (b).  
 
Of interest, INTS5/8 heterodimer showed the strongest signal (enrichment) of INTS3 in the 
elution fraction. This suggests that, of all constructs tested, the INTS5/8 heterodimer is the most 
stably associated with the INTS3/6-DDX26B heterotrimer. Mass spectrometric analysis of the 
fragments of the LDS-PAGE gel corresponding to the sizes of INTS3, INTS6 and DDX26B 
(between 75 kDa and 150 kDa) showed with red rectangles in Figure 4.7b confirmed the 
western blot results. The unique spectra count for INTS3 and INTS6 were about 1.5 - 2 folds 
higher in the pulldown with INTS5/8 heterodimer compared to the other 
subunits/subcomplexes while DDX26B was enriched to lesser amount (Figure 4.7c). Pulldown 
with INTS1 showed the second highest spectra counts for INTS3, INTS6 and DDX26B 
confirming the earlier observation that INTS1 interacts with INTS3/6 heterodimer (Figure 
4.4c). The interaction between INTS3/6-DDX26B and INTS5/8 was reproduced by in vitro 
pulldown using partially purified proteins (Figure S7d lane 8). Based on these results, I created 
a pentameric co-expression vector of INTS3, INTS5, INTS6, INTS8, and DDX26B.  
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4.1.8 Co-expression and purification of the INTS3/5/6/8-DDX26B heteropentamer 
The INTS3/6-DDX26B heterotrimer and INTS5/8 heterodimer forms oligomers and run at the 
void volume of gel filtration columns during purification (Figure S3 and S6). This suggests the 
subcomplexes may be misfolded or some protein-protein interaction surfaces are exposed 
(hydrophobic). Therefore, it was expedient to evaluate the oligomerization behavior of the 
resultant pentameric complex under purification conditions given that the constituent 
subcomplexes forms oligomers. To these ends, I made a baculovirus harboring the expression 
cassettes for INT subunits in the INTS3/5/6/8-DDX26B heteropentamer (Figure 4.8a). 
Preliminary pulldown experiments from SF21 cells infected with the V1 baculovirus confirmed 
expression and interaction of the constituent subunits (not shown). 
After pioneering test runs, the final purification strategy for the heteropentamer included an 
amylose affinity purification followed by anion exchange chromatography on a 5 ml HiTrap Q 
and gel filtration chromatography on Sephacryl S-300. Mass spectrometric analysis of the 
elution peak revealed all subunits of the heteropentamer are present in the peak fraction (Figure 
4.8b). Based on this result it is clear that the heteropentameric complex is stable under this 
purification condition. The elution peak from gel filtration runs at 40 ml which coincides with 
the theoretical void volume of the 120 ml gel filtration column (Figure 4.8c). The ratio of UV 
absorption at 260 nm to 280 nm was 0.9. These observations suggested the complex might be 
oligomerizing and the 260/280 ratio suggests DNA contamination. To ascertain the 
oligomerization state of the purified complex, negative stain transmission electron microscopy 
was conducted on a uranyl acetate stained sample of the elution peak. The negative stain 
micrograph revealed majority of the particles are in the expected size range of 200-300 Å for a 
complex of an estimated molecular weight of 450 – 500 kDa assuming single copies of each 
protein is in the complex. This shows that, despite eluting close to the void volume of the gel 
filtration column, the heteropentamer is not aggregated. There are however few particles that 
are bigger than the expected dimensions of the complex of interest which might be oligomers. 
These bigger particles may also represent clustering of particles induced by the harsh uranyl 






Figure 4.8. Expression, Purification and characterization of INTS3/5/6/8-DDX26B heteropentameric 
subcomplex. (a) A cartoon representing the expression and purification strategy. A baculovirus expressing all 
the subunits of the heteropentamer with a 6xHis-MBP (t) tag on INTS6 is shown. (b) An LDS-PAGE analysis 
of fractions from gel filtration chromatography on Sephacryl S-300 and mass spectrometric identification of 
proteins there-in. Mass spectrometric unique spectra counts for each protein is indicated in the brackets. (c) A 
chromatogram of the gel filtration run shown in (b). (d) A representative negative stain micrograph of the peak 
fraction of the gel filtration chromatography of the heteropentamer. Selected particles of the approximate 
expected diameter are indicated with red circles and oligomers or staining-induced clusters are indicated with 





4.1.9 The INTS3/5/6/8-DDX26B heteropentamer interacts with INTS2/7 heterodimer 
Partially purified INTS2/7 heterodimer showed some interaction with INTS5/8 heterodimer 
albeit not stoichiometric (Figure S7d, Lane11). Co-infection assay in Figure 4.7 demonstrates 
a weak interaction between INTS2/7 heterodimer and INTS3/6-DDX26B. In contrast, the 
INTS2/7 heterodimer did not interact with the INTS10/13/14 heterotrimer and the cleavage 
module (INTS4/9/11) (Figure S7d Lane 9 and lane 10 respectively). These results predicted an 
interaction between INTS2/7 heterodimer and the INTS3/5/6/8-DDX26B heteropentamer. To 
test this, I made a baculovirus harboring the expression cassettes of INTS2, INTS3, INTS5, 
INTS6, INTS7, INTS8, and DDX26B with affinity tag on either INTS5, or INTS6 or INTS7 
(Figure 4.9a left panel). The elution fractions from amylose affinity pulldown from SF21 cells 
expressing the V1 viruses were analyzed on LDS-PAGE and blotted with anti INTS2 and INTS5 
antibodies. INTS2 co-purifies with INTS5 in all three constructs according to the western blot 
results (Figure 4.9a right panel). Mass spectrometric identification of proteins in each fraction 
confirms the western blot result showing that INTS2/7 heterodimer interacts with the 
heteropentameric subcomplex and could be co-purified by one affinity tag. This 
heteroheptameric subcomplex of INTS2, INTS3, INTS5, INTS6, INTS7, INTS8 and DDX26B 
is hereafter referred to as core Integrator (core-INT).  
4.1.10 Purification of INTS2/3/5/6/7/8-DDX26B (Core-INT) 
Several expression and purification conditions were tested to identify the most optimal 
conditions for purifying core-INT. It was important to tag a subunit that would purify a 
stoichiometric complex. 6xHis-MBP tag at the N-termini of INTS5, INTS6 and INTS7 were 
tested. Tagging of INTS5 resulted in overrepresentation of INTS5/8 heterodimer while tagging 
INTS6 and INTS7 produced relatively better results when compared to tagged INTS5 (Figure 
4.9a left panel). INTS6 however degrades and it was necessary to affinity tag this subunit to 
reduce its degradation. I first tagged the N-terminus of INTS6; however, the affinity tag could 
not be removed by the TEV protease. Secondary structure prediction showed formation of a 
beta sheet at the very N-terminus of INTS6, which may incorporate the TEV cleavage site. The 
affinity tag at the C-terminus of INTS6 was then attempted. This did not solve the degradation 
of INTS6 and N-terminus affinity tag on INTS6 was chosen as the tag of choice for co-







Figure 4.9. Identification and purification of heptameric core-INT. (a) A cartoon of a baculovirus 
expressing heptameric core-INT comprising INTS2, INTS3, INTS5, INTS6, INTS7, INTS8, DDX26B (left 
panel). An LDS-PAGE analysis of the elution fractions of amylose affinity pulldown from SF21 cells infected 
with the V1 baculoviruses of core-INT with affinity tag on INTS5 (Lane 1) or INTS7 (Lane 2), or INTS6 (lane 
3). Proteins were identified by mass spectrometry. Western blot analysis of the same fractions with anti INTS2 
and anti INTS5 antibodies is appended to the bottom of the LDS-PAGE. (b) An LDS-PAGE analysis of the 
peak elution fractions of a HiTrap Q anion exchange purification of the heptameric core-INT. Mass 
spectrometric unique spectra count of the core-INT subunits in the peak fraction is affixed to the LDS-PAGE. 
(c) A representative uranyl acetate negative stain electron micrograph of the peak fraction from (b). Particles 
meeting the expected size are shown with red circles/oval. A few smaller particles are shown with blue squares. 
A scale bare is provided. 
 
For optimizing the purification, I varied pH, salt (type and concentration), cell lysis strategy 
(sonication/French press) and additives. Lysis by French press did not make any significant 
change to the stability of the complex when compared to sonication and therefore brief 
sonication was chosen (see methods). I obtain similar results when KCl or NaCl was used as 
the main salt. However, the complex completely degraded when MES pH 6.5 was used for 
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purification whereas purification in HEPES pH 7.4 and Tris pH 8 yielded similarly better 
results. For the purposes of downstream crosslinking experiments, HEPES pH 7.4 was chosen 
over Tris pH 8 as a buffering agent. It was also observed that longer expression (longer than 72 
hrs) resulted in low yield. Hi5 cells expressing this complex were therefore harvested 48 – 60 
hours after infection (best case was 48 hours). Also, baculovirus expressing this complex turn 
to decay unusually fast (about a month) compared to baculoviruses expressing other constructs 
which are infective after a year of storage at 4 oC.  
The final purification protocol included an amylose affinity step followed by anion exchange 
chromatography which removes over stoichiometric INTS6 and its major degradation product 
(Figure 4.9b). The elution from ion exchange on HiTrap Q column was evaluated for 
homogeneity and oligomerization using negative stain electron microscopy. The micrograph in 
Figure 4.9c shows that the peak fraction from HiTrap Q elution had a heterogenous population 
of complexes with little or no aggregates. This heterogeneity may come from INTS3/6 
heterodimer and/or INTS3/6-DDX26B heterotrimer and/or INTS3/5/6/8-DDX26B 
heteropentamer which has the same behavior on ion exchange as core-INT. Gel filtration 
chromatography was not a favored choice to separate these different populations of complexes 
as it could not separate the complex (core-INT) from aggregates of INTS3/6 heterodimer and 
INTS3/6-DDX26B heterotrimer and from INTS3/5/6/8-DDX26B heteropentamer because they 
have similar sizes and run close to the void volume of the gel filtration columns tested. The 
complex was therefore further purified via a shallow 15-30 % sucrose gradient. Smaller 
subcomplexes including INTS3/6 heterodimer were separated in early fractions (lower 
percentage sucrose) of 1 - 5. The heptameric complex had peak fractions from 7 to 11 which 
tailed into higher fraction (Figure 4.10a). Mass spectrometric analysis confirmed the presence 
of all subunits showing this is a stable complex. 
To evaluate the homogeneity of the purified complex, negative stain electron microscopy was 
done on the 11th fraction from the sucrose density gradient (Figure 4.10c). The negative stain 
micrograph had homogenous single particles with diameter ~250 - 350 Å. The particles did not 
differ drastically from the heteropentameric complex (INTS3/5/6/8-DDX26B) (Figure 4.8c). 
The sucrose density gradient successfully separated the heptameric complex from smaller 
subcomplexes that were present in the peak fraction from anion exchange chromatography on 





Figure 4.10. Purification and characterization of core-INT. (a) LDS-PAGE analysis of a 15-30% sucrose 
density gradient of core-INT. Odd numbered fractions were analyzed. Proteins in peak fraction (11) were 
identified by mass spectrometry. (b) A section of a uranyl acetate negative stain electron microscopy 
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micrograph of the peak fraction of the sucrose density gradient. Particles of the core-INT are indicated with 
Red circles/ovals. Micrograph was acquired at 37,000x magnification and a pixel size of 3.3 Å/pixel A scale 
bar is provided. (c) A section of cryo electron microscopy micrograph at 120,000 magnification and a pixel size 
of 1.23 Å/pixel. Particles were automatically picked in WARP (Tegunov & Cramer, 2019) (yellow circles). (d) 
A diagram of selected 2D class averages of core-INT processed in cryoSPARC2 (Punjani et al., 2017). A 
particle box size of 500 Å was used. (e) Different views of a low-resolution electron microscopy map of core-
INT. Initial model was generated from few selected classes in cryoSPARC2. The initial model was used for 
iterative classification and refinement of the data which converged in the map presented with an estimated 
resolution of 20 Å.  
 
Given how homogenous the sample from sucrose gradient was under negative stain electron 
microscopy conditions, its behavior in ice was evaluated using cryo-EM. To this end, fractions 
9 - 11 from sucrose density gradient were fixed by crosslinking with 0.1% (v/v) 
glutarylaldehyde (see methods). Samples were dialyzed overnight to remove the crosslinker 
and sucrose before cryo-grids were prepared (see method). Initial screening of the cryo-grids 
in a 200 kV Glacios transmission electron microscope revealed homogenous single particles 
(Figure 4.10c). The particles from cryo-EM screening looked similar in shape and dimension 
to those observed in the negative stain micrographs. The diameter of the particles in ice was 
between 250 - 350 Å which may represent different views of a complex of 600 - 700 kDa in 
size. The quality of the particles on the cryo grids were suitable for data collection and single 
particle analysis. An overnight data set was collected on the 200 kV Glacios transmission 
electron microscope at a magnification of 120,000x and a pixel size of 1.23 Å/pixels which 
yielded ~250,000 particles picked and preprocessed in Warp (Tegunov & Cramer, 2019). 2D 
class averages were calculated using cryoSPARC (Punjani et al., 2017) (Figure 4.10d). The 
calculated 2D class averages lacked high resolution features suggesting a poor alignment of the 
particles. An initial 3D model was calculated from a selected group of the 2D class averages 
which was used for further iterative classification and refinement of the data set yielding a 
doughnut shaped 3D volume for the core-INT at an estimated resolution of 20 Å. I could not 
obtain high resolution features of the core-INT from this data set due to misalignment of the 
particles. This may be due to conformational heterogeneity/flexibility in the complex. It is also 
possible core-INT maybe be denatured by freezing during cryo-grid preparation (Nogales et al., 






4.1.11. XL-MS reveal inter-subunit interactions within core-INT 
The INTS3/6-DDX26B heterotrimer was identified as a subcomplex of INT based on high 
confidence chemical crosslinks between INTS3/6 heterodimer and DDX26B (Figure 4.6a). 
There was no crosslink between INTS3/6-DDX26B heterotrimer and subunits of INTS5/8 
heterodimer as well as between INTS2/7 heterodimer and INTS5/8 heterodimer although 
pulldown experiments show interaction between these modules (Figure S7). Using co-infection 
assays, I showed INTS3/6-DDX26B heterotrimer interacts with INTS5/8 heterodimer resulting 
in a heteropentameric subcomplex (Figure 4.7 and 4.8) which in turn interacts with INTS2/7 
heterodimer (Figure 4.9) to form the core-INT. To have a glimpse into how the subunits are 
interacting within the core-INT, we employed XL-MS using BS3 as well as the zero length 
crosslinker, 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC). Core-INT purified from 
ion exchange chromatography was crosslinked with 3 mM BS3 or 5 - 100 mM EDC at room 
temperature for 30 min. For EDC mediated XL-MS, I did a titration of the crosslinker from 0 – 
100 mM and run the crosslinked core-INT on LDS-PAGE. Concentrations that showed 
sufficient crosslinked products (5-100 mM) were excised from the gel for mass spectrometric 
analysis. 
Previously observed BS3 chemical crosslinks between INTS3 and DDX26B as well as between 
INTS3 and INTS6 were reproduced (compare Figure 4.6a and Figure 4.11a). Additionally, 
there were many high confidence crosslinks between C-terminal half of INTS6 to the N-
terminal half of INTS3. Also, DDX26B had widespread crosslinks to INTS6 which were not 
observed in Figure 4.6a. INTS8 of the INTS5/8 heterodimer had BS3 crosslinks to all subunits 
of the core INT (especially to INTS6) but INTS7 and INTS5. This suggests that, INTS8 makes 
several contacts with subunits of the core INT and brings with it INTS5. There was no inter-
subunit BS3 crosslink between INTS5 and the other subunits of core INT. This might be due 
to lack of Lys residues in the interacting interface of INTS5 or INTS5 is buried in the inner core 
of the complex inaccessible to the crosslinker. INTS2 of the INTS2/7 heterodimer had extensive 
crosslinks to INTS6. Particularly, the C-terminal half had many crosslinks to the C-terminal 
half of INTS6 in the same region that has crosslinks to INTS3 creating an interaction hub 
between the three proteins. INTS2 additionally has BS3 crosslinks to its interaction partner, 





Figure 4.11. Crosslinking mass spectrometry reveals inter-subunit connections in core-INT. (a) A cartoon 
representing BS3 chemical crosslinking network of core-INT. Subunits are indicated as rectangles and chemical 
crosslinking between Lys residues are indicated with black line segments. Red dashed lines between INTS5 
and INTS8 indicates they are known interacting subunits. (b) A cartoon of EDC mediated chemical crosslinking 
network within core-INT. Coloring scheme and legend is the same as in (a). A file with all observed crosslinks 
can be provided upon request. 
 
There were also BS3 chemical crosslinks between INTS2 and INTS8 which may buttress the 
observed interaction between INTS2/7 and INTS5/8 heterodimers (Figure S7 lane 11). BS3 
crosslinking depends on the availability of Lys residue within a crosslinking distance (< 30 Å) 
(Leitner et al., 2010, 2016). This constrain means that only protein-protein interaction interfaces 
with Lys residues can be captured with BS3 mediated XL-MS. EDC, a so called zero length 
crosslinker, provides a complementary option to buttress BS3 XL-MS results because it 
crosslinks amino groups of Lys side chains (and alpha-amino groups of N-terminal residues) to 
carboxyl groups of Asp and Glu side chains and carboxyl group of C-terminal residues. The 
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caveat to EDC XL-MS is that, due to its short length, crosslinking groups must be in close 
proximity. This distance restrain leads to very low number of crosslinked peptides when EDC 
is used for XL-MS experiment. Nonetheless, EDC crosslinks are very valuable because of this 
distance restrain (Leitner et al., 2010). EDC mediated XL-MS was done on the core-INT. As 
expected, there were very few crosslinked peptides observed compared to BS3 mediated XL-
MS (Figure 4.11b) despite excess EDC in the crosslinking reaction. EDC mediated chemical 
crosslinks were observed between the N-terminal region of INT5 and the C-terminal regions of 
DDX26B and INTS8. Interaction between these regions of these subunits were not captured by 
BS3 mediated XL-MS exemplifying how EDC mediated XL-MS can complement BS3 
mediated XL-MS.  
 
4.1.12. Purification of INTS4/9/11 and INTS10/13/14 heterotrimers 
Interaction between INTS4 and INTS9/11 heterodimer led to a better expression and solubility 
of INTS9/11 heterodimer in affinity pulldown experiments (Figure 4.2a). To arrive at the 
construct that showed good affinity purification, I tested different tagging options. 6xHis-MBP 
affinity tag on INTS4 resulted in poor expression of INTS4 and hence the complex could not 
be purified. On the contrary, having a 6xHis tag on INTS4 allowed good expression of INTS4 
and purification of the INTS4/9/11 trimer (Albrecht et al., 2018). This suggests that the bulky 
MBP tag might be interfering with the assembly of INTS4/9/11 trimer. In purification of INTS4 
alone, 6xHis-MBP affinity tag did not have any adverse effect (Figure S5c and d). Additionally, 
6xHis-MBP affinity tagging of INTS11 was also tested. This tagging option proved to be 
efficient yielding high purity and stoichiometric INTS4/9/11(Figure 4.2a). The final 
purification strategy used included a Ni affinity purification followed by amylose affinity. The 
affinity tag was then removed using 6xHis tagged TEV protease followed by Ni affinity 
purification to remove the TEV protease and the affinity tag. The trimeric complex was finally 
purified by gel filtration. The stoichiometric trimer eluted with a peak fraction at 16.5 ml on a 
Superose 6 Increase 10/300 gel filtration column (Figure 4.12a). Albrecht and colleagues had a 
similar result when they purified the INTS4/9/11 heterotrimer using a Tris based buffer system 





Figure 4.12. Purification of INTS4/9/11 and INTS10/13/14 trimeric subcomplexes of INT. A gel 
filtration chromatogram displaying UV absorbance of collected fractions at 260 and 280 nm. Fractions 
analyzed are indicated on top of the LDS-PAGE gel of the purification of INTS4/9/11 (a) and INTS10/13/14 
(b).  
 
The protein Asunder (Asu) and Von Willebrand associated protein 9 (VWA9) have been 
identified as additional subunits of INT in an RNAi screen in Drosophila and named INTS13 
and INTS14 respectively (Jiandong Chen et al., 2012b). Chen and coworkers also showed 
interaction between Drosophila IntS10 and IntS14. By systematic co-expression, I discovered 
in this study that INTS13 and INTS14 forms a heterodimer (Figure 4.3b) which is stable under 
gel filtration conditions (Figure S5a and b). Furthermore, I demonstrated that the INTS13/14 
heterodimer interacts with INTS10 using co-expression and pulldown assays (Figure 4.3d, e 
and f). To test the stability of this complex, a purification strategy was established which 
involves affinity purification via HisTrap and amylose affinity chromatography and a final gel 
filtration step to show the complex is homogeneous (Figure 4.12b). To get full length proteins 
it was necessary to affinity tag INTS13 as it turn to have N-terminus degradation. Using 6xHis 
affinity tag works as good as using the MBP affinity tag on INTS13 for the purification of the 
trimeric subcomplex. 
4.1.13 The Cleavage module interacts with INTS10/13/14 heterotrimer. 
Amylose affinity pulldown using purified cleavage module (CM) and INTS13/14 heterodimer 
shows these subcomplexes interact (Figure S7a lane 6). It was therefore expected that the 
cleavage module will interact with the INTS10/13/14 heterotrimeric subcomplex. To test this, 
I immobilized purified 6xHis-MBP tag INTS10 on amylose resin and incubated it with the 
purified INTS13/14 heterodimer and the CM. Results in Figure S7c Lane 7 shows the formation 
of a hexameric complex of INTS4, INTS9, INTS10, INTS11, INTS13 and INTS14. To further 
corroborate this pulldown result, I formed the hexameric complex using purified CM and 
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INTS10/13/14 heterotrimer. The reconstituted hexamer was purified from the free 
heterotrimers via analytical gel filtration using Superose 6 Increase 3.2/300 column (Figure 
4.13a). There was a clear shift in the retention volume of the CM showing the formation of a 
bigger complex. Based on these results, the INTS10/13/14 heterotrimer is named the cleavage 
module interacting module (CMIM). To test whether this interaction between the two modules 
is stable enough for co-purification, a baculovirus expressing the six subunits with an affinity 
tag on INTS13 was created. It was important to tag INTS13 because it suffers a small N-
terminus degradation which abolishes the interaction between the two modules (results not 
shown). Amylose affinity pulldown from SF21 insect cells infected with a baculovirus 
harboring the expression construct for the hexameric subcomplex confirms the formation of the 
hexameric complex (Figure 4.13b). However, attempts to co-purify the hexameric complex 
routinely led to the purification of just the CM or the CMIM when INTS11 or INTS13 was 
affinity tagged respectively. This suggests the interaction between the two modules is not strong 
enough to withstand the purification conditions tested (results not shown). Furthermore, 
attempts to visualize the hexameric complex under cryo conditions failed as the complex fell 
apart into the constituent subcomplexes. This was the case with or without fixation with various 
crosslinkers. This observation also shows that the interaction between the two modules is rather 
weak confirming results from the attempted co-purification.  
The hexameric complex was further characterized using BS3 mediated XL-MS to understand 
how the subunits within the two trimers are interacting and how the two trimers are interacting 
to form the hexamer (Figure 4.13c). As expected, high confidence crosslinks were observed 
between the known interacting C-terminal regions of INTS9 and INTS11 (Wu et al., 2017) 
showing the validity of the crosslinking experiment. There were also a lot of high confidence 
crosslinks between the region spanning the predicted HEAT repeat of INTS4 and the C-terminal 
region of INTS11. This agrees well with the proposed binding of INTS4 via its HEAT repeats 
to the C-terminal interacting domains of INTS9 and INTS11 (Albrecht et al., 2018). A predicted 
N-terminal loop of INTS4 (Residue 1-20) also had a lot of crosslinks to one specific Lys residue 
(Lys159) of INTS9 suggesting INTS4 makes addition contact with INTS9 forming a triangular 
interaction network. The crosslink of INTS9(Lys159) to INTS4 was also observed when INT 
was identified as a substrate of PP2A (Herzog et al., 2012b).  
The CMIM on the other hand, forms a linear interaction network with no crosslinks between 
INTS10 and INTS14. Drosophila IntS10 and 14 have been shown to interact (Jiandong Chen 
et al., 2012b). There is only 21% and 30% sequence identity between Drosophila and human 
INTS10 and INTS14 respectively from amino acid sequence alignment. It is therefore likely 
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the interaction between the two subunits is not conserved in the human INT. It is also possible 




Figure 4.13. Protein-protein interaction between the cleavage module and INTS10/13/14 heterotrimer. 
(a) Assembly of a hexameric complex of the cleavage module and INTS10/13/14 using analytical gel filtration. 
Chromatograms showing the elution profiles of cleavage module (green), the INTS10/13/14 heterotrimer (red) 
and the resultant hexameric complex (blue) are shown. An LDS-PAGE gel of fractions from the hexameric 
complex is shown with the retention volumes of the fractions analyzed. (b) LDS-PAGE analysis of amylose 
affinity pulldown from SF21 insect cells expressing the hexameric complex. Input (I) and elution (E) fractions 
were analyzed. Proteins bands in the elution fraction were identified by mass spectrometry. The prefix letter ‘t’ 
stands for 6xHis-MBP affinity tag. (c) A cartoon representing the BS3 mediated chemical crosslinking network 
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within the hexameric complex. Colored rectangles represent different subunits of the complex with amino acid 
residue numbers provided. Black line segments represent observed chemical crosslinks. A file with all observed 
crosslinks with their spectra counts and max scores can be provided upon request. 
 
The N-terminal region of INTS13 had several crosslinks to the N-terminal half of INTS10 
whereas the C-terminal half had crosslinks to INTS14. This way, INTS13 connects INTS10 
and INTS14 in this heterotrimer in the human INT. There were very few inter-subcomplex 
crosslinks compared to the crosslinks within the two subcomplexes in the hexamer. Whilst this 
lack of inter-subcomplex crosslinks can be explained in terms of lack of Lys residues at 
interaction interfaces, it is likely due to the transient, weak and conformationally flexible nature 
of the interaction between the two modules. This later explanation is supported by the instability 
of the hexameric complex during purification and under cryo conditions.  
 
4.1.14 Reconstitution of 10-subunit and 13-subunit subcomplexes of INT   
The core-INT (section 4.1.9 and 4.1.10), the cleavage module (CM) and the cleavage module 
interacting module (CMIM) (section 4.1.12) together constitute 13 of the 15 subunits of the 
INT. The purification of these modules has been established (described in the aforementioned 
sections). The interaction between these modules was tested to ensure they are functional 
subcomplexes of the INT. Firstly, since the interaction between the CM and the CMIM was not 
stable under purification condition, I tested the stability of the interaction between the core-INT 
and the CMIM under purification conditions. The CMIM had shown a better interaction with 
INTS3/6-DDX26B trimeric component of the core-INT compared to the CM (Figure 4.7 and 
Figure S7d lane 6) whereas INTS5/8 and INTS2/7 heterodimers did not have any interactions 
with either the CM or the CMIM. To test interaction between the core-INT and the CMIM, I 
co-infected Hi5 insect cells with baculoviruses expressing the two subcomplexes with affinity 
tag on INTS6 as in the core-INT (Figure 4.14a). The purification of the 10-subunit complex of 
core-INT and CMIM was done using the purification strategy described for core-INT. Analysis 
of the elution fractions from ion exchange on LDS-PAGE followed by mass spectrometric 
identification of the proteins showed INTS10, INTS13 and INTS14 (subunits of the CMIM) 
co-purify with the core-INT via a single affinity tag on core-INT subunit, INTS6 (Figure 4.14b). 
The CMIM does not bind to HiTrap Q anion exchange column when purified on its own and 
must have high affinity binding to the core-INT to form a stable complex under ion exchange 
conditions up to 500 mM NaCl. This shows that, the CMIM interacts stably with the core-INT 
having survived a full purification protocol including ion exchange chromatography contrary 
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to its interaction with the CM described in section 4.1.13. However, the yield of this 10-subunits 
subcomplexes was extremely low (< 100 µg from 4-5 L of insect cells).  
 
 
Figure 4.14. Interaction between the core-INT, cleavage module and the cleavage module interacting 
module. (a) A cartoon representing baculoviruses expressing core-INT and cleavage module interacting 
module. The prefix ‘t’ on INTS6 represent 6xHis-MBP affinity tag. (b) An LDS-PAGE analysis of fractions 
from a HiTrap Q ion exchange purification of the 10-subunits subcomplex of INT from co-infection of the two 
baculoviruses in (a). The elution from amylose affinity purification was directly applied to the HiTrap and the 
flow through from the HiTrap (Amylose elution) was collected and analyzed alongside the peak elution fractions 
from the HiTrap Q. Proteins in the elution were identified by mass spectrometry. (c) Amylose affinity pulldown. 
Affinity tagged core-INT was immobilized on amylose beads and then incubated with CM and CMIM or none. 
As a background binding control of CM and CMIM were also incubated with beads without core-INT. Elution 




Since the yield of the core-INT is slightly better, it was better to reconstitute the complex from 
purified subcomplexes. I tested the formation of a 13-subunit complex of these three modules 
of INT from purified components using amylose affinity pulldown. To this end, purified core-
INT was immobilized on amylose beads using the affinity tag on INTS6. Bound core-INT was 
then incubated with CM and CMIM. A background binding control was also done where only 
CM and CMIM were incubated with the beads without the affinity tagged core-INT. LDS-
PAGE analysis of the maltose elution from the background control shows the CM and CMIM 
do not bind nonspecifically to the beads (Figure 4.14c lane 3) whiles core-INT bound as 
expected (Figure 4.14c lane 4). The two modules bound to the core-INT and co-eluted showing 
the formation of a 13 subunits subcomplex of the INT (Figure 4.14c lane 5). The complex was 
also reproduced using analytical gel filtration (not shown). 
 
4.1.15 Reconstitution of the full Integrator complex from purified components 
The reconstituted 13-subunit subcomplex of the INT described in the preceding section (4.1.14) 
was missing the 250 kDa INTS1 and the 49 kDa PHD zinc finger containing INTS12 subunits 
of INT. Although these subunits are known to interact in Drosophila (Jiandong Chen et al., 
2013) and now in human (Figure 4.4a), this heterodimer could not be purified because of the 
poor expression and degradation of the subunits during purification. INTS1 showed interactions 
with other subcomplexes such as INTS13/14 heterodimer (Figure 4.4b) and INTS3/6 (Figure 
4.4c). Purification of neither complexes yielded full length INTS1. Attempted purifications of 
the full length INTS1 lead to low yield and aggregated protein (Figure S1). Purification of 
INTS12 led to a severe degradation of the full-length protein to ~25 kDa N-terminal fragment. 
Protein disorder prediction of INTS12 showed a small structured domain of residues 1-50 
shown to bind INTS1 in Drosophila (Jiandong Chen et al., 2013) and the PHD domain (159 -
215). The rest of the protein is predicted to be disordered (Figure 4.1 INTS12). The N-terminal 
region INTS12(1-194) was cloned and a purification was attempted (Figure S2). This truncated 
domain of INTS12 was also aggregated suggesting it lacks some interaction partner. I used 
amylose affinity pulldown to test whether these partially purified INTS1 and INTS12 interact 
with the 13-subunits INT subcomplex described in section 4.14.  
To achieve this, affinity tagged core-INT was arrested on amylose beads and then incubated 
with the CM, CMIM, INTS1 and INTS12. A background binding of the untagged 
subcomplexes/subunits was tested by incubating them with amylose beads in the absence of the 
affinity tagged core-INT. An LDS-PAGE analysis of elution fractions showed in Figure 4.15a 
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lane 8 indicates the untagged subcomplexes/subunits do not interact nonspecifically with the 
beads. The CM and the CMIM co-purified with the core-INT in the elution of the test (Figure 
4.15a lane 9,10 and 11) as observed previously in Figure 4.14c lane5. 
 
 
 Figure 4.15. Reconstitution of full INT and its crosslinking network. (a) Amylose affinity pulldown. 
Affinity tagged core-INT was immobilized on amylose beads and then incubated with CM and CMIM, INTS1 
and INTS12. As a background binding control, INTS1, INTS12, CM and CMIM were also incubated with beads 
without core-INT. Elution fractions from the background test (bg) as well four sequential elutions from the test 
binding were analyzed on LDS-PAGE. (b) A cartoon representing EDC mediated chemical crosslinking 
network of the reconstituted INT. Subunits are indicated as rectangles and chemical crosslinks between Lys 
residues are indicated with black line segments. (c) A cartoon of BS3 mediated chemical crosslinking network 
within INT. Coloring scheme and legend is the same as in (b). A key explaining acronyms is provided. A file 
detailing all crosslinks and their scores can be provided on request. 
 
Interestingly, partially purified INTS1 and INTS12 also co-purified with the 13-subunits 
indicating the formation of the full INT (Figure 4.15a lane 9,10 and 11). This indicates that, the 
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partially purified INTS1 and INTS12 are in a state that they can be bound by their cognate 
interaction partners/interfaces within the INT.  
To further characterize how the different subunits and subcomplexes of INT are interacting, we 
used BS3 and EDC mediated XL-MS (Figure 4.15b and c). In contrast to XL-MS results 
presented in section 4.1.6, here a complex assembled and purified via a single affinity tag (on 
INTS6 subunit of core-INT) was used ensuring a better purity and homogeneity. The elution 
fractions from the amylose affinity pulldown was crosslinked with 3 mM BS3 or a gradient 
from 5 – 100 mM EDC as described for the core-INT (section 4.1.11). For EDC crosslinking, 
samples were loaded on LDS-PAGE and bands corresponding to crosslinked complexes were 
excised for mass spectrometric analysis. There were very few crosslinks peptides observed for 
the EDC crosslinked samples and INTS5 and INTS14 were not detected at all (Figure 4.15b). 
This might be due to the stringent distance restrains imposed by the EDC crosslinker. The in-
gel digestion method used is usually associated with significant sample loses (Leitner et al., 
2010) and may contribute to the low number of crosslinked peptides observed. The EDC 
mediated crosslinks between subunits of the core-INT observed in Figure 4.11b could not be 
reproduced. There were low confident crosslinks observed between subunits of different 
subcomplexes. The BS3 mediated XL-MS experiment on the other hand produces many high 
confidence crosslinks (Figure 4.15c). The crosslinking pattern within the core-INT subunits in 
this experiment was mostly consistent with the results of crosslinking the core-INT alone 
(Figure 4.11a) suggesting the core-INT did not undergo drastic conformational changes upon 
binding the other subcomplexes and subunits. There were high confidence crosslinks between 
subunits of the CM but not as many crosslinks were observed compared to when the complex 
of the CM and CMIM was crosslinked (Figure 4.13c). Notably, crosslinks between the C-
terminal interacting domains of INTS9 and INTS11 were not observed. This might be an 
experimental artefact or the CM might be in a different conformation (potentially 
extended/relaxed) when in context of the full INT. The crosslinks observed between the CM 
and CMIM were also not observed in the context of the full INT. It is possible that the two 
modules may no longer be in close proximity in the context of the full INT. Crosslinks between 
the C-terminal regions of INTS13 and 14 were preserved between this experiment and when 
the complex of CM and CMIM was crosslinked whereas crosslinks between the N-terminal 
regions of INTS13 and INTS10 were no longer present. Interestingly, there were many high 
confidence crosslinks between the C-terminal region of INTS13 to the C-terminal regions of 
INTS3 and INTS6 of the core-INT. This may represent some of the interaction interfaces 
between the two modules accounting for the stability of the interaction between them seen in 
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Figure 4.14. There were crosslinks observed between different subunits to both INTS1 and 
INTS12 suggesting how these two subunits might be incorporated into the Integrator complex. 
To get a better overview of how these two subunits interact with the rest of the subunits of the 
INT, their purification must be improved. 
 
4.1.16 Identification of a soluble domain in INTS1 and its interaction with INTS12  
The largest subunit of INT, INTS1 was very challenging to express and purify (Figure S1). 
INTS1 does not have any known folded domain except the predicted N-terminal DUF3677 
domain. Its amino acid sequence has a lot of predicted disordered domains (Figure 4.1 INTS1). 
I could not co-purify the full length INTS1 with its identified interaction partner (INTS12) or 
subcomplexes (INTS13/14 and INTS3/6 heterodimers) (Figure 4.4) as INTS1 was poorly 
expressed and degrades. This shows that, these interaction partners are not able to stabilize the 
full length INTS1. To test which part of INTS1 is expressible and soluble on its own, the INTS1 
protein was divided into an N-terminal half (residues 1-1010) and a C-terminal half (residues 
1010-2190). I expressed these variants as well as the DUF3677-containing N-terminal domain 
(residues 1-294) and a small predicted domain in the C-terminal region (residues 2045 – 2190) 
in the absence of solubility tags. A Ni affinity pulldown from Hi5 insect cells expressing 6xHis 
tagged versions of these variants showed that only the DUF3677-containg N-terminal domain 
(residues 1-294) was clearly overexpressed (Figure 4.16a lane 1) while the other variants were 
at background levels. Attempts to purify this soluble domain showed it was co-purifying with 
a chaperon and forming oligomers (Figure S1e and f). This result implies that INTS1(1-294) is 
lacking some interaction partner. To identify which subcomplex of INT binds this domain of 
INTS1, a co-infection assay between a baculovirus expressing 6xHis tagged INTS1(1-294) and 
baculoviruses expressing core-INT, CM or the CMIM was done. Each of these modules had an 
affinity tagged subunit for subsequent amylose affinity pulldown. Additionally, I made a 
baculovirus expressing a 6xHis tagged INTS1(1-294) and INTS12(1-194) to test if these two 
domains interact (Figure 4.16b).  
A western blot analysis of input and elution samples of amylose affinity pulldown from Hi5 
cells expressing 6xHis tagged INTS1(1-294) shows the protein is expressed and does not bind 
amylose beads nonspecifically (Figure 4.16c lane 1 and 2). The same analysis was done on Hi5 
cells co-infected with combinations of baculoviruses shown is Figure 4.16b and c. There was 
signal for 6xHis tagged INTS1(1-294) in the elution fractions indicating this domain of INTS1 
have some interaction with all the subcomplexes of INT. Given that the same number of cells 
was used in the pulldowns and all parameters were kept constant for all experiments (except 
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the expression levels), it appears that the CMIM (A+D) has a better interaction with this domain 
of INTS1 compared to the core-INT and the CM. Given the core-INT is poorly expressed 
compared to the CM, it might have a better interaction with INTS1(1-294) compared to the CM 





Figure 4.16. Identification of a soluble domain in INTS1 and its interactions with INT subcomplexes 
INTS12. (a) expression and solubility test of INTS1 domains. An LDS-PAGE analysis of elution samples of 
Ni affinity pulldown from insect cells expressing variants of INTS1. Residues encompassing each domain is 
indicated on top of the gel. (b) A cartoon representing baculoviruses used in co-infection assay. The INT 
subunits in each baculovirus are indicated and the subunit with affinity tag is labeled with ‘t’. (c) Amylose 
affinity pulldown from co-infection assay. An LDS-PAGE analysis of input (I) and elution (E) samples of 
pulldown from Hi5 cells infected with various combinations of baculoviruses in (b). The virus(es) used in each 
infection is/are indicated on top of the gel. A western blot analysis for 6xHis-INTS1(1-294) from the same 
samples is appended to the bottom of the LDS-PADE gel. (d) Ni affinity pulldown of 6xHis-INTS1(1-294) and 
INTS12(1-194). An LDS-PAGE analysis of input (I) and elution (E) samples of a Ni affinity pulldown from 
Hi5 cells expressing 6xHis-INTS1(1-294) and INTS12(1-194). (e) An LDS-PAGE analysis of fractions from 
gel filtration chromatographic purification of INTS1(1-294)/INTS12(1-194) heterodimer showing they form a 
homogenous complex. The retention volume of the fractions analyzed are indicated on top of the gel. (f) A gel 
filtration chromatogram of INTS1(1-294)/INTS12(1-194) purification showing the two domains interact and 
elute as a single homogenous peak. 
 
The N-terminal domain of INTS1 is likely involved in the interaction observed between 
INTS13/14 heterodimer and INTS1 (Figure 4.4b). 
An N-terminal microdomain in Drosophila INTS12 (residue 1-45) has been shown to interact 
with INTS1 (Jiandong Chen et al., 2013). A co-expression experiment demonstrated that human 
INTS1 and INTS12 also have interaction (Figure 4.4a). It is not known which part of INTS1 
interacts with INTS12. To test whether the soluble and stable N-terminal domain of INTS1 
(residue 1-294) interacts with the stable N-terminal domain of INTS12 described in Figure S2, 
I made a baculovirus expressing the two domains with a 6xHis tag on INTS1(1-294). A Ni 
affinity pulldown from Hi5 cells infected with this baculovirus shows the two domains interact 
and are co-purified via the affinity tag on INTS1(1-294) (Figure 4.16d). Both of the INTS1 and 
INTS12 stable and soluble domains forms oligomers when purified independently (Figure S1e, 
f and S2d, e) suggesting they lack interaction partner(s). Co-purification of these interacting 
domains however prevented this oligomerization (Figure 4.16e and f) showing that the residues 
that might be responsible for the oligomerization are involved in the interaction between these 
domains. 
 
In conclusion, the inter-subunit interaction network within the Integrator complex has been 
delineated using co-infection in insect cells coupled to affinity purification and crosslinking 
mass spectrometry. INT can be divided into four subcomplexes namely the core-INT 
(comprising INTS2, INTS3, INTS5, INTS6, INTS7, INTS8 and DDX26B), the cleavage 
module (made up of INTS4, INTS9 and INTS11), the cleavage module interacting module 
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(composed of INTS10, INTS13 and INTS14) and INTS1/12 heterodimer (or their interacting 
N-terminal domains). The purification of these modules has been established and importantly 
the full INT can be reconstituted from the separately purified subcomplexes. I also provided a 
crosslinking network of the subunits (using BS3 mediated XL-MS) providing a proxy of how 
the subunits are connected within the Integrator complex in the absence of high-resolution 
structures. 
 
4.2 Interaction between INT and RNA Pol II elongation complex 
The role of the Integrator complex in RNA Polymerase II (Pol II) transcription has been widely 
studied and reviewed in (Baillat & Wagner, 2015; Rienzo & Casamassimi, 2016a). These 
studies suggest that the INT (or certain subunits) must have direct interactions with key players 
of Pol II transcription. However, these studies lack direct evidence of interaction between INT 
and Pol II transcription complexes using purified components. Here, I traced interaction 
between the Integrator complex and INTS3 and the pause elongation complex of Pol II-DSIF-
NELF (PEC) (Vos, Farnung, Urlaub, et al., 2018) using the reconstituted INT and subunit 
INTS3.  
4.2.1 INTS3 interacts with NELF and the Pause Elongation Complex (PEC) 
The INTS3 subunit of INT was shown to be a part of the SOSS complex where is was called 
SOSS-A (Huang et al., 2009; Li et al., 2009; Ren et al., 2014; Skaar et al., 2009). This subunit 
was also shown to co-fractionate with the negative elongation complex (NELF) when NELF 
associated protein complexes from co-immunoprecipitation was separated on glycerol gradient 
(Stadelmayer et al., 2014). This suggests INTS3 may have a functional association with the 
NELF complex independent of INT. To test whether this interaction can be recapitulated in a 
purified system, I created a baculovirus co-expressing the four-subunits NELF complex with a 
6xHis tag on NELF -C and MBP tagged INTS3. The NELF subunits, A and E have long 
stretches of disordered regions named tentacles (Vos, Farnung, Urlaub, et al., 2018). To test 
whether these tentacles are important for interaction with INTS3, the NELF tentacle mutants 
were also co-expressed with INTS3. Amylose affinity pulldown from Hi5 insect cells co-
expressing MBP tag INTS3 and the NELF variants showed that INTS3 interacts with wild-type 
NELF as well as the tentacle mutants (Figure 4.17a). These results confirm the observed in vivo 
interaction between the NELF complex and INTS3 (Stadelmayer et al., 2014) and further shows 
that the disordered regions in NELF -A and -E are dispensable for this interaction (Figure 
4.17a). To assess which regions of INTS3 are important for interaction with NELF, various 
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truncation mutants of INTS3 with MBP tags were created (Figure 4.17b). These truncations 
were co-expressed with wild-type NELF complex and amylose affinity pulldown followed by 
western blot for 6xHis tagged NELF -C was used to evaluate interactions. The results in Figure 
4.17c shows that all the variants of INTS3 interact with the NELF complex. This implies 
multiple regions of the INTS3 protein contact various regions/subunits of the NELF complex. 
Attempts to purify full length INTS3 normally results in aggregation (not shown). Purification 
of INTS3-NELF complex shows the complex is stable under the purification conditions used 
(Figure 4.17d). Interestingly, the excess INTS3 by-product of the co-expression was not 
aggregated proposing co-expression with the NELF complex may help the folding and 
solubility of INTS3 (Figure 4.17e). 
 
 
Figure 4.17. Interaction of INTS3 and NELF complex. (a) INTS3 interacts with wt-NELF and NELF tentacle 
mutants. Western blot analysis of input (I) and elution fractions (E) of amylose affinity pulldown from Hi5 cells 
co-expressing INTS3 and the various variants of the NELF complex. A, B, C, and E represents the NELF 
subunits, A and E represent NELF A(1-188) and E(1-138) tentacle mutants respectively. (b) Cartoon 
representing INTS3 truncation mutants with the residue numbers indicated. (c) Interactions between INTS3 
variants and wt-NELF. LDS-PAGE and western blot analysis of input (I) and elution (E) fractions of amylose 
affinity pulldown from Hi5 cells co-expressing the NELF complex and the various truncations of INTS3 
indicated on top of the gel. In variant iv, the western blot signal is masked by the high concentration of that 
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variant which co-migrates with NELF -C at the same apparent molecular weight. (d) Purification of INTS3-
NELF complex. An LDS-PAGE analysis of peak fractions of a gel filtration chromatographic purification of 
INTS3-NELF complex. The retention volume of the fractions analyzed are indicated on top of the gel. (e) 
Purification of INTS3. A gel filtration chromatogram of the excess INTS3 by-product of INTS3-NELF complex 
purification showing the elution peak. A slice of an LDS-PAGE analysis of the peak fractions is appended. 
 
The negative elongation complex (NELF) is so named for its role in repressing transcription 
elongation (Narita et al., 2003; Yamaguchi et al., 1999). A structure of repressed (paused) 
transcription elongation complex of Pol II, NELF and DSIF (PEC) was recently solved (Vos, 
Farnung, Urlaub, et al., 2018). I have recapitulated an interaction between INTS3 and NELF 
(Figure 4.17). The follow-up question was, how does the interaction between NELF and INTS3 
affect NELF binding to the elongation complex? To address this question, the PEC was formed 
in the presence of INTS3. Results presented in Figure 4.18a and b show that a PEC can be 
formed in the presence of INTS3. The presence of INTS3 in the PEC did not have any 
discernible impact on in vitro transcription elongation and pausing (not shown).  
We used XL-MS to further characterize how INTS3 is interacting with the PEC. To achieve 
this, the peak fractions of INTS3-PEC (Figure 4.18a and b) was crosslinked with 2 mM BS3 
and the crosslinked product was analyzed by mass spectrometry. The previously observed 
crosslinking pattern within the PEC (Vos, Farnung, Urlaub, et al., 2018) was reproduced 
showing the complex was intact and did not undergo any dramatic conformational changes 
upon binding INTS3 (Figure 4.18c). As expected, INTS3 mostly crosslinked to the subunits of 
the NELF complex with few crosslinks to RPB2, RPB5 and RBP7 subunits of Pol II. Crosslinks 
to the Pol II subunits have low scores except the one to RPB5. There were no crosslinks between 
INTS3 and DSIF subunits, SPT4 and SPT5. The crosslinks between INTS3 and the NELF 
subunits span the entire length of INTS3 protein showing that, INTS3 makes multiple contacts 
with NELF confirming the results of the INTS3 truncations in Figure 4.17c. The RBP5 and 
RBP7 subunits of Pol II are located close to the NELF complex in the structure of the PEC 
(PDB 6GML) allowing INTS3 to contact these subunits of Pol II and hence the crosslinks to 
these subunits. The residue of RBP2 subunit that crosslinked to INTS3 on the contrary is located 
on the side of Pol II opposite to the side bound by NELF. The crosslink between INTS3 and 
RPB2 therefore may not represent a specific interaction between these proteins. 
I attempted to determine a cryo-EM structure of the INTS3-PEC complex but obtained only the 
structures of PEC, Pol II-DSIF and Pol II (results not shown). This suggests INTS3 dissociated 
from NELF and for that matter PEC during cryo-EM sample preparation. Only 10% of the 
particles was the PEC showing that NELF has a low occupancy on the Pol II-DSIF complex. 
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This was also observed previously by Vos and colleagues (Vos et al., 2018) suggesting that 
additional factors might be needed to stabilize the paused complex of Pol II-DSIF-NELF.  
 
 
Figure 4.18. Interaction of INTS3 and the pause elongation complex (PEC). (a) Formation of an INTS3 – 
PEC. A gel filtration chromatogram (absorbance at 280 nm) showing formation of the INTS3-PEC (blue). The 
elution profile of INTS3 alone is shown in green and peaks of excess factors and nucleic acids are labeled. (b) 
Formation of INTS3-PEC. An LDS-PAGE analysis of the fractions from the gel filtration chromatographic 
separation of the INTS3-PEC complex. The retention volumes of the fractions analyzed are indicated on top of 
the gel. (c) A cartoon representing the crosslinking network between INTS3 (blue rectangle) and the PEC. Grey 
circles represent subunits of Pol II, light green circles (DSIF subunits SPT5 and SPT4) and magenta (NELF 
subunits). Crosslinks within the PEC are shown by black line segments and crosslinks between INTS3 and PEC 




4.2.2 The reconstituted INT interacts with the PEC 
INT associates with Pol II to perform its roles in transcription elongation and termination. The 
reported roles of INT in transcription often involve DSIF and NELF which are a part of the 
PEC (Baillat & Wagner, 2015; Rienzo & Casamassimi, 2016a). The PEC therefore represents 
an attractive starting point to study the involvement of INT in Pol II transcription and regulation 
in vitro. During these initial studies, I did not explore the roles of CTD phosphorylations on the 
interaction between INT and PEC. Nonetheless endogenously purified Pol II may have the 
needed CTD phosphorylation for interaction with INT. To test whether INT binds to the PEC, 
PEC was formed as described previously (Vos, Farnung, Urlaub, et al., 2018) but in the 
presence of INT. The subcomplexes of INT were pre-incubated together to allow the assembly 
of INT. The preformed INT was added to Pol II before NELF and DSIF were added. I then 
purified the complex on a 15-30% sucrose density gradient. As controls, PEC formed from 
similar amount of Pol II, NELF and DSIF as well as the constituent subcomplexes of INT were 
also run on the gradient. The INTS1 and INTS12 interacting domains, the CM, and CMIM were 
in the top 8 fractions of the gradient (Figure 4.19a-c) and core-INT run as shown in Figure 
4.10a. The PEC has a peak from fraction 8 to 10 which tails to fraction 13 (Figure 4.19e). In 
the presence of INT, Pol II, DSIF and NELF migrated to fraction 14, 15 and 16 showing the 
formation of a bigger complex of INT and PEC hereafter referred to as INT-PEC (Figure 4.19f 
and Table S1). The CM and CMIM alone do not bind the PEC when tested. Mass spectrometric 
analysis of fraction 16 identified unique peptides for all the expected proteins in the INT-PEC 









Figure 4.19 Interaction between INT and PEC. An LDS-PAGE analysis of fractions from 15-30% sucrose 
density gradient of CM (a), CMIM (b), INTS1/12 interacting domains (c), core-INT same as Figure 4.10a (d). 
PEC (e) and INT-PEC (f). The fractions analyzed are indicated at the bottom of each gel. The red line segment 
shows the peak fractions. Note that in (b) INTS13 partly degrades and runs at the same molecular weight as 
INTS10. And in (f) fraction 17 was mistakenly loaded before 16. 
 
4.2.3 XL-MS identifies subunits involved in the interaction between INT and PEC  
To uncover which subunits of INT contact PEC, we used BS3 mediated XL-MS.  
To this end, I formed the PEC and purified it on analytical gel filtration to remove excess NELF 
and DSIF. Preformed INT was then added to PEC and incubated for 30 min at 30 oC. The 
complex was directly crosslinked without further purification due to limiting amounts of core-
INT. Initial attempts to purify the INT-PEC prior to XL-MS analysis resulted in sample lost 




Figure 4.20. Overview of BS3 crosslinking network of INT-PEC. The Venn diagram shows the 
overlap between two independent experiments. Only crosslinks in the intersection were used for the 
final visualization. Pol II subunits are colored gray and highlighted in a gray background, DSIF 
subunits are colored green and highlighted by a green transparent background, NELF subunits are 
colored hot pink and highlighted with a transparent pink background and INT subunits are colored 
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orange and grouped by a yellow background. For clarity, only inter crosslinks are shown. Crosslinks 
between INT and PEC are shown by blue lines while other crosslinks are shown by gray lines. 
Crosslinks within INT, NELF, Pol II were also not shown for clarity. Crosslinks between Pol II and NELF -A 
and NELF -C are shown because INT crosslink to the same regions of those NELF subunits. 
 
Crosslinking experiments were repeated two times and crosslinks that were reproduced in both 
experiments were used as final results. We observed 1169 crosslinks that were reproduced in 
the two independent experiments amounting to 55% of all crosslinks (Figure 4 Venn diagram). 
Crosslink network between INT subunits is largely reminiscent to our results when INT alone 
was crosslinked shown in Figure 4.15 except crosslinks between INTS5 and INTS8 as well as 
crosslinks from INTS11 to INTS1 and INTS12 suggestive of some conformational changes in 
INT upon binding PEC. Crosslinks within PEC were mostly consistent with results from Vos 
and colleagues (Vos, Farnung, Urlaub, et al., 2018) with some deviations. Notably, we did 
observe reproducible crosslinks between the C-termini of NELF-A and NELF-E to the subunits 
of DSIF. 
Results showed in Figure 4.20 reveal crosslinks between several subunits of INT to PEC. 
INTS1, INTS3, INTS6, INTS8, INTS10, INTS11 and INTS12 have the most crosslinks to PEC, 
suggesting that these subunits play a major role in the interaction between INT and PEC. 
INTS2, INTS9, and INTS13 had fewer crosslinks to PEC. INTS4, INTS5, INTS7, and INTS14 
had no crosslinks to PEC.  
INTS1, INTS3, INTS6, INTS8, INTS11 and INTS12 subunits of INT have crosslinks to RPB1, 
RPB2, RPB5 RPB8 and RPB11 subunits of Pol II.  INTS1, INTS3, INTS6, INTS8, INTS9, 
INTS11 and INTS12 have crosslinks to subunits of the NELF complex. INTS1, INTS2, 
INTS10, and INTS11 have crosslinks to DSIF subunits especially SPT4. For a visual 
appreciation of the location of INT crosslinks in real space, I mapped them on the model of 
PEC (PDB 6GML) and shown as orange spheres (Figure 4.21). INT crosslinks are located on 
the front view of Pol II between NELF and around the downstream DNA and extends to SPT4 
and the upstream DNA and exiting RNA (Figure 4.21a). There were no crosslinks on the back 
view of Pol II 180o away from the front view (Figure 4.21b). It appears INT traces the path of 
NELF and DSIF on Pol II as crosslinks between INT and Pol II are mostly on regions of Pol II 
that have crosslinks to these factors. This highlights how INT, NELF and DSIF may 
collaborates in regulating Pol II during pause – release on protein coding genes and during 
termination of snRNA genes. INTS1(1-294) has the most and the highest scoring crosslinks. 
Notably, INTS1(K17) to RPB2(K151) had a lot of hits and the highest score.  The N-terminus 
of INTS1 have additional crosslinks to RPB2(K821) and SPT5(K322) which are located 24 Å 
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and 32 Å from RPB2(K151) respectively in PEC structure (PDB 6GML) showing the N-
terminal of INTS1 is located in this region and may contact the upstream DNA. All these 
residues are in unstructured loops around the RNA exit tunnel of Pol II and can interact with 
the predicted unstructured N-terminus of INTS1. The N-terminus of INTS1 have many 
crosslinks to INTS11 and may localize INTS11 and the CM close to the exiting RNA for 
processing.  INTS1 have high score crosslinks to the NELF complex as well. INTS1(K100) has 
crosslinks to NELF -A(K190) and (K371) which are located in the flexible ‘tentacle’ of this 
protein and to NELF -B(K146). INTS12(1-294) crosslinks to the terminal residue of SPT4 (A2) 
which is located close to the region where most of INTS1 crosslinks are located. INTS8 may 
form an important bridge between NELF and Pol II having crosslinks to NELF -B (K85 and 
K118) and RPB5 (K12). Similar to INTS8, INTS3 have crosslinks to NELF -A(K161), 
RPB1(K213) and RPB2(K327) suggesting how this subunit might bridge the interaction 








Figure 4.21 Mapping of crosslinks between INT and PEC on the PEC atomic model (PDB 6GML). 
Crosslinking residues of the PEC are shown as orange spheres and labeled together with the residue of INT they 
crosslinked to. (a) A ‘front’ view of PEC with the downstream DNA pointing out of the page. Coloring scheme 
is the same as in Figure 4.20. Most of INT crosslinks are located on this view of PEC. Residues that crosslink 
to INT are shown as orange spheres. (b) A ‘back’ view of PEC 180o around the vertical axis relative to the front 
view in (a). The upstream DNA in indicated. (c-f) Zoomed-in of regions with crosslinks. Crosslinked residues 
are labeled together with the INT residue they crosslinked to. (c) and (d) are related by a 90o anticlockwise 
rotation and (e) and (f) by a 90o clockwise rotation 
 
 
In conclusion, I recapitulated interaction between NELF and INTS3 using purified proteins. I 
also demonstrated for the first time, in vitro interaction between INT and paused transcription 
elongation complex of Pol II, DSIF and NELF. There are multiple INT subunits involved in 
this interaction, specifically INTS1, INTS3, INTS8 and INTS11 had high confidence crosslinks 





































5 Discussion and Conclusions 
5.1 Recombinant production of INT and its inter-subunit interaction network 
Pioneers in biochemical reconstitution of transcriptional complexes relied on chromatographic 
fractionation of cell/tissue homogenates, which are laborious and often results in minute 
amounts of protein (Roeder & Rutter, 1969; Sekimizu et al., 1976). In vitro biochemical studies 
in the transcription field were revolutionized by advancements in recombinant DNA 
technology. This technology allows for the expression and purification of proteins in good 
quality and quantity that will otherwise not be available from endogenous sources (Lis, 2019). 
With the advent of cloning, Escherichia coli and Saccharomyces cerevisiae proved useful 
resources for recombinant protein production because they are easy to manipulate genetically 
and can be cultured in large amounts at a relatively low cost (Nevalainen et al., 2005; Peti & 
Page, 2007; Puig et al., 2001; Vieira Gomes et al., 2018). Overexpression in E. coli and S. 
cerevisiae may not be ideal for proteins from higher eukaryotes because the necessary 
machinery for protein folding and installing post translational modification may be lacking 
(Vieira Gomes et al., 2018). In such cases, insect and mammalian cells are important 
alternatives although they are relatively difficult to manipulate genetically and are more 
expensive to culture. Nonetheless, the baculovirus - insect cell recombinant protein expression 
system have gained high grounds in the expression of large molecular complexes which led to 
high resolution cryo-EM structures of TFIIH (Schilbach et al., 2017), the anaphase promoting 
complex (Zhang et al., 2013) just to name a few. This is due to the availability of well-
established technologies for efficient cloning of genes and consistent production of 
baculoviruses and cell lines for protein expression (Berger et al., 2004; Gradia et al., 2017; 
Luckow et al., 1993; Trowitzsch et al., 2010).  
In this study, I used the baculovirus - insect cell recombinant protein expression system to 
reconstitute INT. It was not possible to clone all 15 subunits into a single baculovirus because 
of the large size of the genes. The largest virus I constructed was 34,000 bp, coding for 8 
subunits of INT. This challenge can be circumvented by co-infection with multiple 
baculoviruses. I therefore employed a bottom-up approach where I identified interacting 
subunits and then combined them into bigger subcomplexes of INT for co-expression and 
purification (Section 4.1). Initial expression tests in insect cells showed that all subunits of INT 
can be expressed individually. This prompted the idea to purify all the subunits independently 
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and reconstitute INT in vitro. However, purifications often resulted in oligomerization of most 
of the subunits, which is suggestive of suboptimal purification conditions or misfolding due to 
a lack of an interaction partner. After testing several buffer conditions without successfully 
solving the problem of oligomerization, I opted to identify interacting subunits by co-infection 
and pulldown assays. Using this strategy, I discovered previously unknown interactions 
between subunits of INT (Section 4.1.3).  
Combining the results of the systematic co-infection assays and the information about known 
interacting subunits allowed the creation of 3 baculoviruses for co-infection. Purification of 
INT from Hi5 cells co-infected with the three baculoviruses and XL-MS experiment led to the 
identification of novel interaction between INTS3/6 heterodimer and DDX26B (Section 4.1.5 
and 4.1.6). This trimer formed the basis for the identification of a heteropentameric subcomplex 
(Section 4.1.7) and then the heteroheptameric core-INT (Section 4.1.9). This way the 15 
subunits of INT were grouped into 4 subcomplexes named core-INT (7 subunits), CM (3 
subunits), CMIM (3 subunits) and INTS1/12 (2 subunits) (Figure 5.1).  
The construct expressing core-INT is 34,000 bp in size. It was difficult to clone additional 
subunits into it and when done successfully, there was little or no protein expressed. I therefore 
established purification protocols for the CM, CMIM and identified soluble and interaction 
domains in INTS1 and INTS12 for in vitro reconstitution of INT. Using amylose affinity 
pulldown and analytical gel filtration, I discovered an interaction between the CM and CMIM. 
This interaction was however not stable under purification conditions tested implying that the 
interaction might be weak and transient. The CMIM interacts with the core-INT forming a 
complex which is stable in 500 mM NaCl during purification. To further probe the interaction 
between the subcomplexes of INT, XL-MS was conducted on the reconstituted INT. INT was 
formed by pulldown using MBP tag on INTS6. From the XL-MS results, the CMIM and 
INTS1/12 heterodimer have a lot of crosslinks to the core-INT whereas the CM has fewer 
crosslinks (Section 4.1.15). It is therefore possible that the CM is a dissociable module of INT 
while the other subunits form the functional core of INT (Figure 5.1).  
 
 




Figure 5.1. A model of subunit-interactions within INT. INT subunits are represented by 
circles/ovals scaled to the number of amino acids in the specific subunit. Subcomplexes that are stable 
under a tested purification condition are encircles with dashed circles. Black dashed line indicated 
interaction between subcomplexes inferred from XL-MS. Lines are weighted according to the number 
of crosslinks observed between the subcomplexes. Red dashed lines represent interactions shown by 
pulldown assay. 
 
5.2 Modularity of INT 
Large macromolecular complexes are often divided into submodules. Both the Mediator 
complex and TFIIH have dissociable kinase modules (Kornberg, 2005; Schilbach et al., 2017). 
Since the discovery of INT, it has been speculated that INT might also exhibit modular 
architecture given its large size (Baillat et al., 2005; Baillat & Wagner, 2015; Rienzo & 
Casamassimi, 2016b). The question remains whether the core-INT, CM, CMIM and INTS1/12 
heterodimer subcomplexes reported here represent functional modules of INT in vivo. The CM 
which shares substantial similarities with the cleavage module of the mammalian CPF was 
described by another independent group and characterized as the cleavage module of INT 
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(Albrecht et al., 2018). Chromatin immunoprecipitation coupled to sequencing (CHIP-seq) 
analysis of INT subunits shows that INTS5 of the core-INT binds the promoter region while 
INTS11 subunit of the CM binds preferentially to the 3’ region of snRNA genes (Egloff et al., 
2012). Furthermore, Drosophila INTS12 has a CHIP-seq peak at the promoter region of Hsp70 
whereas INTS9 subunit of the CM peaks at the 3’ end (Gardini et al., 2014). These results show 
at least INTS9/11 dimer are recruited to genes independent of the rest of the INT insinuating 
that they might be a part of dissociable module of INT.  
INTS13 subunit of the CMIM was identified to play a role in enhancer activation together with 
NAB2 at poised enhancers (Barbieri et al., 2018). Mass spectrometric analysis of anti-INTS13 
immuno-precipitated material separated by gel filtration shows enrichment of INTS10, INTS14 
and INTS13 in a lower molecular weight fraction, distinct from the full INT (Barbieri et al., 
2018). This suggests that the subunits within the CMIM interact in vivo and the CMIM may 
represent functional module of INT. In vivo interaction of Drosophila INTS1 and INTS12 has 
been reported (Jiandong Chen et al., 2013). However, it is not known whether this is a functional 
module of INT. INTS5, INTS6 and INTS7 subunits of core-INT but not INTS11 co-purified 
with RPAP2 (Gardini et al., 2014). It can therefore be speculated that these subunits are in one 
module of INT in vivo.  
5.3 The CM of INT is similar to the CM of mammalian CPF 
The INTS9/11 heterodimer has clear similarities with CPSF73 and its regulatory subunit 
CPSF100 of the CPF. All these proteins have an N-terminal metallo beta-lactamase and a beta-
CASP domains and a less characterized C-terminal domain. INTS11 and CPSF73 are 
endoribonucleases. INTS9 and CPSF100 have the same folds as INTS11 and CPSF73 but are 
not active endoribonucleases (Albrecht & Wagner, 2012; Baillat et al., 2005; Mandel et al., 
2006). INTS4 interacts with INTS9/11 heterodimer to form the CM of INT. INTS4 has N-
terminal HEAT repeats similar to Symplekin (SYMPK), which is the third protein in the CM 
of the mammalian CPF (Albrecht et al., 2018; Y. Zhang et al., 2019) (Figure 5.2).  
I purified the CM (Section 4.1.12) and attempted to determine its structure by x-ray 
crystallography and cryo-EM. I could not identify crystallization conditions for the full-length 
CM and after limited proteolysis. I then switched to cryo-EM where I could obtain a low-
resolution 3D map of the CM at ~22 Å (Figure S8). The CM appears to be trilobal in shape 
similar to the CM of the mammalian CPF which was solved to a medium resolution by cryo-
EM (Zhang et al., 2019). The two complexes likely have similar 3D structure due to the 
similarity in the amino acid sequence of their subunits. It also emerges that they have a lot of 
conformational flexibility. This flexibility may account for poor alignment of their particles and 
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hence the low resolution (Nogales et al., 2016). Addition of interaction partners may restrict 
this flexibility and allow for a better resolution. A recent study of the histone pre-mRNA 3’ 
formation machinery which includes CM of the CPF was a clear demonstration of this notion. 
Symplekin, CPSF100 and CPSF73 made extensive interactions with both proteins and nucleic 
acids to adopt a rigid conformation. In this conformation, a high resolution structure was 
determine which led to an atomic model for the histone pre-mRNA 3’ formation machinery 
including the CM of the CPF (Sun et al., 2020). In similar direction, I attempted cryo-EM 
studies on a complex of the CM and the CMIM. However, the complex did not survive tested 
cryo conditions and fell apart or got denatured.  
 
 
Figure 5.2. Homology between CMs of INT and CPF. A cartoon representing subunits of the CMs. 
Similar subunits are drawn together and scaled to their respective number of amino acids. Conserved 
domains namely metallo beta-lactamase (ML), -CASP, and HEAT repeats are indicated. Less 
conserved C-terminal domains (CTD) are also shown.  
 
5.4 INT interacts with PEC 
The reconstituted INT interacts with PEC in agreement with the widely reported role of INT in 
Pol II pause-release (Baillat & Wagner, 2015; Elrod et al., 2019; Gardini et al., 2014; Rienzo 
& Casamassimi, 2016b; Stadelmayer et al., 2014). Result of XL-MS shows that INTS1, INTS3, 
INTS6, INTS8, INTS10, INTS11 and INTS12 play major roles in the interaction between INT and 
PEC (Section 4.2.3). These subunits have multiple high confidence crosslinks to subunits of 
NELF and Pol II. It emerges that INT interacts with both NELF and DSIF in agreement with 
data showing that INTS4, INTS6, INTS9, INTS11 and INTS12 have binary interaction with 
NELF -A and INTS6 interacts with SPT5 (DSIF subunit) in pulldown assays (Yamamoto et al., 
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2014). There might be other crucial interactions that were not captured by XL-MS because Lys 
residues are not found at the respective protein interfaces - a limitation of BS3 mediated XL-
MS. Also, interaction between INT and the exiting RNA as well as DNA may be important for 
stabilizing the complex. 
Phosphorylation of Pol II CTD on Ser7 and Ser2 of the heptad repeat has been shown to be 
important for INT recruitment (Baillat et al., 2005; Egloff et al., 2007, 2010). However, INT 
does not have any predictable CTD/phosphorylated CTD interaction domain. INT recruitment 
via a phosphorylated CTD is thought to be mediated by other proteins such as RPAP2 which 
binds CTD phosphorylated on Ser7 and interacts with INT (Egloff et al., 2012). In this study, 
Pol II was not phosphorylated in vitro prior to the formation of INT-PEC complex. However, 
endogenously purified Pol II may already carry various phosphorylations on the CTD. We 
detected high-confidence crosslinks between INTS1, INTS4, INTS6, INTS11, INTS12, 
INTS13 and INTS14 to various subunits of Pol. This implies INT has intimate interactions with 
Pol II apart from a possible interaction with the CTD. This suggests that, phosphorylated CTD 
might be crucial for only the initial specific recruitment of INT to the transcriptional complex. 
After this phosho-CTD-dependent specific recruitment, INT then makes intricate interactions 
with other subunits of Pol II and NELF to elicit its function in transcription regulation. Some 
of these interactions are with loops buried deep inside the Pol II active center suggesting that 
INT might influence RNA synthesis upon binding the PEC. Future work shall focus on the 
impact of INT binding on RNA synthesis and Pol II pause-release in vitro.  
5.5 INTS3 interacts with NELF and PEC, a potential role of SOSS complex in Pol 
II transcription 
 An in vivo interaction between INTS3 and NELF which is functionally distinct from INT was 
reported suggesting INTS3 may have other roles in transcription outside INT (Stadelmayer et 
al., 2014). Using purified proteins, I demonstrated that INTS3 physically interacts with multiple 
subunits of NELF. The NELF -A and -E tentacles (Vos, Farnung, Urlaub, et al., 2018) are not 
important for this interaction. Furthermore, I showed INTS3 interacts with the PEC mostly via 
interactions with NELF (Section 4.2.1). The functional relevance of the interaction between 
INTS3 and NELF is not known (Stadelmayer et al., 2014). INTS3 belongs also to the SOSS 
complex involved in single stranded DNA (ssDNA) binding, DNA damage response and 
genome stability (Huang et al., 2009; Ren et al., 2014; Skaar et al., 2009). It is possible that the 
SOSS complex interacts with paused Pol II elongation complex via interactions between INTS3 
and NELF. Long pauses of Pol II may lead to exposed ssDNA and R-loop formation (Proudfoot, 
2016). The SOSS complex may thus be recruited by NELF the major pausing factor (Kwak & 
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Lis, 2013; Vos, Farnung, Urlaub, et al., 2018; Yamaguchi et al., 1999). This would protect the 
ssDNA and prevent DNA single strand and double strand breaks. INTS3 and SOSS-B1/NABP2 
subunit of the SOSS complex co-immunoprecipitated with NELF -B, SPT5 and Pol II from 
Hela cells showing that the SOSS complex associates with Pol II in cells (Skaar et al., 2015). 
Further experiments are needed to understand the role of the SOSS complex in Pol II 





























Discussion and Conclusions 
 81 
 
6. Future Perspectives 
This study is paramount to in vitro studies that shall reveal structural and biochemical details 
of the roles of INT in Pol II transcription. Some of these in vitro results may inform in vivo 
experiments that can help understand the roles of INT in the congested nuclear environment of 
the cell. A few of these experiments are suggested below. 
Structural analysis of INT 
I have described a protocol for the reconstitution of the 15 subunit INT and used negative stain 
and cryo-EM to evaluate the quality of the different INT subcomplexes. Cryo-EM on core-INT 
and CM produced low resolution maps revealing the overall shapes of these subcomplexes. 
These maps cannot be interpreted further because of the limited resolution. Pulldown and XL-
MS experiments also revealed how various subunits within INT are interacting at the protein 
level. Future structural studies are needed to provide molecular details on how the subunits are 
interacting within INT. A high-resolution cryo-EM structure of the full INT can provide this 
molecular insight. Cryo-EM requires relatively low amount of protein (Nogales et al., 2016) 
and can be done despite the low yield of core-INT per purification. The full INT may be 
reconstituted from the subcomplexes via amylose affinity pulldown, analytical gel filtration or 
sucrose density gradient. The preliminary cryo-EM studies on the core-INT and the CM shows 
these subcomplexes might be flexible or denatured under cryo conditions resulting in low 
resolution. The full INT may behave differently as flexible domains may be bound by 
interaction partners potentially restricting their conformational freedom. The problem of 
protein denaturation during cryo sample preparation is often caused by protein adsorption to 
the air-water interface. This problem can be solved by using cryo-grids coated with materials 
like carbon support or graphene oxide which adsorbs the protein particles (D’Imprima et al., 
2019). Moreover, different detergents can be used to saturate the air-water interface thereby 
protecting the proteins from denaturation (Chen et al., 2019). 
Structural studies on INT subcomplexes can be expanded by using x-ray crystallography. More 
suitable targets for such approach would be individual domains of INT subunits, which could 
be identified bioinformatically, and smaller subcomplexes. For example, the soluble interacting 
domains of INTS1/12 (Section 4.1.16) could be suitable for crystallization attempts. The 
production of smaller subcomplexes comprised of different subunits can be guided by the XL-
MS data provided in this study. This can provide molecular insight into how various subunits 
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are interacting within their respective subcomplexes and within INT. Structures of very flexible 
domains may be tackled by nuclear magnetic resonance (NMR) spectroscopy. 
 
Biochemical and structural analysis of INT in the context of Pol II transcription 
This study provided initial results on the interaction between INT and PEC in vitro which is 
prerequisite to gaining a mechanistic understanding of the roles of INT in Pol II pause - release. 
The next step will be to evaluate the influence of this interaction on Pol II transcription using 
RNA extension in vitro transcription and pausing assays described by Vos and coworkers (Vos, 
Farnung, Boehning, et al., 2018; Vos, Farnung, Urlaub, et al., 2018). By using the full INT or 
the purified subcomplexes, it will be possible to pin down which specific subunit/subcomplexes 
are important for specific roles of INT in Pol II pause - release and transcription in general. In 
vitro transcription termination assays can also be used to dissect termination roles of INT. This 
could be done by in vitro transcription through the 3’ box of an snRNA DNA template. The 
contribution of specific subcomplexes in such termination assays may be deciphered by 
excluding them from the assay. Pol II CTD kinases such as CDK7 and CDK9 and phosphatases 
like RPAP2 and PP2A have been shown to be important for the in vivo functions of INT (Egloff 
et al., 2007, 2010, 2012; Solis-Mezarino & Herzog, 2017). With the in vitro reconstituted 
transcription system, the complex interplay of various CTD phosphorylation states can be 
studied in a more systematic way. This could be done by testing the impact of phosphorylation 
and dephosphorylation by different combinations of the kinases and phosphatases on the 
recruitments of INT and on in vitro transcription by Pol II in the presence of INT. These 
functional studies may help to identify functionally relevant targets for structural studies. 
The INT-PEC complex described here (Sections 4.2.2 and 4.2.3) could be a starting complex 
for understanding mechanistically, how INT associates with Pol II elongation complexes using 
cryo-EM. This may help to clarify how INT subunits are interacting with Pol II, DSIF and 
NELF subunits during promoter proximal pausing/early transcription elongation. Such a 
structure, complemented by functional studies described above, can provide molecular details 
on the contribution of INT in Pol II transcriptional pause and release. Furthermore, key players 
which have been shown to interact with both INT and Pol II, such as RPAP2 (Egloff et al., 
2012), may be needed to stabilize the complex of INT and Pol II transcription elongation 
complexes for cryo-EM. In vitro phosphorylation of the CTD may also be important for the 
formation of a stable complex for cryo-EM analysis, as demonstrated before for the activated 
transcription complex (Vos, Farnung, Boehning, et al., 2018). In case this holistic approach 
proves to be too challenging, one could also identify the subcomplex of INT which stably 
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associate with Pol II elongation complexes for structural analysis. Indeed, to fully understand 
how INT is involved in Pol II transcription, structures of several intermediate complexes will 
be necessary. For example, structures of Pol II-INT, Pol II-DSIF-INT and Pol II-NELF-INT 
may provide important snapshots of conformational changes that occur when INT binds an 
elongating Pol II. Initial biochemical analysis will be needed to ascertain the stability of such 
complexes prior to cryo-EM studies. 
 
In vivo functional studies of INT 
Attempts to understands the roles of INT in vivo have thus far relied on knockdown of INT 
subunits by RNA interference (RNAi). The RNA output is then measured by quantitative 
reverse transcriptase PCR (qRT-PCR) of specific target genes or RNA sequencing genome-
wide or RNA sequencing of specific genes (Baillat et al., 2005; Skaar et al., 2015; Yamamoto 
et al., 2014). RNAi may have off-target effects and often includes prolonged treatment of cells 
with a virus harboring the shRNA which can perturb the cell leading to artificial effect. More 
transient methods for depleting proteins such as degrons (Nishimura et al., 2009) may be 
employed to test the importance of specific subunits of INT on Pol II transcriptional output 
genome-wide. Recent advances in CRISPR-cas technology (Baillat et al., 2016; Pickar-Oliver 
& Gersbach, 2019; Ran et al., 2013) can provide a boost in tagging specific subunits of INT for 
degradation. Coupling transient depletion of INT to additional stimuli such as heat shock and 
stimulation by specific factors like EGF will be instrumental in understanding signal dependent 
roles of INT in transcription regulation. Also, metabolic labelling coupled to transient transcript 
sequencing (TT-seq) (Schwalb et al., 2016) may tell us how perturbations of INT affect the 
synthesis rate of Pol II transcription. Additionally, other genome-wide techniques such as PRO-
seq, GRO-seq, mNET-seq in combination with TT-seq can provide further characterization of 
the contribution of INT in Pol II transcription especially in promoter proximal pause and release 
(Kwak et al., 2013; Lis, 2019; Nojima et al., 2015). This approach was exemplified by Gressel 
and colleagues on CDK9 (Gressel et al., 2017).  
Only few subunits of INT have been used so far to identify the genomic targets of INT in CHIP-
seq experiment due to the lack of high quality antibodies for all subunits (Baillat & Wagner, 
2015). Using CRISPR-cas technique, one may tag each subunit of INT with affinity tags such 
as FLAG or HA which will allow efficient CHIP-seq experiments to identify genomic targets 
of all subunits of INT. This will clarify the key question of whether all subunits of INT are 
simultaneously present at various locations on a gene. It will further help to identify stable 
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subcomplexes of INT in vivo which may represent functional modules of the complex by co-
purification.  
Metabolically labeled newly synthesized RNA can be crosslinked to proteins directly binding 
then by exposure to UV light. When coupled to immunoprecipitation of specific subunits of 
INT using protocols such as PAR-CLIP (Photoactivatable Ribonucleoside-Enhanced 
Crosslinking and Immunoprecipitation) (Danan et al., 2016; Spitzer et al., 2014) one can 






























7 Supplementary methods and results 
7.1 Supplementary methods 
7.1.1 Expression and Purification of INTS4 
Expression 
The ORF for full length INTS4 was cloned into the MacroLab 438-C vector which contains an 
N-terminal 6xHis-MBP affinity tag. V0 and V1 viruses were produced for this construct. Protein 
expression and harvesting of cultures was done according to the protocol described for the 
cleavage module (INTS4/9/11) in section 3.4.1. The Hi5 cells expressing INTS4 was 
resuspended in 35 ml of lysis buffer (20 mM Tris 7.5, 500 mM NaCl, 1 mM EDTA, 1 mM 
DTT, 0.284 μg/ml leupeptin, 1.37 μg/ml pepstatin A, 0.17 mg/ml PMSF, 0.33 mg/ml 
benzamidine). The harvested cells were flash frozen in liquid nitrogen and store at -80 oC until 
purification. 
Purification 
Frozen pellets were thawed in a water bath at 25 oC and lysed by sonication with 30% amplitude 
for 2 min with 0.6 s pulse on and 0.4 s pulse off. The lysate was cleared by centrifugation at 
87,207xg for 1 hr and filtered with a 0.8 µm syringe filter. The cleared lysate was applied to a 
self-packed amylose column with a total bed volume of 15 ml pre-equilibrated in wash buffer 
(20 mM Tris pH 7.5, 500 mM NaCl, 1 mM EDTA, 1 mM DTT). The amylose column was 
washed with 100 ml of wash buffer before eluting with amylose elution buffer containing 20 
mM Tris pH 7.5, 500 mM NaCl, 1 mM EDTA, 1 mM DTT, 100 mM maltose. The fractions 
containing the protein of interest were pooled and the volume split in two. One part was 
concentrated and applied to a Superose 6 Increase 10/300 gel filtration column equilibrated in 
20 mM Tris pH 7.5, 150 mM NaCl, 10% glycerol, 1 mM EDTA, 1 mM DTT. The peak fractions 
were collected and concentrated. The protein was aliquoted (5 µl), flash frozen in liquid 
nitrogen and stored at -80 oC. The other half was treated overnight with catalytic amounts of 
TEV protease to remove the affinity tag. Subsequently, the sample was applied to an 
equilibrated 5 mL HisTrap column in a reverse nickel affinity step to remove the 6xHis-tagged 
TEV protease, the affinity tag and proteins with undigested affinity tag. The unbound protein 
was collected, concentrated using a 50 kDa cut-off Amicon ultra centrifugation filter and 
applied to a Superose 6 Increase 10/300 gel filtration column equilibrated in gel filtration buffer. 
The elution peak was concentrated, the protein was aliquoted (5 µl), flash frozen in liquid 





7.1.2 Expression and purification of INTS10 
Expression  
The ORF for full length INTS10 was cloned into the MacroLab 438-C vector which contains 
an N-terminal 6xHis-MBP affinity tag. V0 and V1 viruses were produced for this construct. 
Protein expression and harvesting of cultures was done according to the protocol described for 
the cleavage module (INTS4/9/11) in section 3.4.1. The harvested Hi5 cells expressing 6xHis-
MBP-INTS10 was resuspended in 35 ml of lysis buffer (20 mM HEPES pH 7.4, 300 mM NaCl, 
30 mM imidazole, 10% glycerol, 1 mM DTT, 0.284 μg/ml leupeptin, 1.37 μg/ml pepstatin A, 
0.17 mg/ml PMSF, 0.33 mg/ml benzamidine) per litre of culture. The harvested cells were flash 
frozen in liquid nitrogen and stored at -80 oC until purification. 
Purification 
Lysis of cells and clearance of the lysate was done as described for INTS4 in section 7.1.1 
above. The cleared lysate was applied to a pre-equilibrated 5 ml HisTrap column at a flow rate 
of 2 ml/min and the column was washed with 100 ml of wash buffer (20 mM HEPES pH 7.4, 
300 mM NaCl, 10% glycerol, 1 mM DTT). A self-packed amylose column with a total bed 
volume of 15 ml pre-equilibrated in wash buffer was connected in tandem to the 5 ml HisTrap 
column. The bound protein was eluted from the HisTrap column onto the amylose column using 
Ni elution buffer containing 20 mM HEPES pH 7.4, 300 mM NaCl, 10% glycerol, 1 mM DTT, 
250 mM imidazole. The HisTrap column was detached and the amylose column was washed 
with 100 ml of wash buffer before eluting with amylose elution buffer containing 20 mM 
HEPES pH 7.4, 300 mM NaCl, 10% glycerol, 1 mM DTT, 100 mM maltose. The fractions 
containing the protein of interest were pooled. INTS10 precipitated when the affinity tag (which 
is also a solubility tag) was removed by TEV protease digest. The protein from amylose elution 
was therefore collected, concentrated using a 30 kDa cut-off Amicon ultra centrifugal filter and 
applied to a Superose 6 Increase 10/300 gel filtration column equilibrated in gel filtration buffer 
containing 20 mM HEPES pH 7.4, 500 mM NaCl, 10% glycerol, 1 mM DTT. The elution peak 
was concentrated, aliquoted, flash frozen and stored in 5 µl aliquots at -80 oC.  
 
 
7.1.3 Expression and purification of INTS13 – INTS14 heterodimer 
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Expression and purification of this heterodimer was done as described for INTS10. Briefly, the 
ORF of INTS13 was cloned into the MacroLab vector 438-C and that of INTS14 was cloned 
into a 438-A vector. The two vectors were combined by LIC and V0 and V1 baculoviruses were 
produced. Protein expression was done in Hi5 insect cells as described for INTS10. Protein 
purification was done using the buffer conditions and strategy described for INTS10. Both 
affinity-tagged and untagged versions of this heterodimer were produced. 
7.1.4 Expression and partial purification of INTS1 and INTS1(1-294) 
Expression 
The ORF for full length INTS1 was cloned into the MacroLab 438-C and 438-B vectors which 
contain an N-terminus 6xHis-MBP and 6xHis tags respectively. Truncated versions of INTS1 
consisting of residues 1-294, 1-1010, 1010-2190 and 2045-2190 were created from the INTS1-
438 -B construct by round-the-horn PCR and cloning. V0 and V1 viruses were produced for 
these constructs and protein expression from each variant of INTS1 was tested by amylose 
affinity pulldown for the full length INTS1 and Ni affinity pulldown for the truncation variants. 
Protein expression of the full length or the INTS1(1 - 294) truncation variant were induced by 
infecting 2x 600 ml of Hi5 insect cells at 1x106 cells/ml with 300 µl of the respective V1 viruses 
in a 3 l flask. Cell, density, viability and size were monitored in 24 hrs intervals and cells were 
diluted to maintain a density of 1x106 cells/ml. Cultures were harvested when viability dropped 
below 85% (usually within 72 hrs) by centrifugation at 328xg for 30 min. The supernatant was 
discarded and the cell pellet was resuspended in 35 ml of lysis buffer (20 mM HEPES pH 7.4, 
300 mM NaCl, 30 mM imidazole, 10% glycerol, 1 mM DTT, 0.284 μg/ml leupeptin, 1.37 μg/ml 
pepstatin A, 0.17 mg/ml PMSF, 0.33 mg/ml benzamidine) per litre of culture. The harvested 
cells were flash frozen in liquid nitrogen and store at -80 oC until purification.  
Purification 
Purification of full length INTS1 was very problematic as INTS1 degrades during purification 
and forms oligomers/aggregates when analysed by gel filtration chromatography. Different 
buffer systems and purification strategies were tried to no avail. The final protocol that was 
adopted for partial purification was as follows. Cell pellets were thawed in a water bath at room 
temperature and lysed by sonication with 30% amplitude for 2 min with 0.4 s pulse on and 0.6 
s pulse off. The lysate was cleared by centrifugation at 87,207xg for 1 hr and filtered with a 0.8 
µm syringe filter. The cleared lysate was applied to a pre-equilibrated 5 ml HisTrap column at 
a flow rate of 2 ml/min and the column was washed with 100 ml of high salt wash buffer (20 
mM HEPES pH 7.4, 1 M NaCl, 10% glycerol, 30 mM imidazole, 1 mM DTT) followed by 50 
ml of low salt wash buffer (20 mM HEPES pH 7.4, 150 mM NaCl, 10% glycerol, 30 mM 
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imidazole, 1 mM DTT). A self-packed amylose column with a total bed volume of 15 ml pre-
equilibrated in wash buffer was connected in tandem to the 5 ml HisTrap column and the 6xHis-
MBP tagged INTS1 was eluted from the 5ml HisTrap column onto the amylose column using 
Ni elution buffer containing 20 mM HEPES pH 7.4, 150 mM NaCl, 10% glycerol, 1 mM DTT, 
250 mM imidazole. The HisTrap column was detached and the amylose column was washed 
with 100 ml of wash buffer before eluting with amylose elution buffer containing 20 mM 
HEPES pH 7.4, 150 mM NaCl, 10% glycerol, 1 mM DTT, 100 mM maltose.  
For the truncated variant (INTS1(1-294)) which had only a 6xHis tag, the amylose step was 
skipped and the protein was eluted with 0-100% gradient of Ni elution buffer containing 500 
mM instead of 250 mM imidazole. The samples from amylose/nickel elution peaks were 
applied to a 5 ml HiTrap Q column equilibrated in low salt wash buffer. The column was 
washed with 100 ml of low salt wash buffer and eluted with a 0-100% gradient of high salt 
wash buffer. Elution fractions containing proteins of interest were collected, concentrated using 
a 50 and 10 kDa cut-off Amicon ultra centrifugal filter for full length INTS1 and INTS1(1- 
294) respectively and stored is 5 µl aliquots at -80 oC. This was used for pulldown assays. 
Several other buffer systems with variations in PH, salt concentration and additives were 
attempted for the purification of INTS1.  
 
7.1.5 Expression and partial purification of INTS12 and INTS12(1-194) 
Expression and purification of INTS12 and its truncation variant was as described for INTS1 
and INTS1(1 - 294) respectively. INTS12 was cloned into a MacroLab 438-C and 438-B and 
the truncation was generated in INTS12-438-B construct using round-the-horn PCR. Similar to 
INTS1, the purification of full-length INTS12 and its truncated version was very difficult. 
Using several different purification strategies the protein could be partially purified, although 
not to high purity. 
7.1.6 Expression and partial purification of INTS5/8 heterodimer 
Expression 
The ORF of INTS5 was cloned into a MacroLab 438-C vector and the ORF of INTS8 was 
cloned into a 438-A vector. The two vectors were combined by LIC. V0 and V1 viruses for the 
construct expressing 6xHis-MBP-INTS5 and INTS8 were made. Expression was induced in 
Hi5 cells by infecting 600 ml of cells at 1x106 cells/ml with V1 virus at 1:2000 v/v virus to 
culture ratio. Cultures were monitored for 72 hours and cells were harvested by spinning at 
328xg for 30 min. Pellets were re-suspended in lysis buffer containing 50 mM HEPES pH 7.4, 
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500 mM NaCl, 10% glycerol, 30 mM imidazole, 1 mM DTT, 0.284 μg/ml leupeptin, 1.37 μg/ml 
pepstatin A, 0.17 mg/ml PMSF, 0.33 mg/ml benzamidine (50ml per litre of culture) and flash 
froze in liquid nitrogen before storage at -80 oC. 
Purification. 
The purification of this heterodimer was challenging due to the formation of aggregates when 
analysed by gel filtration. The following protocol was used for partial purification. 
Pellets were quickly thawed in a water bath at room temperature and transferred onto ice. Lysis 
was done by sonication (30% amplitude for 5 min, 0.6 s pulse on and 0.4 s pulse off). After 
sonication, the lysate was cleared by centrifugation at 87,207xg for 30 min and the supernatant 
was transferred into an ultracentrifuge tube and further spun for 1 hr at 45000 rpm using a Ti45 
rotor in an ultracentrifuge (Beckman Coulter). Subsequently, supernatant was then filtered 
through a 0.8 µm filter and applied to a 5ml HisTrap column using a peristaltic pump. The 
column was transferred to an Aekta system and washed with 100 ml of the lysis buffer without 
protease inhibitors. Bound protein was eluted with a gradient (0-100%) of nickel elution buffer 
containing 50 mM HEPES pH 7.4, 500 mM NaCl, 10% glycerol, 500 mM imidazole, 1 mM 
DTT. The peak fractions of the elution were pooled and 2 mg of 6xHis tagged TEV protease 
was added and dialyzed against a dialysis buffer (50 mM HEPES pH 7.4, 150 mM NaCl, 10% 
glycerol, 30 mM imidazole, 1 mM DTT) overnight at 4 oC to remove the affinity tag and 
decrease the imidazole concentration. A 5 ml HisTrap, 5ml HiTrap Q and 5ml HiTrap Sp were 
connected in tandem in the following order: HisTrap followed by HiTrap Q followed by HiTrap 
Sp. The columns were equilibrated in dialysis buffer and the TEV-digested sampled was 
applied using the peristaltic pump and the flow through and wash fractions were collected. After 
sample application, the columns were separated and the TEV protease, affinity tags and proteins 
with undigested affinity tag bound to the HisTrap column were eluted with 25 ml of the nickel 
elution buffer. The ion exchange columns were separately eluted with 25 ml of ion exchange 
elution buffer (50 mM HEPES pH 7.4, 500 mM NaCl, 10% glycerol, 30 mM imidazole, 1 mM 
DTT). Samples (4 µl) were taken from all fraction and analysed on LDS-PAGE. Protein of 
interest bound the anion exchange column and this fraction was take and concentrated to 2 ml 
for gel filtration. A Superdex 200 Increase 10/300 and a Superpose 6 Increase 10/300 gel 
filtration columns were equilibrated into gel filtration buffer containing 50 mM HEPES pH 7.4, 
200 mM NaCl, 10% glycerol, 1 mM DTT and 1 ml aliquot of the protein was applied to each. 
The protein of interest eluted close to the void volume of each column suggesting this 
heterodimer forms oligomers. The peak fractions from both gel filtration runs were pooled and 
applied to a 1 ml Mono Q anion exchange column pre-equilibrated in gel filtration buffer. After 
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washing with 10 ml of the gel filtration buffer, the column was eluted with a gradient (0-100%) 
of buffer QE (50 mM HEPES pH 7.4, 1000 mM NaCl, 10% glycerol, 1 mM DTT). The peak 
fractions were pooled and dialyzed against GF buffer overnight. The sample was concentrated, 
aliquoted, flash frozen and stored at -80 oC. This was used for pulldown assays with other 
subcomplexes. For the purification of affinity tagged variant of this heterodimer, the second 
anion exchange on Mono Q was omitted. 
7.1.7 Expression and partial purification of INTS2/7 heterodimers 
Expression 
Expression was done as described for INTS5/8 heterodimer from a baculovirus harbouring the 
ORF for INTS2 and 6xHis-MBP-INTS7. The cultures were harvested and cell pellet was 
resuspended in a lysis buffer containing 25 mM Tris–HCl pH 8, 0.2 M NaCl, 10 mM BME, 10 
uM ZnSO4, 10% glycerol, 30mM imidazole, 0.284 μg/ml leupeptin, 1.37 μg/ml pepstatin A, 
0.17 mg/ml PMSF, 0.33 mg/ml benzamidine (50ml per litre of culture) and stored at -80 oC.  
Purification  
The purification of INTS2/7 heterodimer was also very problematic as it forms 
oligomers/aggregates when analysed by gel filtration chromatography. Different buffer systems 
and purification strategies were tried to no avail. The final protocol that was adapted for partial 
purification was as follows. Cell pellets were thawed in a water bath at room temperature and 
lysed by sonication with 30% amplitude for 2 min with 0.4 s pulse on and 0.6 s pulse off. The 
lysate was cleared by centrifugation at 87,207xg for 1 hr and filtered with a 0.8 µm syringe 
filter. The cleared lysate was applied to a 5 ml HisTrap column (pre-equilibrated in wash buffer) 
at a flow rate of 2 ml/min and the column was washed with 100 ml of wash buffer (25 mM 
Tris–HCl pH 8, 0.2 M NaCl, 10 mM BME, 10 µM ZnSO4, 10% glycerol, 30 mM imidazole). 
A self-packed amylose column with a total bed volume of 15 ml pre-equilibrated in wash buffer 
was connected in tandem to the 5 ml HisTrap column and the bound protein was eluted from 
the HisTrap column onto the amylose column using Ni elution buffer containing 25 mM Tris–
HCl pH 8, 0.2 M NaCl, 10 mM BME, 10 uM ZnSO4, 10% glycerol, 250 mM imidazole. The 
HisTrap column was detached and the amylose column was washed with 100 ml of wash buffer 
before eluting with amylose elution buffer containing 25 mM Tris–HCl pH 8, 0.2 M NaCl, 10 
mM BME, 10 uM ZnSO4, 10% glycerol, 30 mM imidazole, 100 mM maltose. Fractions 
containing the INTS2/7 heterodimeric complex were pooled and treated overnight with 6xHis-
TEV protease and lambda phosphatase (home made in our laboratory) in the presence of 1 mM 
MnCl2 to remove the affinity tag and potential post-translational phosphorylations from the 
insect cells. The protein was applied again to an equilibrated 5 ml HisTrap in a reverse nickel 
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affinity step to remove the TEV protease, the affinity tag and proteins with undigested affinity 
tag. The unbound protein was collected and applied to a 5 ml HiTrap Q column equilibrated in 
low salt wash buffer. The column was wash with 100 ml of wash buffer and eluted with a 
gradient (0-100%) of high slat wash buffer (25 mM Tris–HCl pH 8, 1 M NaCl, 10 mM BME, 
10 µM ZnSO4, 10% glycerol, 30 mM imidazole. Elution fractions containing proteins of 
interest were collected, concentrated using a 100 kDa cut-off Amicon ultra centrifugal filter 
and stored is 5 µl aliquots at -80 oC. This was used for amylose pulldown experiments with 
other subcomplexes without further gel filtration chromatography as protein elutes in the void. 
7.1.8 Expression and partial purification of INTS(3/6)-DDX26B heterotrimer. 
Expression 
The ORF for INTS3 was cloned into the MacroLab 438-C vector and the ORFs of INTS6 and 
DDX26B were each cloned into the 438-A vector using LIC. The three vectors were combined 
into a multiprotein expression vector using LIC (see methods) and V0 and V1 baculoviruses 
were produced in Sf9 and SF21 insect cells respectively. Protein expression of this construct 
was as described for the heteropentameric subcomplex (INTS3/5/6/8-DDX26B) in section 
3.4.3. The cells were harvested by centrifugation at 328xg for 30 min and the pellets were re-
suspended in lysis buffer containing 20 mM HEPES pH 7.4, 300 mM NaCl, 10% glycerol, 10 
mM BME, 0.284 μg/ml leupeptin, 1.37 μg/ml pepstatin A, 0.17 mg/ml PMSF, 0.33 mg/ml 
benzamidine (50 ml per litre of culture) and flash froze in liquid nitrogen before storage at -80 
oC. 
Purification 
Lysis of cells and clearance of lysate was described (Section 3.4.3). The cleared lysate was 
applied to a pre-equilibrated self-packed amylose column with a total bed volume of 15 ml at a 
flow rate of 1 ml/min and the column was washed with 100 ml of wash buffer (20 mM HEPES 
pH 7.4, 300 mM NaCl, 10% glycerol, 10 mM BME). The bound protein was eluted with 
amylose elution buffer containing 20 mM HEPES pH 7.4, 300 mM NaCl, 10% glycerol, 10 
mM BME, 100 mM maltose. The fractions containing the trimeric complex were pooled and 
diluted with zero-salt buffer to bring the NaCl concentration to ~200 mM. The diluted protein 
was applied to a 5 ml HiTrap Q column equilibrated in low salt ion exchange buffer containing 
(20 mM HEPES pH 7.4, 200 mM NaCl, 10% glycerol, 10 mM BME). The column was washed 
with the low salt buffer and bound protein was eluted with a gradient (0-100%) of high salt 
buffer (20 mM HEPES pH 7.4, 1 M NaCl, 10% glycerol, 10 mM BME) over 100 ml. The 
fractions containing the trimeric complex of 6xHis-MBP-INTS3, INTS6 and DDX26B were 
pooled and concentrated to 1 ml using a 100K cut-off Amicon Ultra Centrifugal filter (MERCK 
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Millipore). The protein was applied to a Superose 6 Increase 10/300 gel filtration column 
equilibrated in the low salt ion exchange buffer and fractionated into 0.5 ml fractions. The 
fractions containing the pure monomeric trimer were pooled, concentrated and stored in 5 µl 
aliquots at -80 oC. 
 
7.1.9 In vitro pulldowns with purified subunits and subcomplexes 
To test the interaction between purified components of INT, amylose affinity pulldown was 
used. The experimental set-up was similar to the one described in section 3.4.5. 
7.1.10 Cryo-EM analysis of the cleavage module of INT (INTS4/9/11). 
Cryo-EM data for this sample was collected under cryogenic conditions using an FEI Titan 
Krios G2 transmission electron microscope operated in EFTEM mode at 300 kV, energy filter 
slit set to 20 eV and working with a K3 direct detector (Gatan). Data collection was done 
automatically with the serialEM (Mastronarde, 2005) software at 81,000x magnification (1.05 
Ä/pixel). Three images were collected per foil hole with an electron dose rate of 23.15 e-/px/s 
and an exposure time of 1.99 s resulting in a total dose of 40 e/Å2. The images were fractionated 
over 40 frames and a defocus range of 1.5 - 3 µm was used. The movie frames were aligned, 
motion and contrast transfer function corrected in WARP (Tegunov & Cramer, 2019). Particles 
were automatically picked in WARP. Calculation of 2D class averages, generation of initial 
model and 3D volume calculations were done in RELION 2.2 (Kimanius et al., 2016; Scheres, 
2012).  
 
7.2 Supplementary Results 
Purification of INT subunits and initial subcomplexes 
The co-expression assays described in the results section (section 4.1) were crucial for the 
identification of physically interacting subunits/subcomplexes of INT. The design of some of 
these co-expression assays were informed by in vitro pulldown assays using purified/partially 
purified subunits/subcomplexes of INT. The results of co-expression with few exceptions were 
supported by in vitro pulldown assay using purified components. The results of the purifications 
(attempted) of the subunits/subcomplexes of INT used mainly for pulldown assays are 
described below. 
7.2.1 Expression and partial purification of INTS1 and INTS1(1-294) 
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The largest subunit of INT, INTS1 was one of the most difficult subunits of INT to work with 
because it is poorly expressed, degrades, and oligomerizes during purifications. When 
expressed separately as a single subunit, the degradation could be reduced and some intact full 
length INTS1 makes it to gel filtration stage of purification. During gel filtration 
chromatography, the protein elutes in the void volume suggesting oligomerization/aggregation 
(Figure S1). Several additives including but not limited to detergents, different salts, different 
pH buffers, and chelating agents such as EDTA were added to the purification buffer to 
remove/reduce the aggregation but to no avail. Figure S1c and d are representative LDS-PAGE 
and gel filtration chromatogram of a typical purification of INTS1.  
From domain and disorder predictions, INTS1 has a small domain of unknown function (DUF) 
at the N-terminus and the rest of the sequence consist mostly of disordered loops with high 
protein binding propensities interspersed by helical secondary structures (Figure 4.1 INTS1 and 
Figure S1a and b). The expression and solubility tests of the N- and C-terminal halves as well 
as the C-terminal region (amino acids 2045 to 2190) in the absence of solubility tags showed 
that they are poorly expressed as no clear enrichment over background proteins was observed 
(Figure 4.16a lane 2, 3 and 4). Conversely, the DUF3677 containing N-terminal region 
(residues 1-294) showed clear overexpression and solubility when expressed alone without any 
solubility tag (Figure 4.16a lane 1). Despite the clear expression and solubility of this domain, 
it also formed oligomers when purified separately as shown by gel filtration chromatography 
(Figure S1e and f). This observation suggests that this stable and soluble domain of INTS1 is 




Figure S1. Partial purification of INTS1 and INTS1(1-294) variant. Domain and secondary structure 
prediction output of INTS1(1-1010) (a) and INTS1(1010-2190) (b) using the online tool DomPred. A key 
explaining the features is provided in the top right corner of each plot. It was necessary to split the amino acid 
sequence into two because the software could not handle the full sequence. An LDS-PAGE (c) and gel filtration 
chromatogram (d) of a typical purification of full length INTS1 showing that the protein elutes at the void 
volume of the column. An LDS-PAGE analysis (e) and gel filtration chromatogram (f) of a typical purification 
of the INTS1(1-294) variant of INTS1 showing it eluted at the void volume of the column together with the 
Hsp70 chaperone. Protein identities were confirmed by mass spectrometry. 
7.2.2 Expression and partial purification of INTS12 and INTS12(1-194) 
The PHD domain-containing INTS12 is predicted to be the most disordered subunit of INT 
(Figure 4.1 INTS12 and Figure S2c) and consequently one of the most challenging subunits of 
INT to express and purify. Similar to the purification of INTS1, several attempts were made to 
purify this subunit. The protein degrades from its C-terminus to a small N-terminal part which 
oligomerizes and co-purify with Hsp70 from the insect cell as shown by gel filtration 
chromatography (Figure S2a and b). Therefore, a truncation variant encompassing the N-
terminal micro domain and the PHD domain (residues 1 – 294) which lacked most of the C-
terminal low complexity amino acid sequence was created (Figure S2c). This variant of INTS12 
was stable but also co-purifies with the chaperon and oligomerizes as validated by gel filtration 
chromatography (Figure S2d and e) suggesting it is lacking one or more key interaction 




7.2.3 Expression and partial purification of INTS5/8 heterodimer 
The INTS5/8 heterodimer was identified during the systematic co-expression of subunits of 
INTS (Section 4.1.3, Figure 4.3a). Unlike INTS1 and INTS12, the subunits of this heterodimer 
express well and are stable under the purification conditions tested. However, similar to INTS1 
and INTS12 but to a lesser extent, the purified heterodimer forms oligomers and eluted partly 
at the void volume of all gel filtration columns tested (Figure S3c). This suggests that the 
heterodimer might have some exposed hydrophobic surfaces that are potentially involved in 
protein-protein interactions which accounts for the various oligomeric populations observed on 
gel filtration. A primary sequence analysis of INTS5 showed that there are no known domains 
predicted in the sequence and that there are widespread unstructured regions albeit with high 
protein binding propensities (Figure 4.1 INTS5). A sequence analysis of INTS8 on the other 
hand showed the presence of 4 TPR motives known for protein-protein interaction (Zeytuni & 
Zarivach, 2012b) as well as disordered regions that could potentially act as protein binding sites 
(Figure 4.1 INTS8). The cornucopia of protein binding regions in these two proteins may imply 






Figure S2. Partial purification of INTS12 and INTS12(1-194) variant. An LDS-PAGE analysis of fractions 
from gel filtration chromatography (a) and a corresponding chromatogram (b) of a representative attempted 
purification of INTS12. Proteins were identified by mass spectrometry. (c). Amino acid sequence analysis of 
INTS12. Predicted and stable domains are indicated with rectangles. An LDS-PAGE (d) and gel filtration 
chromatographic (e) analysis of a typical attempted purification of INTS12(1-294) variant. Both the full-length 
and truncated INTS12 elutes at the void volume of the gel filtration column. For each chromatogram, UV 








Figure S3. Partial purification of INTS5/8 heterodimer. An LDS-PAGE analysis of fractions of a gel 
filtration chromatographic purification of affinity tagged INTS5/8 heterodimer (a) and untagged INTS5/8 
heterodimer (b). The fractions analyzed are indicated on top of each gel. ‘t’ indicates 6xHis-MBP affinity tag. 
The identities of the proteins were confirmed by mass spectrometry. Note in (b) INTS5 (108 kDa) without 
affinity tag runs at the same molecular weight as INTS8 (113 kDa). (c). A representative gel filtration 
chromatogram of INTS5/8 heterodimer showing the UV absorbance at 280 nm and 260 nm.  
 
7.2.4 Expression and partial purification of INTS2/7 heterodimers 
The idea of protein-protein interaction between INTS2 and INTS7 was prompted by an 
observed chemical crosslink between this two subunits in a study characterizing the substrates 
of PP2A (Solis-Mezarino & Herzog, 2017). As expected, co-expression of the two subunits 
showed that they form a stable heterodimer (Figure 4.2b). Similar to the INTS5/8 heterodimer, 
the INTS2/7 heterodimer oligomerizes under all purification conditions tested (Figure S4). The 
amino acid sequence analysis predictions of INTS2 and INTS5 are similar. They both indicate 
structured regions interspersed with potentially protein binding disordered regions with no 
known domains (Figure 4.1 INTS2). The N-terminal region of INTS7 (residues 1 - 500) is 
predicted to form an armadillo-like repeat while the C-terminal region is predicted to have 
disordered loops with high protein binding probabilities. The INTS2/7 heterodimer is predicted 
to have a lot of protein-protein interactions similar to the INTS5/8 heterodimer. Therefore, it 
may self-associate in the absence of associated interaction partners and form oligomers to 





Figure S4. Partial purification of INTS2/7 heterodimer. (a) An LDS-PAGE analysis of fractions of a gel 
filtration chromatographic purification of the affinity tagged INTS2/7 heterodimer. The fractions analyzed are 
indicated on top of the gel. The proteins were confirmed by mass spectrometry. ‘t’ indicates 6xHis-MBP affinity 
tag (b) A typical gel filtration chromatogram of the purification of the affinity tagged or untagged versions of 
INTS2/7 heterodimer showing that the dimer elutes in the void volume. The UV absorption at 260 and 280 nm 
is shown. (c) An LDS-PAGE analysis of the purification of the INTS2/7 heterodimer without affinity tag after 
Mono Q anion exchange chromatography. 
 
7.2.5 Purification of INTS4, INTS10 and INTS13/14 heterodimer 
The interaction between INTS13 and INTS14 subunits of the INT was also discovered during 
the systematic co-expression assays (Figure 4.3b). This subcomplex expressed well and can be 
purified to homogeneity (Figure S5a and b). Unlike INTS2/7 and INTS5/8 heterodimers, it did 
not oligomerize (Figure S5a). The void peak in Figure S5b contained affinity tagged variant of 
INTS13 which was resistant to TEV protease digest. This fraction was probably aggregated or 
misfolded and was separated from the monomeric INTS13/14 heterodimer. 
Also, the single subunits INTS4 and INTS10 were purified for in vitro pulldown assays. The 
purifications of these two subunits were the most straightforward as they expressed well, were 
soluble and did not oligomerize on gel filtration. Both proteins have a void peak suggestive of 
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some oligomerization but represented only a small fraction of the total yield and was discarded 





Figure S5. Purification of INTS4, INTS10 and INTS13/14 heterodimer. An LDS-PAGE of the gel filtration 
chromatography analysis of INTS4, INTS10 and INTS13/14 heterodimer. The retention volume of the fractions 
analyzed are indicated on top of each gel. Protein identities were confirmed by mass spectrometry. The UV 
absorbance at 280 and 260 nm is shown (a) An LDS-PAGE analysis of gel filtration fractions of INTS13/14 
heterodimer. (b) A gel filtration chromatogram for the purification of INTS13/14 heterodimer. (c) An LDS-
PAGE analysis of gel filtration fractions of INTS4. (d) A gel filtration chromatogram for the purification of 
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INTS4. (e) An LDS-PAGE analysis of the gel filtration fractions of INTS10. (d) A gel filtration chromatogram 
for the purification of INT10. 
 
7.2.6 Expression and partial purification of INTS3/6-DDX26B 
This trimer was discovered by co-expression of the full INT, partial purification and 
crosslinking mass spectrometry (Figure 4.6). It was purified in order to perform in vitro 
pulldown assays against other purified subcomplexes/subunits. This subcomplex also showed 
some aggregation/oligomerization together with a fraction of monomeric protein (Figure S6). 
The tagged INTS3 was over-stoichiometric and the excess could not be separated from the 
complex (Figure S6a). The void peak contained some degradation products of INTS6 and the 
insect cell’s Hsp70 chaperone suggestive of misfolding or exposed hydrophobic surfaces. The 
fractions containing monomeric complex (peak) devoid of chaperon and INTS6 degradation 
were used for pulldown assays. 
 
 
Figure S6. Purification of INTS3/6-DDX26B heterotrimer. (a) An LDS-PAGE analysis of elution fractions 
of gel filtration chromatography of the heterotrimer. The fractions analyzed are indicated on top of the gel. 
Identification of proteins was done by mass spectrometry. (b) A gel filtration chromatogram of the heterotrimer. 
The void peak and the peak of interest are indicated. The UV absorption at 280 nm and 260 nm are plotted. 
 
7.2.7 Identification of inter subunit/subcomplex interaction via amylose affinity 
pulldown 
As part of the preliminary experiments to identify interaction subunits/subcomplexes and to 
complement results from co-infection assay, pulldown experiments were done using affinity 
tagged subunit or subcomplex against untagged subunits or subcomplexes.  
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In this way, the interaction between the cleavage module (INTS4/9/11) and INTS13/14 
heterodimer was discovered (Figure S7a lane 6) which provided the hint for the hexameric 
subcomplex described in section 4.1.13. Interaction between INTS10 and INTS13/14 from co-
expression (Figure 4.3) was also supported (Figure S7b lane 8) and finally the hexameric 
subcomplex was first formed via affinity pulldown (Figure S7c lane 7). There was a weak 
interaction between the INTS3/6-DDX26B heterotrimer and the INTS10/13/14 heterotrimer 
(Figure S7c lane 6). The INTS3/6-DDX26B heterotrimer also interacts with the INTS5/8 
heterodimer (Figure S7c lane 8). The INTS5/8 heterotrimer also showed some interaction with 
INTS2/7 heterodimer (Figure S7c lane 11). Interactions between the INTS3/6-DDX26B 
heterotrimer and INTS5/8 heterodimer supported the heteropentameric subcomplex in section 
4.1.8 and interaction between INTS2/7 heterodimer and INTS5/8 heterodimer informed the 
experiments leading to the discovery of core-INT (Section 4.1.9). Furthermore, the 
subunits/subcomplexes which did not interact in this assay helped design and streamline the co-





Figure S7. Interaction between purified subunits/subcomplexes of INT. LDS-PAGE analyses of input 
samples and elution fractions from pulldown or background binding of untagged subunits/subcomplexes. The 
plus sign (+) indicates that the specific subunit/subcomplex in that row was added in that particular pulldown 
experiment. ‘t’ indicates the 6xHis-MBP affinity tag. (a) Amylose affinity pulldown between affinity tagged 
INTS4/9/11 and INTS5/8 against untagged INTS2/7, INTS5/8 and INTS13/14. (b) Amylose affinity pulldown 
of affinity tagged INTS10 against INTS2/7, INTS5/8, INTS13/14 heterodimers and INTS4/9/11 heterotrimer. 
(c) Formation of hexameric complex of 6xHis-MBP-INTS10, INTS13/14 heterodimer and INTS4/9/11 
heterotrimer. (d) Amylose affinity pulldown between affinity tagged INTS3/6-DDX26B and INTS2/7 against 
untagged INTS5/8 heterodimer, INTS4/9/11 and INTS10/13/14 heterotrimers. 
 
7.2.8 Structural characterization of the cleavage module (INTS4/9/11) 
The cleavage module was one of the first subcomplexes of INT to be successfully purified. 
Crystallization of the subcomplex proved unsuccessful (results not shown). Cryo-EM has been 
successfully used to determine the structure of complexes of equivalent size of 200 kDa (Fan 
et al., 2019; Kumar et al., 2019). Prior to cryo-EM experiments on the cleavage module, 
negative stain EM was used to access the quality of the purified cleavage module (Figure S8a 
to c). The negative stain micrograph revealed uniformly distribute particles of approximately 
10 nm in diameter showing that the cleavage module is not aggregated. 2D class averages were 
calculated in RELION and revealed different views of the particles. An ab initio 3D model was 
generated from a subset of the data in RELION and used for iterative 3D classification and 
refinement resulting in four different 3D classes (Figure S8c). The 3D classes calculated form 
the negative stain data revealed a trilobed structure for the cleavage module.  
The cleavage module was further analysed by cryo-EM (Figure S8d to f). Particles were 
uniformly distributed on cryo grids indicating the sample is applicable for cryo-EM data 
collection (Figure S8d). A cryo-EM data set was collected and processed (see methods). The 
calculated 2D class averages did not show any high-resolution features suggesting the particles 
could not be aligned (Figure S8e). The 3D classes obtained from the 2D class averages had an 
estimated resolution of 20 Å and also lacked high-resolution information (Figure S8f). The low-
resolution structure revealed a trilobed shape for the cleavage module similar to the shape 
obtained from negative stain EM. Also, the overall shape of the cleavage module suggests that 
its lobes are very mobile and have a huge conformational freedom. This may be the reason for 
the misalignment observed in the 2D and 3D class averages. Such conformational flexibility 




Figure S8. Structural characterization of the cleavage module. (a) A representative negative stain 
micrograph of the cleavage module. A scale bar is provided. (b) An image of selected 2D class averages of the 
cleavage module calculated from the negative stain data set. (c) Representative 3D classes of the cleavage 
module obtained from the negative stain data set. The ab initio model is indicated with the red box. (d), (e) and 





Table S1. Mass spectrometric identification of protein in INT -PEC. Band in 
fraction 16 of the sucrose density gradient of INT-PEC was used for the analysis. 
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